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General Introduction
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1.1 Life Sciences
The life sciences encompass a wide range of research fields aiming to understand biological 
systems on all levels. Today, four billion years after life first arose on earth, it has diversified 
into three domains: eukaryotes, prokaryotes, and archaea, each consisting of innumerable 
species. Several million species are currently found in nature and described by scientists and 
a multitude of this number has yet to be categorized [1]. An even larger number of species 
have evolved, thrived and become extinct again in the four billion year history of live on 
earth [2]. Life can be studied in many different ways, and while biology remains at the 
heart of the life sciences, many more specialized fields have sprung up. Life science research 
projects are involved in the study of organisms, understanding of biological processes and 
pathways, interactions within cells, transport of compounds within and between cells, the 
production of useful products, defence versus external threats, reactions to stimuli and stress, 
and many other areas of interest. 
 To be able to study life from all these different angles scientists produce and consume 
large amounts of data. One data driven classification for research fields in the life sciences 
is directly linked to the data aspect of biological systems that is studied. Nomenclature for 
these classifications commonly uses the subject of interest appended with the suffix omics, a 
neologism referring to obtaining a class of bio-data in high throughput. A large number of 
different omics techniques and methodologies have been developed of which a few that we 
encountered while working on this thesis are listed here. 
1) Genomics;
2) Transcriptomics;
3) Proteomics;
4) Secretomics;
5) Interactomics;
6) Variomics;
7) Metabolomics;
8) Fluxomics;
Different aspects of biological systems are thus studied by different high-throughput 
omics techniques. Genomics projects, for example, focus on the genome of an organism. 
Transcriptomics focuses on the subset of those genes that are transcribed under specific 
conditions such as a disease or external stimuli. Proteomics studies the expression of proteins 
and secretomics how a subset of these proteins is secreted which is important for commercial 
protein engineering. Interactomics aims to understand the interactions among the many 
biological components in a system, for instance, the full protein-protein interaction network 
of a cell. Variomics studies the variation in DNA and protein sequences between individuals 
and populations for applications in healthcare. Metabolomics studies metabolites and 
fluxomics their fluxes in, out, and through cells or cell organelles.
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The overall goal of research projects in all these fields is to improve the understanding of 
life in all its varieties. A broader viewpoint encompassing data from multiple fields and in-
depth analyses are often required to study biological components and mechanisms. Small 
perturbations in biological processes may have huge consequences requiring studying the 
entire system instead of just a single component. Systems biology studies how higher-level 
properties emerge from complex networks of interactions among the many individual 
components of biological systems. Systems biology projects include an iterative cycle of 
experimental generation of heterogeneous data sets, the analyses of these data sets, and their 
subsequent integration into mathematical models. Several cycles are usually required to 
generated and fine tune a model for a specific purpose. The work described in this thesis 
mainly focusses on data integration. In addition, several tools are discussed for data analyses 
and in some projects predictions were experimentally verified.
 Systems biology projects require high quality data to accurately predict biological 
phenomena. Nowadays, a substantial part of life science research is data centric requiring 
a wide variety of equipment, methodologies, and tools used to produce those bio-
data. Biological data is thus produced by lots of different researchers, laboratories, and 
organizations, and made available to the research community in lots of different ways. Due 
to the size and complexity of these data sets, structured storage methods are required to allow 
research projects to access and utilize the full potential of these data sets. On-line databases are 
nowadays commonly used to offer public access to data from research projects. For example, 
institutes such as NCBI, EBI, or CMBI offer public access to databases that contain many 
different data types such as protein sequences [3–5], structures [6,7], annotations [3,8] or 
publications [9]. 
 Frequently used data types, such as sequences and structures, have largely been 
internationally standardized. These data types tend to get deposited in publicly accessible 
databases hosted by large universities or governmental organizations that have the required 
financial backing to maintain these repositories for years on end. These data types, for example 
protein sequences or gene expression data, are generally of a low information content, and 
relatively easy to produce with currently available high throughput techniques. Higher quality, 
experimentally derived data sets such as pathway fluxes and ligand binding studies are more 
detailed. These datasets are, however, more difficult and expensive to produce because much 
more human expertise and more expensive equipment is required to generate the data. Public 
databases are often not available for these highly specialized data types due to the smaller 
number of producers and consumers. These data sets are therefore usually offered by the 
producers themselves, despite the costs and burden of maintaining in-house data repositories. 
New developments and improvements in equipment and software tools will lead to easier 
and more cost efficient methods of producing these datasets. Additionally, increased storage 
efficiency and an improved ability to store diverse data types in generic databases will lead to 
easier and cheaper hosting of data sets. Combined, these developments will lead to a continuous 
increase in the amount and quality of data that will become publicly available [10–12].
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The availability of many diverse data sets for scientist is important as novel insights into 
systems of interest can be gained not only by novel research and experiments but also by 
combining and integrating existing data. Even data originally generated for a completely 
different purpose might be relevant and useful for a novel question when properly integrated 
with all other existing knowledge. Research projects thus produce and consume lots of 
different data types that have to be interlinked and integrated into a database to be of any 
use. This thesis describes how molecular class specific information systems (MCSISes) can be 
used to handle a vast amount of highly heterogeneous data and how it can use these different 
data types to answer a wide variety of protein structure and function related molecular 
questions. MCSISes implicitly and explicitly use the 4 billion years of evolution when 
coping with multiple structure and multiple sequence alignments as vehicles to transfer 
information between biological entities.
Heterogeneous data
Organizing multiple biological datasets into a single framework for use in research projects 
is often complicated by the large heterogeneity of those datasets. The combination of 
heterogeneous datasets, however, can be extremely beneficial for research projects. The 
following four examples demonstrate the usage of systems that integrate highly heterogeneous 
datasets and the application of these systems in biomolecular research projects. The first 
example comes from a project at the University of Nijmegen using an MCSIS, the subsequent 
three are from our own work with the 3DM platform, which is based on MCSIS technology.
1) Drug design projects focus on the discovery and development of medicines. Common 
targets for drug design studies are Nuclear Receptors, a class of transcription factors regulated 
by hormones or metabolites. Approximately 13% of all FDA drugs approved up to 2006 
target a member of the Nuclear Receptor family, making it the second most often targeted 
family after the G protein-coupled receptors [13]. Nuclear receptors are composed of two 
main domains, a DNA binding domain (DBD) and a ligand binding domain (LBD), and 
a series of smaller domains of unknown structure and function. The DBD binds specific 
hormone response elements (HRE) on the genome which can be found in the promoter 
regions of genes. The promoter region of a gene can contain multiple HREs and an HRE 
can be present in the promoter of multiple genes. A single receptor can therefore regulate 
the transcription of a large number of genes and have a significant effect on the organism. 
Nuclear Receptors themselves are regulated by ligand binding to the LBD which activates 
or deactivates the receptor complex. The LBD region consists of an alpha helical sandwich 
containing binding sites for the ligand, co-activator, and co-repression molecules [14]. The 
human genome encodes 48 different nuclear receptors. Most of these receptors are associated 
with specific activator and inhibitor ligands. Other receptors are not strongly associated with 
a particular ligand but may instead be activated by metabolic intermediates such as fatty 
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acids, thereby acting as metabolic sensors. For several so-called orphan receptors however, 
specific ligands have not yet been found [15]. Nuclear Receptors can be activated or inhibited 
by conformational changes in the LBD which either blocks or opens up the ligand and 
co-activator binding sites. Hormone receptor activators and inhibitors are highly interesting 
for pharmaceutical companies either as medicine or to influence hormone related processes 
such as fertility, birth control, or certain types of cancers. Developing a new activator or 
inhibitor for a Nuclear Receptor is however a very time consuming and labour intensive 
process. The common procedure for drug target discovery is to create a large library of 
potential ligands. New leads coming from this library are then tested, modified, and 
improved using directed evolution until suitable candidates are found. These candidates are 
then tested first on animals, and when successful applied in small scale medical trials. The 
entire process of developing a new compound takes years and costs billions of dollars without 
the guarantee of a successful outcome. To better understand the underlying mechanisms of 
nuclear receptors and to aid in drug target development the NuclearDB molecular class 
specific information system (MCSIS) was developed [16]. The NuclearDB focuses on nuclear 
receptors from human and many other species and integrates data from different fields into 
a single database. Using large sequence alignments from the NuclearDB, Folkertsma et al. 
[17,18] discovered a residue position that is involved in inhibitor binding but not activator 
binding. This knowledge is crucial for a better understanding of the binding mechanisms, 
functional properties, and conformational changes of Nuclear Receptors, and can be directly 
applied to develop new activators and inhibitors. 
2) Enzymes are capable of converting a wide range of substrates through a large number 
of different reactions. Some enzymes have specialized in the rapid conversion of a specific 
substrate whereas other enzymes are capable of converting a wide range of related substrates 
often at slower conversion rates. Substrate specificity and optimization of substrate 
conversion by enzymes is required for the improvement of existing or development of novel 
biotech processes such as for the production of chemicals. Bio-based methods, for example 
for the production of plastics or bio-fuels, are a fast growing market. Novel methods to 
replace existing chemical processes are also of interest as the chemical methods often produce 
pollution and require significant energy inputs.
 In this example MCSIS technology is used to pin-point a key residue for substrate 
specificity in oxaloacetate hydrolase. Oxaloacetate hydrolase (OAH) is an enzyme that 
hydrolyses oxaloacetate, a product of the TCA cycle, into oxalic acid. Oxalate, the dianion 
of oxaloacetate, is a toxic compound often produced by fungi for self-defence purposes. The 
presence of the OAH gene can therefore be used as an indication of oxalate production and 
thus toxicity. Aspergillus niger, a fungi used for the production of food additives such as 
citric acid, contains the OAH gene and four additional homologous loci that may or may 
not be OAHs. It is important to determine whether A. niger, or any other commercially used 
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fungus, has the capability to produce the toxic oxalate compound and if so which gene(s) are 
responsible. 
 A 3D Molecular Class Specific Information System (3DM) for the 
Phosphoenolpyruvate mutase/Isocitrate lyase superfamily was built to store and connect 
available heterogeneous data sets. Study of correlated mutations between alignment positions 
in the superfamily revealed a network of nine residues [19]. For most of these positions the 
function was unclear, but several are located around the active site of the enzyme. Combined 
analysis of the correlated mutations network with protein annotations pointed out a serine 
that is completely conserved in a subset of proteins known to provide OAH functionality. 
Mutation studies were performed to study the role of this serine in potential OAH producing 
enzymes. Serine residues were mutated to other amino acids in proteins with known OAH 
activity and inserted into proteins without OAH activity. The results of these studies show 
that the serine is indeed required for the conversion of oxaloacetate through binding of the 
OH side group in the active side. The results also show that these mutations have hardly 
any effect on the affinity of OAH for any of its other substrates. Replacing the serine in the 
active site changes the conformation of the active site and reduces the binding potential 
of the conversion intermediate. The mutations therefore affected substrate affinity for one 
substrate only, and left the enzyme activity unchanged. Using correlated mutations and 
protein annotations stored in a superfamily knowledge base thus lead to the discovery of a 
key residue in the conversion of oxalocacetate. 
A parallel study targeted L-galactono-γ-lactone dehydrogenase (GALDH) an 
enzyme part of the vanillyl-alcohol oxidase superfamily that consists of both dehydrogenases 
and oxidases. A strong correlation was found between an alignment position and the oxidase/
dehydrogenase classification. Most oxidases have either a proline or a glycine residue on the 
position while dehydrogenases favored other residues. Mutating the alanine on the position 
to a glycine in GALDH led to a 400 fold increase in oxygen reactivity. Detailed study of the 
structure of the dehydrogenase indicated the targetted position acted as a gatekeeper, with 
larger residue preventing oxygen from reaching the active side. Mutating the residue did 
not change the active side and therefore did not affect the natural reduction potential of the 
GALDH enzyme [20].
3) Enzyme reaction mechanisms can be governed by several external factors. For example, 
the availability of co-factor and substrate, regulation of genes, and energy and carbon 
balances are all factors that influence the substrate conversion rate of an enzyme. To replace 
chemical processes by biological processes, for example for the production of high value 
chemicals, novel systems must either be cheaper, more environmentally friendly, or faster 
than existing methods. Improvement of enzyme activity is therefore another major focal 
point of enzyme engineering studies. The previous example showed the application of 
heterogeneous datasets to alter the substrate specificity of an enzyme, without changing 
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the activity. Using another superfamily the opposite was also shown to be possible: increase 
activity without changing the substrate affinity [19]. The RmlC like cupin superfamily 
consists of over 2,000 proteins which share a common ß-barrel fold. Cupin family members 
are functionally very diverse, though most members are enzymes with active site residues 
located each time at corresponding positions in the ß-barrel [21]. Correlated mutation 
analysis revealed a co-evolution network of positions mostly surrounding the active site. The 
pair of strongest correlating positions, interestingly, was not found near the active site but in 
a structurally conserved loop on the protein’s surface. Little was known about the function of 
the residues in this network, and available literature for the superfamily listed relatively few 
single mutants at these positions. The available mutations in the two correlating positions 
in the surface loop almost universally lead to a decrease in activity, suggesting both positions 
are involved in substrate conversion. The combined amino acid occurrence data of both 
positions in a superfamily alignment of several thousand proteins revealed that five residue 
combinations were highly overrepresented (fig. 1.1). These five residue combinations, out of 
the possible 400, are present in more than 5% of the sequences, and these five combinations 
account for 65% of all sequences in the superfamily. The phosphoglucose isomerase (PGI) 
enzyme from Pyrococcus furiosus (PfPGI) was selected for mutational screening as it is 
one of the best characterized members of the superfamily. PfPGI has the combination PY 
as wild type in the conserved surface loop which occurs in only 0.78% of all superfamily 
members. Several single and double mutants were made at these positions and the enzyme 
activities of all mutants were determined. The single mutants both had reduced enzyme 
Figure 1.1: Partial residue occurrence data for two alignment positions. The 20 common amino acids are 
shown on both axes, and the occurrence of the corresponding amino acid pair is shown in the table itself. Abundant 
combinations are highlighted in bold. For example, 25,95% of all sequences in this alignment contain a GD motif 
on the two positions. The 0.42% of sequences containing no residues on both positions is a combination of 
alignment errors and truncated fragments.
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activity (P27A resulting in AY that is not observed in superfamily members, and Y28G 
resulting in PG that is observed in 3.36% of superfamily members). Of the three double 
mutants, two were able to compensate for the loss of activity of the single-mutants. The 
third double mutant (P27A/Y28G leading to AG that is observed in 11.23% of superfamily 
members) not only compensated for the loss of activity caused by the single mutants, but 
increased activity to twice that of the wild-type enzyme. In summary, a large, high-quality 
protein alignment combined with correlated mutation data was instrumental in this project. 
Automatic scanning of available superfamily literature provided information regarding the 
possible roles of the positions of interest in the PfPGI enzyme. Protein activity could be 
improved without affecting substrate affinity because the surface-loop is far away from the 
active site residues in the folded structure. The next step is now, of course, to understand 
why this remote loop is so important for activity.
4) Detection of pathogenic non-synonymous mutations in disease related genes is a 
major focus of DNA diagnostics. In this example an MCSIS was used for a case study 
on pathogenicity prediction. Fabry’s disease is a monogenetic disorder linked to the alpha-
galactosidase (GLA) gene that was the selected target. Deficiencies in GLA lead to the 
accumulation of globotriaosylceramide in cells throughout the body. This accumulation 
leads to impairment of cell function in tissue throughout the body resulting in a highly 
diverse spectrum of symptoms. Correctly diagnosing patients for Fabry’s disease without 
DNA diagnostics is therefore difficult [22]. Since Fabry’s disease is monogenentic by nature, 
mutations in the GLA gene can potentially be used in clinical diagnosis. A mutation in the 
GLA gene is a difference between the GLA gene of a suspect individual with respect to the 
reference sequence. With on average a difference of 1 in every 1,200 nucleotides between 
two human individuals, distinguishing between natural variation and pathogenic mutations 
is a complex task as many differences between sequence data from patients and reference 
genomes are simple cases of natural variance. 
 Mutations are often classified into three groups based on phenotype: benign, 
malignant, and undetermined. Logically, malignant mutations are the focus of many research 
groups in hospitals around the world [23]. Statistically relevant and otherwise characterised 
malignant mutations found with DNA diagnostics based patient studies are often published 
in literature. Benign mutations can be retrieved from single nucleotide polymorphism 
(SNP) databases such as dbSNP [24]. The so called ‘undetermined variants’ however, pose 
a problem due to normal genetic variation between individuals. A method was developed 
to predict the pathogenicity of these variants using a wide variety of data types such as: the 
function of the mutated amino acid, endogenous function of the gene or protein, location 
in the protein structure, solvent accessibility, ligand contacts, existing mutational data, etc. 
[25]. To store the large amount of data required for these analyses a 3DM system was used 
for easy interlinking of data and rapid availability. Classifying variants for use in diagnosis 
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requires a high level of certainty because the results of a misdiagnosis range from a costly 
but ineffectual treatment to patient death. Variant classification should therefore rely on as 
many, high-quality data as possible. 
 
Feature Value Pathogenicity Weight
Occurrence of A at position 89 0.81% 95.94% 100.00
Conservation of most conserved residue 43.96% 43.96% 30.00
Sidechain accessibility 0.4% 93.57% 40.00
Bumps 0 0.00% 25.00
Hydrophobicity Switch no NA NA
Buried hydrophilic position no NA NA
Fabry disease mutation(s) 20 95.00% 100.00
Pathogenic mutations(s) from other human genes 7 70.00% 70.00
Identity of nearest sequence containing the mutant as wildtype 0.13 80.00% 50.00
Grantham distance 96 50.00% 10.00
Blosum62 score -1 20.00% 10.00
An alpha amylase protein superfamily, containing GLA, was used for variant classification. 
The superfamily contains almost 5.000 proteins and 3.700 known mutations from literature 
obtained using the Mutator tool (described in chapter 1.4). Additionally, thousands of 
annotations such as signal peptides, sequence conflicts, and active sites were retrieved from 
GenBank and Uni-Prot. Contact, RMSD, and solvent accessibility of alignment positions 
were determined using crystal structures. All available data are combined and weighed to 
calculate a pathogenicity factor to indicate the likelihood of the mutation being pathogenic 
(table 1.1). Validator includes a classifier to cluster known mutations and predict the 
pathogenicity of these mutations based on all these data. This knowledge can be used to 
determine whether observed mutants and phenotypes are indeed linked. Comparison with 
existing mutation databases, such as the HGMD, showed Mutator was able to collect more 
mutations from literature. Several mutations classically associated with Fabry’s disease were 
evaluated using models of GLA in combination with the available data types. Evidence for 
pathogenicity could be found for most variants such as high conservation of the wildtype 
Table 1.1: Statistical analysis of a mutation suspected to cause Fabry’s disease mutation. Table shows the 
analysis for mutation p.L89A in GLA. Analysis based on the alpha-amylase superfamily that contains 4.704 
sequences. Each part of the analysis is shown as a single line. For example, the first line shows that only 0.81% 
of the superfamily sequences contain an alanine at position 89. The pathogenicity and weight of the analysis are 
based on this value, and used for the overall pathogenicity prediction. Overall pathogenicity for this mutant was 
predicted as 77.6% likely pathogenic.
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residue in the superfamily or steric clashes due to sidechain orientation. Validator is however, 
not the final solution for patient diagnosis as the function and regulation of a gene can be 
influenced by many different factors and even subtle influences can have large repercussions. 
Validator was shown to give a clear overview of the effects of mutations in the gene; 
knowledge that can be used in clinical diagnosis.
Interoperability of Heterogeneous Data Types 
The examples in the previous section illustrate the importance of collecting and linking 
heterogeneous data types, and show the difficulties encountered while doing so. To be 
of maximum use in research projects, data needs to be integrated into a framework of 
knowledge, be directly available, easy to use, and extendible with new knowledge. The 
research projects described in the examples use knowledge bases containing heterogeneous 
datasets interlinked with structure-based multiple sequence alignments. Heterogeneous 
data types can be linked when an inherent relation between the different types exists. For 
several life science data types such shared characteristics are present. For example, the link 
between sequence and structure data for a protein is straight forward. The nucleotides on 
the chromosome code for amino acids, which fold into the three-dimensional structure of 
the protein. Other data types such as pH resistance, viral immunity, or gene synteny are 
much harder to link as these data types do not describe similar or directly related biological 
entities. Life-science data is data of biological systems and should therefore preferably be 
integrated on the basis of a biological relationship. Sequence and structure alignments are 
therefore a suitable kernel to link many different data types, such as protein structures and 
residue annotations. Data can also be linked to other data using descriptions of the data 
and the relations between the data types. New metadata data models such as RDF [26] 
are currently implemented to describe a data type and the type of relation between one 
data type and another. These techniques are very flexible and applicable to almost all types 
of data. Biological knowledge can be incorporated into such a descriptive scheme using 
ontologies [27]. Many biological ontologies exist, each specializing in a different area such 
as transcriptomics or patient and disease related data. RDF based techniques are very flexible 
and can be used to link almost any data. Unfortunately datasets annotated using different 
ontologies are seldom interoperable resulting in many highly specialized applications that 
cannot be used for wider research. 
 A large number of bioinformatics tools are available to support researchers in life 
science projects. These tools attempt to offer an integrate environment for the storage, 
linking, and retrieval of heterogeneous data sets based on alignments, RDF annotations, 
or other techniques and frameworks. Several prominent types of bioinformatics tools are 
described in more detail in the next section. As the number of available tools is huge and 
specialized reviews are available aimed at parts of the bioinformatics eco-system [28–30] a 
complete overview is omitted.
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Data Integration Tools
Access to many databases and tools is nowadays provided by webservices [31,32]. 
Webservices allow data to be retrieved from external sources, and tools to be run offsite 
using standardized protocols. This greatly simplifies the analysis process as the tools and 
databases used do not have to be installed locally. Furthermore, the standardized data format 
and communication protocols ensure tools written in different programming languages or 
on different operating systems can communicate with each other seamlessly. Many different 
webservices are available for example to retrieve sequences, predict phosphorylation sites, 
construct multiple sequence alignments, determine transcription factor binding sites etc. 
[33,34]. Several tools are available to combine these webservices into workflows to automate 
common procedures. Applications such as Taverna [35] and web-based platforms such 
as Mobyle [36] and REMORA [37] are examples of tools that offer the integration of 
webservices into workflows. 
 Reproducible Research Systems (RRS) is a relatively recent term used to describe 
systems that focus on the reproducibility of results by storing and publishing workflows 
of data analyses [38]. An RRS offers a persistent workspace were data can be stored and 
analysed using different tools. Workflows consisting of a combination of tools, data analyses, 
and parameter settings can be created and applied to different data sets. Workflows can be 
annotated and described extensively and offered publically to be used as supplementary 
materials in articles. RRS thereby tries to make it easier for third parties to perform the 
experiments themselves. RRS systems can use either webservices or tool-specific components 
for the actual analyses. Examples of RRS platforms are Galaxy [39] and GenePattern [40]. 
 Model-driven development uses application models to generate software tools 
for custom purposes. These custom applications are built from stock components for data 
analysis, data import and export, and graphical reporting. A database is generated based 
on the datatypes described in the model, and a frontend is generated to enter, process, and 
visualize the data. Custom functionality can generally be included using external plugins 
or added using custom code in the model. Examples of these tools are MOLGENIS [41] 
and MEMOPS [42]. These tools are aimed at bioinformaticians rather than life science 
researchers as they require in-depth knowledge of techniques such as databases, XML, 
application models, and programming languages. The assembled applications however, can 
be hosted as web-application for general use. 
 The NuclearDB, described in the first example on heterogeneous data sets, is 
an example of a Molecular Class Specific Information System (MCSIS). MCSISes are 
knowledge bases that can be used to integrate and store heterogeneous data sets for a protein 
superfamily. MCSISes use structure-based multiple sequence alignments to interconnect 
different data sets. Reporting tools, data analyses, and data export options are all integrated 
in these systems. Links too many external databases are stored to facilitate data exchange. 
MCSIS systems are available for several protein families such as the Nuclear Receptors and G 
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Protein-Coupled Receptors. These systems were used to validate the scientific and technical 
concepts underlying MCSIS databases [16-18,43-47].
 Many other tools exist to support life science research. Some offer combinations of 
the described techniques while others use completely different working models. geWorkbench 
[48], for example, integrates different functionalities into a workflow for later processing. 
However, only geWorkbench modules can be used for analyses of data, and those modules 
are executed on a grid. This allows for computationally intensive workloads to be designed by 
researchers for subsequent execution on one of the supported life science grids. Many other 
combinations of tools, analyses, and workflows are however, also possible and thousands of 
applications, tools, and services are available to support researchers in their work. 
 Each type of tool was designed for a particular aim, use-case, and target audience, 
and has associated advantages, and drawbacks. Webservice based tools are aimed at 
researchers with some background in bioinformatics. Creating workflows in these programs 
is not unlike programming and some expertise in data handling is therefore required. The 
black-box model of webservices where tools and databases are not available locally however 
results in several drawbacks. The inner workings of webservices, in- and output formats, and 
functional parameters are often sparsely documented if any documentation is available at 
all. Additionally, though the communication protocols used between service and client are 
standardized, the data formats are not. Converters are therefore often required before data 
from one service can be passed to another. The reliability, availability, and performance of 
webservices also vary as the services are offered by third-parties. Webservices for instance 
may stop working or disappear completely without prior notice.
 RRS systems and MCSIS databases are aimed at researchers and therefore designed 
to be intuitive and user-friendly. Installation and maintenance by experienced users however 
remains required to keep the data up-to-date. RRS systems additionally often only offer 
tools installed locally for analysis and data manipulation. These systems are designed to be 
reproducible and are therefore often hesitant to depend on external factors. Users of RRS 
systems are therefore unable to take advantage of the wide range of functionality available 
through webservices as the continued availability of webservice cannot be guaranteed. RRS 
systems therefore run the risk of being used only halfway into a research projects after 
researchers have manually obtained and prepared there data. This workflow severely reduces 
the reproducibility of experiments. Model-driven development tools are aimed squarely at 
bioinformaticians. A lot of in-depth knowledge of software installations and data types is 
required to create the initial model and generate the application. Even with the large number 
of available tools, researchers with an informatics background often create programs of their 
own or mix and match different applications to facilitate research projects. These tools use 
many different techniques to achieve a wide variety of goals. However, these applications 
and workflows are often designed to solve one particular problem, and are therefore highly 
specialized for the research field and project they originate from. 
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This thesis focusses on the development and extension of the 3DM platform. The aim was 
the creation of an easy to use web-based application that offered the integration of many 
different datasets and could be applied to any protein superfamily. Tools that combine 
generic data handling and specific biological knowledge, such as MCSISes, are applicable 
to many different projects and therefore highly useful to assist researchers in many different 
fields. 3DM was based on the MCSIS technology developed at the Centre for Molecular and 
Biomolecular Informatics, Radboud University Nijmegen, Medical Centre. MCSISes can 
be used for vastly diverse projects by using a combination of structure and sequence based 
alignments to link available data sets. Import and export options of data allow MCSISes to 
be used in research projects in conjunction with webservices and other technologies. My 
work has focused on the development of the knowledge base system itself, the underlying 
database, and several tools incorporated into the 3DM platform. I have been personally 
involved as main programmer and system designer in the 3DM projects used as examples 
above.
Evolutionary Considerations
3DM and MCSIS databases are centred on protein super families, and use structure-based 
multiple sequence alignments to interconnect datasets. Sequence alignments are used as base 
or kernel to connect the various data types as they reflect the outcome of millions of years 
of evolution. Evolution, having been defined as ‘descent with modification’, nevertheless 
manifests itself in conservation on several levels. Protein regulation and function in biological 
systems are most conserved as significant changes in either property often lead to reduced 
fitness of the organism. Protein structure and sequence are much less conserved as the 
structure or sequence is irrelevant as long as the regulation and function of the protein are 
conserved. However, the preservation of regulation and function often leads to conservation 
of structure and to a lesser extent sequence. Proteins can be clustered into superfamilies using 
these conservation characteristics. These superfamilies consist of large groups of evolutionary 
related homologs from many different organisms all with similar roles and functions [49].
 Proteins are the active components in many biological systems and they provide 
valuable functionalities such as gene translation, substrate conversion, viral immunity 
systems, energy production, and many more. The function of a protein is determined 
by a combination of structure, sequence, and dynamics. Protein structure and sequence 
are subject to evolution, and so are thus the dynamics and ultimately the function. 
Chromosomal mutations and rearrangements continuously adapt the genomic sequence, 
which results in changes to the sequence, structure, and function of proteins. The function 
of proteins however, is preserved through evolutionary pressure, as defunct proteins often 
lead to competitive survival problems for the whole organism. Similar functionality can, 
however, be provided by different genes as a result of gene duplications, horizontal gene 
transfer, or unbalanced chromosomal translocations. These duplicated genes are much less 
restricted by evolutionary pressure as only one of the homologs is required for the primary 
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function. After gene duplication events some homologs are therefore free to diverge in 
sequence, structure, and function. Due to their common evolutionary origin these proteins 
initially remain structurally related until consecutive mutations leads to divergence beyond 
recognition. Genes that have been duplicated before branch points in the phylogenetic tree 
of life have ended up in multiple organisms through speciation. Superfamilies, therefore can 
contain multiple genes from multiple organisms coding for related but separable functions. 
Superfamilies thus reflect the structural, functional and evolutionary relationships between 
proteins.
Homologous Residues
During evolution proteins are conserved primarily on function, and less on structure and 
sequence. Conserved regions in the structure or sequence of a protein are therefore often also 
functionally conserved [47]. Residues at conserved positions have evolved from an ancestral 
residue at the same position, similarly to how genes in related organisms have evolved from a 
single gene in the common ancestor. These homologous residues are therefore often involved 
in similar functions (fig. 1.2). Consequently, information can be carried over between 
homologous residues; any functional annotation found for a residue in one protein is likely 
also applicable for the corresponding residue in a homologous protein. Determining which 
residues are homologs within a superfamily is therefore an important step in the conversion 
from data to knowledge. Types of annotations that have been shown to be transferable 
between homologous residues include ligand contacts, active site annotations, salt bridges, a 
role in mobility, phosphorylation, etc. Data can however only reliably be transferred between 
truly homologous residue positions. Alignment quality thus is more important than the size 
of the alignment. 
1.2 Alignments
Sequence Alignments
Sequence alignments, normally, are performed by programs such as ClustalW [50] and 
MUSCLE [51] that compare sequences one amino acid pair at a time. A Dayhoff style 
substitution matrix (fig. 1.3) is used to assign a score to each amino acid pair. To construct 
a matrix an overview of allowed mutations within a range of sequences must be obtained 
and evaluated. Originally, matrices were derived from large manually obtained sequence 
alignments for groups of highly similar sequences. The prototype amino acid substitution 
matrix is the PAM matrix calculated by Dayhoff in 1978 using alignments of proteins 
that share 85% identity. PAM matrices are however relatively unsuitable for aligning 
evolutionary more distantly related proteins due to the short evolutionary distance covered 
by the alignment used to calculate the matrix. Therefore, more sophisticated substitution 
design strategies were devised and used to create newer matrices. Henikoff & Henikoff [52], 
for example, used alignments of protein blocks to generate the BLOSUM matrices. 
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Figure 1.2: Superposition of 29 structures from the alpha-amylase superfamily with three homologous 
positions highlighted. The structures are shown in tube style with structurally conserved regions shown in green 
and variable regions in grey. The scene contains one conserved position (yellow) and two correlated positions 
(magenta). The conserved position is a histidine in 96.1% of the 4,900 aligned sequences. The two correlated 
positions are the strongest correlating pair found in the correlation network of this superfamily. Three amino acid 
combinations, WF, EW and QT, account for 60% of the sequences. 
Figure 1.3: The PAM 250 matrix by Dayhoff.
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In principle, substitution matrices contain for each of the 20 proteogenic natural amino 
acids the odds of either a mutation to any of the other 19 amino acids, or that the residue 
remains conserved. Substitutions that result in small changes in amino acid size, charge, 
and/or hydrophobicity are more likely to be accepted than more invasive changes and this is 
reflected in the substitution matrices. In the Dayhoff matrix shown in figure 1.3 for example, 
tryptophan has non-negative substitution scores only for tyrosine and phenylalanine which 
are large aromatic amino acids like tryptophan. Similarly, the highest scoring substitution 
for lysine is arginine which preserves the positive charge of the side chain. The odds of 
residue conservation are also incorporated into the matrices by observing the number of 
synonymous versus non-synonymous mutations. Amino acids that are often involved in 
structural or functional properties, such as cysteine and tryptophan, therefore score higher 
for synonymous mutations than residues such as serine and alanine.
 Substitution matrices are used to generate an optimal pairwise alignment between 
two sequences. Alignments can be either global or local depending on the alignment 
algorithm. Local alignment methods such as BLAST search for regions of similarity between 
two sequences, global alignments attempt to align the two sequences completely. Local 
alignments are therefore better suited for more distantly related sequences that share regions 
of sequence similarity while global alignments are more suited for closely related sequences. 
To create a local alignment of two sequence regions the two sequences are placed on the x 
and y axis and for each position the substitution score for the two amino acids is entered 
into the matrix. The most optimal alignment is determined by walking through the matrix 
along the path that gives the best score (fig. 1.4). Optimal global alignments often contain 
gaps to properly align two sequences. The example alignment matrix in figure 1.4 has two 
solutions depending on whether gaps are allowed or not. If gaps are allowed, and the gap 
open penalty does not exceed -1, the highlighted path is the highest scoring solution. If gaps 
are not allowed, or the gap open penalty exceeds -1, a direct path aligning K-C and E-N 
Figure 1.4: Dayhoff derived alignment matrix 
for the alignment of two amino acid sequences. 
Residues of sequence one are shown in the left 
column and residues of sequence 2 in top row. The 
best alignment is determined by the highest scoring 
path starting from top left to bottom right.
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omits gaps and scores higher. Gap open, and gap elongation penalties can thus be used to 
force the algorithm to favour single larger gaps, multiple smaller gaps, or no gaps at all.
 Several matrices exist to determine the alignment between related sequences such 
as BLOSUM [52], PAM [53], and BATMAS [54]. Most of these matrices are available 
in multiple versions depending on the evolutionary divergence of the sequences used to 
construct the matrix. For example, the BLOSUM62 matrix was derived using an alignment 
of sequences at least 62% identical to each other, and the BLOSUM80 matrix derived from 
sequences at least 80% identical. The BLOSUM62 matrix is therefore better suited for the 
alignment of sequences that have diverged more in comparison to the BLOSUM80 matrix as 
BLOSUM62 includes substitution from nature on larger evolutionary distances. However, 
for alignments of closer evolutionary divergence a BLOSUM80 matrix is better suited as the 
BLOSUM62 matrix will allow substitutions that are unlikely to occur at close evolutionary 
distances. The final goal of sequence alignment procedures is a so-called Multiple Sequence 
Alignment (MSA). An example is shown in figure 1.5 where 31 nuclear hormone receptors 
are aligned by both ClustalW and 3DM.
 Using matrices has several disadvantages. Main drawback is that most matrices are 
themselves based on alignments of sequences or sequence blocks, and thus the choices made 
when constructing those alignments have a direct impact on the quality of the matrix. Any 
bias or error in the original alignment will directly translate into a biased matrix which in 
turn leads to biased alignments. Many authors have suggested improved methods for the 
design of substitution matrices. Jones et al. [55] start with an alignment of sequences that 
are clustered at the 85% sequence identity level. From this alignment a Dayhoff-style matrix 
is generated by multiplying the matrix by itself that then can be used for the alignment 
of family members with a lower sequence identity. Ng and Henikoff made more generic 
family specific substitution matrices like, for example, a matrix for membrane proteins [56]. 
Overington et al. [57] designed matrices for buried and accessible residues, for helical and 
strand residues etc. These matrices can be used when at least one structure is available from 
which the characteristics of each position can be determined. This method was generalised 
for fold recognition (threading) by Bowie et al [58].
 Hogeweg and Hesper [59] further generalised the alignment technology by 
introducing profile based sequence alignments. Profiles are based on multiple (aligned) input 
sequences and each column in a profile reflects the allowed amino acid variability at the 
corresponding position in the alignment. In a sense, a profile can be seen as one matrix for 
each position in the alignment. In case of threading these matrices are determined from the 
characteristics of the protein structure, but in iterative profile based alignment procedures 
such as described by Jones et al, and as implemented in WHAT IF [60], the profiles are 
build-up from the growing alignment itself (see chapter 2.4). 
 In 3DM, we use a hybrid method based on structure superpositions and iterative 
profile alignments that are explained in the remainder of this chapter. The next section 
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discusses structure superposition/comparison methods, and this is followed by the heart of 
3DM, the structure-based sequence alignments.
Structure Superposition
Structures remain conserved over a longer evolutionary time than protein sequences. 
Consequently, for two or more distant homologous proteins it should be easier to correctly 
superpose the structures than to correctly align the sequences. This was already recognized in 
the famous article by Chothia and Lesk [61] on the relation between sequence and structure 
similarity. Sander and Schneider [62] quantified this relation in their seminal article in 
which also the HSSP database technology is introduced and iterative profile alignments are 
applied. Vriend and Sander [63]showed in 1991 that it is possible to automatically superpose 
protein structures, thereby opening up a whole field of research that in this thesis culminates 
in the 3DM platform. Structure superposition however is a CPU intensive problem that can 
be solved in a myriad of different ways. Hundreds of methods and algorithms are therefore 
available today to create structure alignments. 
 Superposing two structures can be defined as finding the best fit between the 
backbones of both structures. Changing the superposition to improve the match in one 
region of the superposition however often leads to a reduced fit in another region resulting 
in an overall non-optimal solution. To superpose two highly similar structures a least-squares 
fitting algorithm is traditionally used. These algorithms determine the optimal rotations 
and translations by minimizing the sum of the squared distances among all structures in 
the superposition [64]. More recently a wide range of different methods has been applied 
to superpose both highly similar and highly diverse structures. Rather than describing all 
programs and methods individually, this section will start with a description of the WHAT 
IF algorithm used by 3DM. Several other programs are subsequently discussed to illustrate 
some of the different methods available to superpose structures. A complete overview of the 
field is difficult to obtain, however a series of reviews and papers together with the Wikipedia 
entry on structural alignment can be used as a starting point [64-67].
 WHAT IF [63] uses a three-step process to create a pair-wise superposition. During 
the first step superposable fragments from two structures are determined by comparing all 
fragments of 10 to 15 residues in length using a distance metric. A list of superposable 
fragments is generated containing all pairs of fragments for which the C-alpha atoms are 
within a specified distance cutoff. Each fragment pair is then superposed using a least-squares 
algorithm. The superposition of each fragment is evaluated using the root mean square 
distance and maximum distance between C-alpha atoms. If these distances do not exceed 
cutoffs of 2.0Å and 3.8Å respectively the fragment pair is considered to be superposable. 
Superposed fragments are subsequently elongated by adding one residue to the C-terminal 
end of both fragments after which the two fragments are again superposed. The elongation 
process continues until the addition of new residues to the fragments results in RMSD 
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Figure 1.5: Partial alignment of 31 Nuclear Receptors by 3DM (top) and ClustalW (bottom). The 3DM 
alignment shows the alignment positions at the top, amino acid colouring based on chemical properties. Each 
line contains the sequence of one protein. Several positions show different characteristics: complete conservation 
on positions 29 and 30, charged residues on position 17, hydrophilic positions such as 15 and 16, and positions 
with a seemingly random distribution such as 3 and 26. Structurally variable regions as identified by 3DM have 
been removed from both alignments.
PGFKNLPLEDQITLIQYSWMCLLSFALSWRS----Q--FLYFA-----------ELCQGMHQ
PGFRNLHLDDQMTLIQYSWMSLMAFSLGWRS----Q--MLYFA-----------DLCQGMRQ
MVFKELEVADQMTLLQNCWSELLVLDHIYRQ----DSILLV-------------SLVLRAQE
VFFKDLKVDDQMKLLQHSWSDMLVLDHLHHR-GLPDET---------LGVPQLGD-------
PHFTSLPLTDQVQLLRAGWNELLIAAFSHRS--DA----IVLA----------NIYDRVLS-
PHFSQLEMEDQILLIKGSWNELLLFAIAWRS------QLMCLM----------QIFDRVLS-
PGFRNLHIDDQITLIQYSWMSLMVFGLGWRS----Q--MLYFA-----------SLCLTMWQ
PHFSELPLDDQVILLRAGWNELLIASFSHRS--DG----ILLA----------AIFDRVLT-
PGFVELSLFDQVRLLESCWMEVLMMGLMWRS--G----KLIFA-----------EIFDMLLA
PGFSTLSLADQMSLLQSAWMEILILGVVYRS--D----ELVYA-----------DLNNAILQ
PGFRNLHLDDQMTLLQYSWMSLMAFALGWRS----N--LLCFA-----------DQCKHMLY
PAFCELPLDDQVALLRAHAGEHLLLGATKRS--DV----LLLG----------RVSIRILD-
PGFVDLTLHDQVHLLECAWLEILMIGLVWRS--G----KLLFA-----------EIFDMLLA
PGFRNLHVDDQMAVIQYSWMGLMVFAMGWRS----R--MLYFA-----------SQCVRMRH
PGFSSLSLSDQMSVLQSVWMEVLVLGVAQRS--D----ELAFA-----------ELGAALLQ
PGFADLPKADQDLLFESAFLELFVLRLAYRS--GK---LIFC------------EWIDSIVE
IFFRELKVDDQMKLLQNCWSELLILDHIYRQ----GTIFLV-------------NLLSLAQE
PMFCELPCEDQIILLKGCCMEIMSLRAAVRY--ET----LTLN-----------VVSDAIFD
PGFTTLTIADQITLLKAACLDILILRICTRY--DT----MTFS-----------PLTDLVFA
PSFSSLFLNDQVTLLKYGVHEAIFAMLASIVDGLL---VA--------------DIIEPKFE
PHFAQVPLDDQVILLKAAWIELLIANVAWCS----QQ--LFLN-----------AIFDRILS
PGFRDLTSEDQIVLLKSSAIEVIMLRSNESF--MS---WTCG------------ELIEPLIK
SYFRDLPIEDQISLLKGAAFELCQLRFNTVF--GT---WECG------------LLLEPMLK
PGFANLDLNDQVTLLKYGVYEAIFAMLSSVMDGML---VA--------------DIMEPKFD
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or maximum C-alpha distances exceeding the thresholds. Fragments that contain residues 
already included in other superposed fragment pairs are ignored to prevent overlapping 
fragments. Additionally, fragments with less than four non-helical residues are ignored as 
helices tend to always be superposable. The second step of the superposition process consists 
of a clustering of superposed fragments to determine if the fragments are part of a larger 
common structure. The distances between the centers of mass and rotation matrix of the 
fragments are compared to exclude fragments that cannot be clustered together. The final 
step of the procedure is a fine-tuning and pruning of the clusters. This step is required as 
several shortcuts and optimizations are used to speed up the superposition resulting in a 
lower overall accuracy. The largest cluster of superposed fragments is again superposed to 
minimize the distance between equivalent C-alpha atoms. The list of equivalent residues 
is then re-examined to ensure all equivalent C-alpha atoms are within the maximum 
distance of each other and are part of a stretch of equivalent residues. To create a superfamily 
superpositioning 3DM uses WHAT IF to create pair-wise alignments of all superfamily 
structures with a master template. From the superfamily superposition WHAT IF produces 
a sequence alignment of structurally equivalent residues that can be used to fine-tune a 
common structural core.
 To create a multiple structure alignment many programs use a progressive approach 
starting from a series of pair-wise alignments. The pair-wise alignments can be created by a 
variety of methods and are stored for easy comparison. MALECON [68] for example creates 
a library of pair-wise structure alignments using SoFist [69]. A multiple-structure alignment 
is generated by progressively combining the pair-wise alignments into one overall alignment. 
Another example of the progressive alignment approach is Mustang [67] that uses dynamic 
programming for the pair-wise alignments.
 MUSTA [70], MultiProt [71], and MASS [72] use geometric hashing procedures to 
find superposable fragments. Geometric hashing procedures start by creating a list of spatial 
coordinates for both objects. These objects are then superposed by randomly selecting pairs 
of coordinates and transforming one of the objects onto the other object. If a transformation 
results in additional matching coordinate pairs the superposition is accepted. MASS searches 
for fragments present in all structures whereas MultiProt and MUSTA support fragments 
only superposable in a subset of the structures. Several techniques are used to elongate the 
fragments, and to combine fragments with a highly similar transformation to create an 
overall superposition. These methods create a multiple-structure alignment using both 
combinatorial and pair-wise procedures and are similar to the procedure used by WHAT IF.
 Ye and Godzik [73] developed a method called Partial Order Structure Alignments 
(POSA), to superpose structures using partial order graphs (POGs) and preserve structurally 
variable regions in the visualization. A guide tree is used to align multiple structures pair-wise using 
an iterative procedure. POSA alignments focus more on including all structure variation into the 
superposition as opposed to WHAT IFs focus on determining structurally equivalent residues.
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CE-MC [74] uses pair-wise structure comparison using a combinatorial expansion (CE) 
algorithm as input. A Monte Carlo (MC) optimization technique is used to create random 
changes in the alignment between two structures. A distance-based scoring matrix is used 
to reject or accept the changes. Several types of permutations are applied both backwards 
and forwards to the aligned fragments in the MC procedure. Validation of the results on 
manually curated families shows an increase in alignment positions and an increase in 
alignment distance over the initial CE derived alignments. Due to the Monte Carlo analysis 
and pair-wise comparisons CE-MC is relatively slow.
 Structure superpositions are highly useful and suitable for a wide range of 
applications. Creating a superposition can however be time consuming especially when 
many or highly divergent structures are involved. Therefore, several databases are available 
that contain predetermined superpositions or classifications of structures into families based 
on these superpositions. SCOP [75], CATH [76], and DALI’s FSSP database [77] are 
examples of these databases. These three methods work different in most details, but have in 
Figure 1.6: Superposed helices in 26 structures from the NR superfamily. Regions in green/cyan are part of the 
common structural core, grey regions are structurally variable.
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common that all structures available from the PDB are structurally classified into a family 
hierarchy. Structure classifications from these databases combined with structure 
superpositions and sequence alignments can be used to assemble large evolutionary divergent 
structure-based multiple sequence alignments for protein superfamilies. 
 The first step in the 3DM procedure to create a superfamily database is retrieving 
all structures classified as belonging to the superfamily. From these superfamily structures 
a superposition is generated (fig. 1.6). The superposition can then be used to determine 
the common structural core of the superfamily. Sequence alignments using the structurally 
conserved regions as anchors can be used to include sequences for which no structure is 
available. As long as structures of homologous proteins are used for the determination of the 
common structural core, very high quality alignments can be obtained. These alignments 
are therefore perfectly suited to construct a superfamily alignment and to interconnect 
heterogeneous data sets. The combination of structure superpositions and iterative profile 
based sequence alignments used to create 3DM databases is detailed in the next section.
Structure-Based Sequence Alignments
For 3DM superfamily systems we combine structure and sequence alignments into a 
single superfamily system (fig. 1.7). To cover the entire family an initial superfamily wide 
superposition is created by superposing all superfamily structures on a master template 
(fig. 1.7a1). A common core of structurally equivalent residues is determined based on 
all superpositions (fig. 1.7a2). Template structures are selected for subsequent sequence 
alignments based on sequence similarity. A profile based iterative sequence alignment 
consisting of four rounds is used to align sequences to the templates (fig. 1.7b1-4). The 
common core residues are used as anchors in the sequence alignments. A superfamily 
alignment is assembled from the individual subfamily alignments. For each aligned sequence 
the residues in the common core are determined and used in the superfamily alignment 
(fig. 1.7c). A technical description of the alignment process and implementation details can 
be found in chapter 2.4. 
 Using a combination of structure superpositions and sequence alignments has 
the advantage that proteins can be included in the alignment based on either structure 
or sequence similarity. This results in a much lower detection limit for distantly related 
proteins. Structure is more conserved then sequence, and the templates used for the sequence 
alignments are at most 80% identical. 3DM is therefore able to include sequences into a 
superfamily database that in a pair-wise alignment would have a sequence identity below 5% 
while still being reasonably confident that the common core residues are properly aligned. 
Compared to structure or sequence alignments, a structure-based sequence alignment thus 
broadens the data included into the alignment and can improve the quality of the sequence 
alignment.
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Within 3DM, alignments are used as basis to incorporate diverse data sets and are used as a 
primary key to link these data sets. For example, mutations, contacts, and annotations can 
be interconnected using alignments. The remaining sections of the first chapter will outline 
some of the different datasets available within 3DM systems.
Figure 1.7: 3DM MSA generation procedure. A superfamily superposition is generated using all structures from 
the superfamily (a1). From the superposition the common structural core of the superfamily is determined (a2). 
Structural templates are selected, and the common core residues of these templates are determined (a3). Individual 
sequence alignments are generated for each template using an iterative profile base alignment procedure (b). 
The common core residues of each aligned sequence are determined by comparison to the common core of the 
templates. The resulting alignments are combined into a superfamily alignment.
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1.3 Correlated Mutations
Datasets consist of many variables some of which might hold dependencies. A dependency 
between two or more variables indicates a possible correlation between the two variables. 
Two variables are dependent upon each other when a change in variable A can be used to 
predict the change in variable B and vice versa. In enzymes, for example, residues in the 
active site are often closely correlated with the substrate. However, many other factors also 
contribute to substrate binding specificty, and there is not necessarily a direct correlation 
between active site residues and the substrate. However, any correlation between residues 
and substrates can be used for various purposes such as predictions of possible substrates 
for newly sequenced proteins or for analyses of the function of active site residues. Many 
examples of such correlations have been found in life science data. The following sections 
will describe several examples of correlations and highlight some of the major contributions 
to the field.
Correlation Based Structure Prediction
Correlations can be determined within and between diverse biological datasets. Correlations 
can for example be determined for expression data with disease state using microarrays, and 
protein reaction efficiency with bound catalysts using essays. One of the first computational 
examples of correlations in the life sciences was RNA structure prediction. RNA structures 
are formed by base-pairing of nucleotides in the RNA molecule (fig. 1.8). Parsch et. al 
[78] determined correlations between complementary regions of RNA molecules using 
alignments and used these regions to predict RNA 
structure. Stretches of matching nucleotides were 
used to predict loops and multiple matching stretches 
were combined to predict the 2D conformation 
of the entire RNA molecule. Perfect conservation 
of nucleotides in the alignment was not required, 
however preservation of base-pair combinations 
was. Therefore, an A-T pair could be replaced with a 
C-G, T-A, or G-C pair but C-T, T-C, G-A, and A-G 
combinations were not allowed on the positions as this 
would prevent base-pairing. An example application 
of this method is shown in figure 1.8. The nucleotides 
on positions 10 through 16 match the nucleotides 
on positions 19 through 25, and two more regions 
of nucleotide correlations can be observed. These data 
can be used to predict the loops formed between these 
nucleotides. The conformation of the complete RNA 
molecule shown in figure 1.8 can be modelled using 
the combined predictions of the loops. 
Figure 1.8: 2D structure of an RNA 
molecule.
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The link between residues or sequence fragments is less direct for proteins. Besides cysteine 
bridges, no unambiguous direct amino acid contacts are formed in proteins. For instance, 
a tryptophan does not inexorably ‘bind’ to a tyrosine as a cytosine does to a guanine. 
Protein structures are therefore harder to predict than RNA structure. Several attempts have 
been made, for example by Göbel et al. who tried to determine secondary structure using 
correlations to predict intra-protein contacts [79]. Their method was tested on 11 protein 
families and validated using known structures belonging to the families. The results showed 
a shorter average distance between the C-beta atoms of amino acids in predicted pairs versus 
random amino acid pairs. The prediction accuracy of their method however ranges between 
40% and 70% which is insufficient for high-quality structure predictions. More recently, 
Marks et al. used a correlation method and data from multiple sequence alignments to 
predict which residue pairs would be in close proximity in folded structures [80]. 3D models 
were generated with constraints placed on the distance allowed between residues predicted 
to be in proximity of each other. In total, 15 proteins with lengths between 50 and 260 
amino acids were modelled using this technique. For each model the RMSD error of at least 
two-thirds of the residues fell within a 2.7-4.5Å band of the actual structure. This technique 
is therefore very promising but improvements in RMSD and an increase in the length of the 
sequences studied are required before applications for full protein modelling are possible. 
Correlations Between Life-Science Datasets
Oliveira et al. used the amino acid variability and entropy obtained from alignments to 
predict the function of amino acids on alignment positions [47]. Five alignments consisting 
of several hundreds of proteins were created for the Globin chains, Ras-like, and Serine-
Figure 1.9: Entropy variability plot. 
Residues are divided into five boxes: 11) 
main functional site, 12) core residues 
surrounding the main functional site, 
22) core residues potentially involved in 
structural or signaling roles, 23) residues 
interacting with modulators, and 33) 
surface residues without a defined 
function.
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proteases families. These families were selected as lots of studies have been done on individual 
family members, and the function of most residues is therefore known. The variability and 
entropy of each position in the alignments was plotted in an entropy-variability graph 
(fig. 1.9). Using family specific criteria the residue positions were assigned to boxes and 
functional predictions were made for each box. The residues found in the main functional 
sites of the proteins were predicted to fall in box 11. The predictions matched overall with 
the known function for the residues. Additionally, positions bordering two boxes often 
showed functional properties of both boxes.
Figure 1.10: Network of correlated positions surrounding the active site of an enzyme from the cupins 
superfamily. Scene shows structure 1GP6 with 4 ligands and an iron ion bound to the active site. Positions in 
the correlation network are shown in magenta, with sidechain atoms, and labeled using alignment numbering. 
Positions in the common core are green/cyan, and positions in variable regions are grey. Some variable residues 
have been removed for clarity.
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Correlations Between Alignment Positions
Alignments reflect the evolutionary history of a superfamily. Some residue positions within 
an alignment are unconstrained and can probably be mutated without any detrimental effect 
on the protein’s function (fig. 1.5, positions 3 and 26). Other residue positions however, are 
either strictly conserved or correlated and linked with specific protein functions. Correlated 
positions must be mutated in tandem to prevent loss of function. This applies to for example 
positions involved in charge clamps, substrate binding, or dimer interfaces. Evolutionary 
pressure is thus visible in alignments as correlations between such alignment positions 
(fig. 1.10). These correlations between alignment positions can be calculated using the 
distributions of amino acids on both positions. Single mutants on positions involved in 
substrate binding or recognition are often disruptive. Double or triple mutants however, 
may change the layout of the pocket sufficiently for a different ligand to be recognized. 
Many residues on these positions interact and must be changed simultaneously (either 
experimentally or by natural processes) for a protein to recognize a different ligand. Positions 
involved in a similar function thus often cluster in correlated networks (fig. 1.11). Correlation 
networks between alignment positions can therefore be used to study groups of functionally 
related positions in alignments, and predict the function of positions in a cluster.
Algorithms
Several algorithms are available to determine correlations between datasets for 3DM we use 
the statistical coupling method [81]. Other popular algorithms include mutual information 
method [82,83], perturbation method [84], and Pearsons correlation method [79].
Figure 1.11: Correlations in the Nuclear Receptor superfamily. Alignment positions shown as nodes, pair-wise 
correlations above 0.7 are shown as edges. Note that several alignment positions correlate with more than one 
alignment position. Examples are 10, 55, 79, and 131.
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Lockless and Ranganathan [81] hypothesized that functionally coupled positions in an 
alignment can be determined by studying amino acid distributions. The distribution of 
amino acids on each position of the alignment is expected to approach the mean amino acid 
abundance determined for all proteins. When two positions in an alignment are functionally 
coupled, the evolutionary pressure to preserve this coupling will be visible in the correlation 
of amino acid distributions on both positions. The statistical coupling energy of two 
positions was determined by comparing the statistical energy vector at both positions in the 
entire alignment with the energy vector of the two positions representing a perturbation of 
amino acid frequencies on one of the two positions. To test their hypotheses, Lockless and 
Ranganathan used a structural alignment of the PDZ domain superfamily. Four structures 
were available of distantly related family members that were structurally well conserved with 
an average RMSD for Cα atoms of 1.4Å but sequentially only 24% identical. An active site 
position linked to ligand specificity was selected for the analysis, and the statistical coupling 
was determined between the selected position and all other positions in the alignment. 
Only 10 positions in the alignment showed coupling with their position of interest, 6 of 
these positions were either structurally near the position of interest, or known to be part 
of the interaction surface. The other 4 positions were assumed to be involved in signalling 
throughout the molecule. A series of double mutants on their position of interest with 
selected coupled and non-coupled positions in the protein yielded confirmed their results. 
Types of Correlation and Potential Problems
Correlated mutations between alignment positions reflect an evolutionary pressure present 
in nature. Therefore the number of sequences in an alignment and the evolutionary distance 
between these sequences are indicative of the type of correlations that can potentially be 
extracted from it. For example, superfamily alignments containing evolutionary distant 
sequences are usually composed of proteins with a wide range of functions. The overall 
correlation signal that can be retrieved from these alignments therefore often points at 
residues essential for protein activity. More closely related alignments focussed on a subfamily 
of proteins with a known related functions show correlations angled towards (substrate) 
specificity or binding affinity.
 Correlations are mathematical expressions of dependence between datasets, or 
variables within datasets. Most correlation algorithms assume the datasets and variables are 
normally distributed. Calculating correlations on biased datasets will result in correlation 
artefacts which appear as genuine correlations. For correlations between alignment positions 
this translates into a requirement of properly sampled alignments. For example, false 
positives correlations can occur when calculating the correlations for family consisting of 
two taxonomic branches using an alignment in which sequences belonging to one branch 
are heavily overrepresented. Conversely, properly constructed alignments have shown that 
including additional sequences into the alignment has no major effects on the correlations. 
Regenerated 3DM systems have shown for multiple families that the addition of new 
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structures and sequences does not fundamentally change the topology of the network of 
correlated mutations. This highlights several important aspects of both correlations and 
alignments: 1) alignments reflect actual evolutionary relationships between proteins; 
2) Correlated mutation analyses on superfamily alignments are not influenced by small 
alignment errors; 3) The method used by 3DM to assemble superfamily alignments is 
robust, repeatable, and produces high quality alignments.
1.4 Mutation Information
Amino acid residues in a protein structure are involved in many different functions such 
as folding, signalling, ligand binding, etc. Mutating these residues can potentially result in 
protein deficiencies such as improper folding, missing hydrogen bonds required for ligand 
binding, or introduction of charged residues in the hydrophobic core of the protein. These 
deficiencies often lead to disruptive phenotypes and the effects of the mutations can therefore 
be used to study the role of specific amino acids positions in proteins. Effects of mutations 
can also be transferred between proteins using alignments. The effect of mutations in a 
protein of interest can therefore be predicted using mutations in homologs. It is therefore of 
vital importance to construct large libraries of mutations when studying protein and amino 
acid function.
Availability of Mutations
Mutations are available from two main sources: mutation databases and scientific 
publications. Manually curated mutation databases exist for various (human) proteins 
of interest, such as for the TP53 tumour repressor protein [85,86] and the BRCA1 and 
BRCA2 breast cancer genes [87]. Several databases focussed entirely on a single species are 
also available such as the HGMD [88] and PMD [89] for human disease mutations and 
the MGD [90] for mutations in mice. These databases are mostly updated and curated 
manually, and it is therefore time consuming to keep them up-to-date. For example, when in 
1995 PMD was first published it contained only data from articles published before 1992. 
PMD has been updated several times since 1995, lastly in 2007. The 2007 update however 
contained no data from articles published after 2003. Keeping hand-curated mutation 
database up-to-date will become increasingly more difficult as the publication rate of articles 
continues to increase. Automation of (parts of ) the retrieval of mutations from literature is 
therefore required to continue to maintain these databases. Several problems arise during 
this automation that will be discussed in the remainder of this chapter.
 Retrieving articles using a web browser is relatively straightforward. Retrieving 
articles for a superfamily however is much more complicated as this requires retrieving 
hundreds or even thousands of articles from many different websites. Potentially relevant 
articles can be preselected using PubMed searches. A search for articles using the keyword 
‘cancer’ as query however, yields 2.6 million results. Adding the keyword ‘mutation’ to the 
query reduces the number of hits to 138 thousand articles. Carefully constructed search 
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queries are therefore required to balance between downloading thousands of articles and 
missing mutations because the article was ruled out by the query. Retrieving the articles 
themselves is also non trivial as articles are not available from a single source. The location 
an article can be retrieved from can be obtained from the PubMed website. The articles 
themselves are mostly hosted by publishers such as the Nature Publishing Group or 
ScienceDirect. There is however no standardized method or location on publisher websites 
from which the article can be retrieved. Therefore, publisher specific procedures are required 
which greatly complicates the automation of article retrieval.
 The second major difficulty lies in the extraction of mutations from articles as there 
is no universally accepted nomenclature for writing mutations in articles. Some publishers 
and papers enforce nomenclature guidelines, however, these have not been standardized. 
Authors therefore, often use a field specific nomenclature which can also differ from person to 
person. An additional complication is the lack of protein or gene names explicitly associated 
to specific mutations in articles. A process called grounding is often required to determine 
the protein and amino acid using data from the article such as species and gene names. For a 
complete list of steps in the mutation extraction process and the difficulties encountered in 
each step see chapter 2.6.
Mutation Retrieval Tools
A multitude of tools are available to assist in the automation of one or more aspects of the 
mutation retrieval process. Most of these tools specialize in only one or two aspects of the 
retrieval process such as tagging of mutations in articles or retrieval of mutations for a specific 
gene family. For the 3DM platform we required a tool to automatically search and download 
articles related to a protein superfamily, find mutations in the article, link the mutations to 
the corresponding protein, remove false-positives, and store the results in a database. We 
designed Mutator [25] to collect mutations for a complete protein superfamily based on the 
concepts of MuteXt [43]. MuteXt was used as base because it was the most complete tool 
available when development of Mutator was initiated. Furthermore, MuteXt contains many 
of the required features such as automatic selection and retrieval of articles, usage of protein 
annotations, assignment of mutations to sequences, and superfamily support. Mutator has 
been applied to several superfamilies and has shown to be an excellent tool for the retrieval 
of superfamily mutations [19,20,25]. An overview of the individual steps of the mutation 
retrieval process, available tools, and potential pitfalls is available in chapter 2.6.
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1.5 Genetic Disorders
Pathogenicity of mutations
One of the many applications of mutation data is in diagnosis of genetic disorders. Many 
disorders have been linked to one or more genes using techniques such as genome wide 
association studies. For example, Fabry’s disease and the GLA gene [91], breast cancer and 
BRCA1 and BRCA2 [92], various cancers and TP53 [93]. One of the motivations behind 
the Human Genome Project was the potential applications of a complete human genome 
in healthcare.  Sequencing individual human genes had been done for years, however the 
Figure 1.12: Validator scene of variant p.Y86K of hGLA. The variant is shown in red, with the Van der Waals 
radius in green. Steric hindrance is observed with residues W81 (top) and M296 (lower right), both highlighted 
in blue.
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Human Genome Project was the first attempt to sequence and assemble the entire complex 
human genome. The project started in 1990 and was originally devised as a 15 year project. 
Advances in equipment and computing, and competition with commercial ventures 
however lead to a mostly complete release of the genome 2 years ahead of schedule [94,95]. 
The US part of the project was funded with 3 billion dollars, the total cost of the combined 
efforts of all project partners is estimated to be much higher. Nowadays both the time and 
finances required to sequence a full human genome have been reduced significantly through 
improvements in technology and methodology [96,97].
 As sequencing costs go down, mass sequencing of disorder related genes for 
diagnostic purposes is becoming feasible [98]. Sequence data from both complete genomes, 
and specific disease related genes from patients, has revealed that natural variation in human 
genes is relatively common. Several projects are therefore currently underway to study and 
document the human variome: the genetic diversity found between individuals and between 
populations [99]. For human, on average 1 nucleotide in 1,200 differs between individuals, 
with an even larger genetic divergence between individuals from different ethnic backgrounds 
[100]. Differences between sequence data from a patient and the “reference” genome can 
therefore not be linked directly to pathogenicity as most variants are natural variations and 
have no significant direct effect on the health of carriers. For gene based disease diagnostics 
a method is thus required to distinguish between natural and pathogenic variants, and to 
predict the pathogenicity of potentially pathogenic variants. Validator (table 1.1 & fig. 1.12) 
was developed for the 3DM platform to predict the possible pathogenicity of unknown 
variants (UVs) found in patient data. Several publications are available describing the use of 
3DM superfamily systems to predict the effects of mutations [19,20,25,101-103].
Validator
Validator uses the many different data types available from 3DM systems to predict the 
pathogenicity of UVs. Effects of the variant on protein structure can be studied using a 
visual representation of the variant, either from a PDB or a homology model (fig. 1.12). 
An accurate determination of the pathogenicity of a variant is very difficult due to the large 
number of factors involved. Amino acids are involved in protein folding, bonds involved in 
substrate recognition, catalytic residues, and many other roles. Mutations of amino acids can 
therefore result in a large number of different phenotypes associated with genetic disorders.
 Due to the difficulties involved in pathogenicity determination Validator is not the 
final step in diagnosing genetic diseases, but merely an aid in the diagnosis of patients. Usage 
of Validator in combination with other techniques can lead to substantial improvements, 
and personalization of treatments which benefits both doctors and patients. Data types used 
by Validator and alternative tools are discussed in chapter 2.7.
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1.6 Applications
This thesis deals with 3DM systems and their potential and application in research in the life 
sciences. Structure-based multiple sequence alignments augmented with external data and 
statistical analyses, can be of great assistance to life science researchers. The 3DM platform 
was designed to automatically construct 3DM systems for specific protein superfamilies. 
3DM systems have been successfully applied to a wide range of applications in protein 
engineering, DNA diagnostics, and drug design both in industry and academia. They have 
been used to:
1) Study the functional mechanisms of a superfamily [103]
2) Improve substrate specificity [19] or thermo-stability [104]
3) Increase enzyme activity [19,20] or enantio-selectivity [103]
4) Predict the effects of mutations in disease linked genes [25]
The first two chapters of this thesis aim at providing a scientific and technical background 
for the 3DM platform. A general overview of the 3DM technology is provided in chapter 
3. Project Hope, a mutant pathogenicity predictor, is described in chapter 4. These first 4 
chapters focus mainly on the technical and scientific background and implementation of 
both 3DM and project hope. The focus in the next 4 chapters shifts from bioinformatics 
to applications of 3DM systems in research projects. Chapters 5 and 6 describe subsystems 
added to the 3DM platform: Comulator for correlated mutation analyses, Mutator for the 
retrieval of mutations from literature, and Validator for variant pathogenicity predictions. 
The final two chapters describe research projects in which 3DM was applied to study the 
alpha-beta hydrolase superfamily and enzymes in the alpha-amylase superfamily. The 3DM 
platform, project Hope, and the 3DM YASARA plugin are the three projects that I have 
devoted most of my time to. My contribution to the research projects described in chapters 
7 and 8 has been limited to the design and implementation of algorithms and data facilities 
that enabled the bioinformatics aspects of these studies.
 To complement the scientific background found in chapter 1, chapter 2 provides 
further insights in the inner workings of 3DM systems. This chapter is almost by definition 
incomplete because 100.000 lines of code (excluding the millions of lines of code in external 
software such as WHAT IF, YASARA, Utopia, etc.) cannot be described in detail in one 
chapter. It is only hoped that chapter 2 gives an impression of the scope of the software 
together with details on the implementation of concepts discussed in this introductory 
chapter. 
 Chapter 3 provides a more concise overview of 3DM and its evolution from earlier 
MCSIS systems. Thirteen 3DM systems were created and published online for examination. 
Examples from enzyme engineering, DNA diagnostics, and drug design projects highlight 
possible applications and uses of these public systems.
40
Chapter 1
Chapter 4 describes Project Hope a tool to analyse protein mutations, similar to 3DM’s 
Validator. Project Hope is aimed at biomedical researchers and relies on webservices, reusable 
external components, for data retrieval. A decision tree is used to predict the effects of the 
mutation on both the function and structure of the protein. Project Hope is developed and 
hosted at the Center for Molecular and Biomolecular Informatics (CMBI) at the Radboud 
Medical Center in Nijmegen as part of the PhD of H. Venselaar.
 Chapter 5 describes the incorporation of the Comulator module for correlated 
mutation analyses (CMA) into the 3DM platform. A CMA algorithm based on statistical 
coupling was implemented to calculate CMA scores between alignment positions. Heatmaps, 
residue combinations on correlated positions, and correlation scores were integrated into the 
3DM visualization modules. Four superfamily alignments of enzyme families were analysed 
using the CMA algorithm. For each of the four families a network of functionally related 
positions was found. Mutational studies showed that residues from these networks were 
mostly involved in specificity and activity.
 Chapter 6 describes Mutator; the 3DM module for retrieval of mutation data 
from literature. A mutation database was assembled for the alpha-amylase superfamily and 
applied to Fabry disease. Validator was written as a DNA diagnostics tool and uses all data 
available in the 3DM platform to predict the pathogenicity of undetermined variants in 
disease linked genes. 
 Chapter 7 describes a 3DM system for the alpha-beta hydrolase superfamily. This 
family contains in excess of 15.000 proteins grouped into 5 distinct structural folds. Due 
to the size of the alignments several adaptations to the 3DM platform were required to be 
able to create superfamily alignments, facilitate the storage, and visualize the contents of the 
database. Automatic generation of phylogenetic trees was also added to the 3DM platform 
for this work. The alpha-beta hydrolase family contains numerous enzymes that have been, 
or could be targets for protein engineering. Subsequent publications by Jochens et. al [105], 
Jochens & Bornscheuer [106], and Hasenpusch et. al [107] describe protein engineering 
projects using the alpha-beta hydrolase 3DM system. 
 Chapter 8, finally, describes the application of a 3DM system in an enzyme 
engineering project focused on thermostability. Study of the enzyme’s crystal structure, and 
rationally designed libraries from 3DM were used to increase the half-life of the enzyme at 
temperatures used in industrial processes.
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2.1 Introduction
The 3DM platform is a bioinformatics toolbox that can be used to create Molecular Class 
Specific Information Systems (MCSIS) for protein superfamilies. This chapter aims to 
provide an overview of the technical background of the 3DM platform, the steps required 
to create a new MCSIS with 3DM and describes the workflow of the main modules used for 
superpositioning of structures, correlated mutation analyses, mutation retrieval, and variant 
pathogenicity predictions. 
 The 3DM platform consists of three main parts; the backend that creates the 
alignments and loads the database, the database itself and the frontend that deals with all user 
interactions (fig. 2.1). Several external tools are integrated into the 3DM workflow such as 
WHAT IF for structural superpositions, determination of contacts and solvent accessibility, 
sequence alignments, and handling of PDB files; YASARA for the creation of structural 
representations; ClustalW for phylogenetic trees; MUSCLE for sequence alignments; and 
ImageMagick for image handling. 
 The 3DM platform and its dependencies consist of millions of lines of code and 
offer lots of functionality. A complete overview of all these functions is omitted for the sake 
of brevity, however a technical oriented in-depth overview of the main components of the 
3DM platform is essential for the interpretation of 3DM analyses. This chapter aims to 
provide such a technical background perspective on several major components of the 3DM 
platform. 
2.2 3DM Platform
Central within each 3DM system is a database that is used to store available superfamily data. 
The first section of this chapter therefore describes the characteristics of the 3DM databases 
and some background information on data stored in these databases. Section 2.3 describes, 
in detail, the process of creating a 3DM system for a superfamily. A twelve step process is 
outlined describing the initial setup, creation of the superposition, subfamily alignments, 
and data incorporation. These first two sections describe the basis of every 3DM systems and 
can be used to study the inner workings of 3DM more closely. Subsequent sections describe 
components added to the 3DM platform to perform various analyses. Section 2.5 describes 
the algorithm used for correlated mutation analyses and the visualization techniques used 
to present this data to the user. This section complements the applied research described in 
chapters 3 and 5 that use correlated mutation analyses to study the characteristics of proteins 
in various superfamilies. Mutation retrieval is the subject of section 2.6. A list of mutation 
retrieval tools are reviewed in addition to the steps discerned in the process. The final section 
contains more details on the DNA diagnostics parts of 3DM with an overview of the data 
types used by Validator in the 3DM analyses, a list of databases containing useful data and 
an overview of available tools. The Mutator and Validator modules described in sections 2.6 
and 2.7 were used extensively in the project described in chapter 6.
Figure 2.1: Overview of domains, modules and dataflows in the 3DM platform. Databases, both the 3DM 
database and external databases, are shown as cylinders, programs and scripts are shown in rectangles. Arrows 
indicate the flow of data between the modules. Bi-directional arrows indicate that data moves both ways. The 
separate domains within the 3DM platform are grouped in rounded squares.  For more information on the 3DM 
database see chapter 2.3, the frontend and backend modules are described extensively in chapter 2.4. Usage of 
external databases is summarized in table 2.1.
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3DM systems revolve around a structure-based multiple sequence alignment (MSA) that 
is generated specifically for each protein superfamily. The MSA, sequences, structures, 
annotations, contacts, mutations, and many other datatypes are gathered by the backend 
and stored in the database. Extensive cross-references ensure adequate interoperability of 
these data types. The generation of an MSA is a twelve step process that will be described 
in detail in chapter 2.4. In short, the generation of an MSA starts with obtaining all 
structures and sequences of superfamily members. All structures are superposed pairwise 
on a master structure using WHAT IF (fig. 1.7 a1) [1]. The superpositioning is used to 
determine the common structural core (fig. 1.7 a2), and to select templates for subsequent 
subfamily alignments (fig. 1.7 a3). Sequence alignments are generated for each subfamily to 
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incorporate closely related sequences for which no structure data are available (fig. 1.7 b). A 
complete superfamily alignment is assembled using the common core positions of all aligned 
sequences (fig. 1.7 c). External data from various databases and providers are incorporated 
into the database and linked to proteins, positions, nucleotides, or amino acids. All these 
external data are interconnected using the MSA as a frame of reference. Users can interact 
with the system using a web interface or suitable external viewers such as the YASARA 
structure viewer [2] or the Utopia PDF reader [3].
External Database Data Provided Section
SCOP Classification of structures into superfamilies 2.4.2
Swiss-Prot/TrEMBL Sequences, annotations, variants and cross-references 2.4.11
PDBe Protein structures 2.4.2
Mutation Databases (MDBs) Mutations & phenotypes 2.4.11
Genbank Sequences, annotations, variants and cross-references 2.4.11
OMIM Diseases 2.4.11
PubMed Articles & references 2.4.11 & 2.6
 Generation of 3DM systems should be as automated as possible to reduce the required 
domain knowledge, manual supervision by human experts, and total time needed for the 
generation of new 3DM systems. This has nearly been achieved for the generation of the 
MSA itself and for the incorporation of external data into the system, both of which are 
>99% automated. Generating a superfamily structure superposition however has not yet 
been fully automated. Determining the optimal superposition of two structures is a complex 
process, and small changes in the transformation often reduce the RMSD in one region 
while increasing it in another. It is therefore impossible to obtain a definitive superposition 
as the outcome will differ depending on the order in which the structures where compared. 
User interaction is especially required in the case of multi domain structures that can 
move relative to each other. Consequently, the determination of the common structural 
core is also non-trivial as the common core and the superpositioning are directly linked. 
For an alignment position to be incorporated into the common core, at least 80% of all 
structures are required to have a residue within 2.5A of the mean position. Any changes in 
the superpositioning therefore have a direct effect on which positions can be included in the 
common core.
Table 2.1: External databases used in the 3DM platform. For each database the primary use case is listed 
together with the section of this chapter where more information can be found.
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2.3 3DM Database
Figure 2.2 shows a condensed overview of the 3DM database schema. As of spring 2012, the 
full schema contains 43 tables, 57 foreign keys, and 37 indices. The full database schema can 
therefore only be viewed interactively. 3DM systems focus on the proteins in one superfamily. 
The sequence of each protein is stored in the Protein table. Information for one protein is 
often scattered over many database so that multiple protein identifiers can be linked to a 
single sequence. Crambin, for example, is available as P01542 and CRAM_CRAAB in 
UniProt; 3NIR, 1AB1, 1CRN and others in the PDB; A01805 and KECX in PIR; 6226577 
in the NCBI Protein database; UPI0000110BEA in UniParc; 0710210A in PRF; etc. 
Different external databases offer different annotations and different levels of details in their 
descriptions, or focus on different biological aspects. Annotations such as species, gene 
name, database of origin, and biological function are therefore stored separately for each 
protein identifier. As the different identifiers describe the same sequence, the annotations 
from the databases are often identical or highly similar. The annotation data is however, used 
for data analysis and clustering. The redundancy resulting from storing identical annotations 
multiple times is therefore outweighed by the ability to store a complete overview of 
annotations for each protein.
 Each amino acid of each protein is stored in a separate record in the AminoAcid 
table. With an average protein length of 400 amino acids this results in, on average, 400 
additional records for each protein. With superfamilies ranging in size from a few hundred, 
Figure 2.2: Condensed 
Enhanced Entity Relationship 
(EER) diagram of the 3DM 
database. Each block represents 
a table, with the name in bold 
at the top and the fields listed 
underneath. Lines indicate 
foreign key relations between 
the tables, with the line 
endings indicating whether the 
relationship is a one-to-one, one-
to-many, or many-to-many key.
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to tens of thousands of proteins this results in a large number of extra records. The cost of 
storing the amino acids separately is however clearly outweighed by the flexibility of being 
able to link many annotations and multiple numbering schemes to individual amino acids.
 Amino acid annotations, descriptions and variant data such as mutations, conflicts, 
trans-membrane regions, active sites, glycosylation sites, phosphorylation sites, repeats, zinc-
finger domains, etc. are stored in the Feature table. Each annotation is linked to the database 
from which it was retrieved and described using metadata. References to publications that 
are linked to the annotation are stored in the Literature table. 
Figure 2.3: Numbering an aligned sequence. Sequence shown in aligned 3DM 
format with structurally conserved residues capitalized and in bold, and residues in 
structurally non-conserved regions in lowercase. Residue numbering is shown above, 
and alignment numbering below the sequence. Core and non-core (variable) regions 
are separated from each other by a space. Structurally conserved residues are numbered 
according to their position in the common core of the superfamily. As not all structures 
in the superfamily contain heterogeneous residues for all positions in the common 
core some positions can remain empty. In the example sequence, no heterogeneous 
residues are present for positions 34 through 37 of the common core. Variable regions 
are aligned and numbered individually for each subfamily. The numbering scheme 
for variable residues includes a character prefix based on the location of the region 
in the subfamily alignment. The first residue in the first variable region is numbered 
a1, the second a2, the first residue in the second variable region is numbered b1, 
etc. Variable regions often differ markedly in their makeup between aligned proteins. 
A loop between two structurally conserved areas, for example, might consist of up 
to 20 residues in one protein while another protein has no residues at all between 
the two areas. Variable regions lacking residues are left empty, marked with a minus, 
and skipped in the numbering such as region c in the example sequence. The fourth 
variable region in the example sequence is therefore prefixed with a d as the character 
prefix indicates the location of the variable region in the subfamily alignment rather 
than the location in the sequence. The process of assigning numbers to residues is 
completely automated. 
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Each amino acid is numbered using two different numbering schemes: its sequential residue 
numbering and the 3DM alignment position numbering. Sequential residue numbering 
starts at one for the first residue in the sequence and increases by one for each amino acid 
in the protein, independent of any alignment. Alignment position numbers depend on the 
location of the residue in the superfamily superposition with a sequential number assigned 
to each position in the common core. Residues in structurally variable regions are numbered 
separately with a region-dependent character prefixed to each residue (fig. 2.3). The alignment 
position number of a residue therefore indicates the position in the structure alignment rather 
than the position in the sequence of the protein. Residues in different proteins with the same 
alignment position number are structurally at a corresponding position. For core regions this 
comparison holds true for essentially the entire superfamily, variable positions however can 
only be confidently aligned within subfamilies. Custom numbering schemes for the alignment 
positions can be defined by the user. These schemes do not have to be ascending or numeric, 
and may instead consist of identifiers for structural elements such as helix1.1. 
Figure 2.4: Families and folds in the alpha-beta hydrolase superfamily. 3DM superfamilies are divided into 
families based on structural folds that are further subdivided into subfamilies. A family represents a subset of the 
complete superfamily with a distinct structural component that is not conserved in the complete superfamily. The 
common core of family I consists of 9 beta-strands and contains 88 positions. This common core is shared by all 
superfamily structures. Families II-VI include additional positions from the beta-sheet and connecting sequences 
on top of the 88 positions of family I. The regions added to the other families represent the distinct folds of the 
families. The phylogenetic tree shown on the right contains all subfamily templates of the Basic 88-core family. 
Each template structure that is also a template in one of the other families is highlighted with the family’s color. 
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Contact data such as disulfide bridges, dimer contacts, ligand contacts, and hydrogen bonds 
are obtained using WHAT IF as described in chapter 2.4.11. Contacts can be stored between 
two amino acids, or between an amino acid and a compound found in a PDB file such as a 
ligand or metal atom. 
 3DM systems focus on protein data but several types of genomic data are also included 
in the database. Genome sequences are stored in the Gene table with the individual nucleotides 
stored in the Nucleotide table. Nucleotides are stored separately for the same reasons as storing 
amino acids separately. Only a limited number of genes are stored because storing each 
nucleotide of each amino acid of each protein would result in an enormous amount of data, 
and genomic data is used only sparsely within 3DM. Genomic data is mainly used by Mutator 
to ground DNA mutations to genes. Published DNA mutations that are relevant to our users 
tend to originate from patient data, or as the result of testing drugs, treatments, or conditions 
on model animals. Therefore only genes from human and model animals such as rat and 
chimpanzee are stored.
 Superfamilies in 3DM systems are divided into families based on structural folds 
(fig. 2.4). Families in turn are subdivided into subfamilies based on structural templates. 
Proteins can be aligned against multiple subfamilies due to similarities between the subfamily 
templates. The Alignment table contains protein alignments combined with alignment derived 
data such as the family, subfamily, and profile similarity for each alignment of each protein. 
Due to sequence similarities between subfamily templates many proteins can be aligned to 
multiple subfamily templates. All possible alignments are stored for each protein although only 
one alignment is used within the 3DM systems (see also chapter 2.4.9). Depending on the 
number of subfamilies and the sequence similarity between the subfamily templates a protein 
can therefore occur multiple times in the Alignment table. 
 Superfamilies can consist of many proteins. In practice, 3DM systems have currently 
been generated for superfamilies ranging from 100 to 115.000 proteins. Large superfamilies 
often consist of multiple sub-groups, often with different functions. The actin-like ATPase 
domain 3DM for example, contains several sub-groups including the hexokinases and 
glucokinases. It is not always desirable or practical to use all proteins when running an analysis 
or when visualizing data. The use of a subset of proteins can often even be beneficial as it allows 
the user to investigate and compare the differences between arbitrarily defined subgroups of the 
superfamily. A filter mechanism has been incorporated into 3DM to facilitate the investigation 
of properties of subsets or differences between subsets of the superfamily. A filter consists of 
a list of proteins that can be created by the user either through a number of search options 
or through manual selection. To increase flexibility upon filter creation several options are 
available, for example, filters can be combined, and all proteins from a filter can be removed 
from another filter. The filtering mechanism allows for a dynamic view of subsets of the 3DM 
system, and has proven a very useful tool for the investigation of superfamily characteristics. 
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2.4 Superfamily Creation
The creation of a 3DM system for a superfamily includes a large number of steps, most of 
which must be executed in the right order. Table 2.2 lists all major steps and indicates in 
which section of this chapter details about that step can be found.
Chapter Step
2.4.1 Create 3DM Environment
2.4.2 Retrieve Structure Data
2.4.3 Superfamily Superpositioning
2.4.4 Update Structure Files With Common Orientation
2.4.5 Determine Structural Conservation
2.4.6 Select Subfamily Templates
2.4.7 Expand Common Core
2.4.8 Subfamily Alignments
2.4.9 Alignment Quality Control
2.4.10 Assemble Superfamily Alignment
2.4.11 Integrate Heterogeneous Data Types
2.4.12 Visualize Superfamily Data
2.4.1 Create 3DM Environment
Some preparations have to be made before a new 3DM system can be created. A database 
as described in chapter 2.3 is created to store superfamily related data. A directory hierarchy 
is also created to serve as backend storage for files required or generated during the creation 
of a new 3DM system. Macros to automate processes using WHAT IF or YASARA, output 
files from the alignment process, and logfiles of most of the alignment steps are stored in 
these directories. The contents of these directories are generally only used to debug problems 
that occurred during the generation of the 3DM system. Users of 3DM systems do not need 
to interact with any of the files in the backend directories.
2.4.2 Retrieve Structure Data
All structures belonging to the superfamily must be collected before a structure alignment 
can be generated. A BLAST search against the PDB database is used with default settings 
to retrieve the structure most similar to the protein of interest. When multiple high scoring 
matches are found a structure is selected based on resolution or elucidation method. This 
master structure is used as the template for the structure alignment. A complete set of 
superfamily structures is subsequently assembled using SCOP and BLAST. The SCOP 
database contains PDB files organized in a superfamily hierarchy categorizing structures 
into classes, folds, and superfamilies. Each SCOP superfamily is subdivided into families, 
Table 2.2: Major steps in the 
creation of a 3DM system for a 
protein superfamily. Numbers 
refer to the chapters were the step 
is explained in detail.
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domains, and proteins. SCOP is curated manually which results in a backlog of recently 
published structures that have not yet been included into the SCOP hierarchy. The most 
recent release of SCOP is currently 1.75, released in June 2009. We are therefore working 
on including family classifications from CATH [4] and perhaps the new HSSP database [5] 
to augment the SCOP classification.
 The SCOP superfamily corresponding to the master structure is determined using 
the structure retrieved from the initial BLAST search against the PDB database. Additional 
BLAST searches are performed using the SCOP entries as queries to retrieve PDBs not 
included in SCOP. PDB files for all selected structures are retrieved from a local mirror of 
the PDB archive. FASTA files are generated for every chain of every structure for use in the 
alignment procedure. 
2.4.3 Superfamily Superpositioning
All superfamily structures are superposed onto the master structure. The superpositioning 
is done using WHAT IF’s MOTIF option which can be found in the SUPPOS menu [6] 
(fig. 1.7, a1) using default settings. The superpositioning procedure used by WHAT IF 
is explained in detail in chapter 1.2. The outcome of the superpositioning procedure is a 
Figure 2.5: Structure-based sequence alignment for P450 superfamily members. The left column contains 
the PDB and chain identifiers of the structures. The first line contains the sequence of the master template. 
Subsequent lines indicate the sequence alignment that was obtained from the structure alignment. Positions in 
the template where the other structures do not have a homologous residue are marked with a minus. Amino acids 
are colored based on chemical properties.
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WHAT IF database with all structures superimposed on the master template. This database 
is used to determine the common structural core and generated updated structure files.
2.4.4 Update Structure Files with Common Orientation
The orientation of structures in the PDB depends on several factors such as the elucidation 
method, experiment, and experimentalist. The origin of superfamily structures is very diverse 
and therefore these structures do not use a common orientation. A unified orientation of 
these structures allows structural scenes to be generated containing an arbitrary selection of 
superfamily structures (fig. 1.2 & 1.6). These scenes can, for example, be used to compare 
ligand docking between structures or study structural diversity by displaying several structures 
at once. WHAT IF is used to apply the transformations obtained from the superfamily 
superposition procedure to generate new structures with a common orientation. These new 
structures can then be used by other programs to display a common view of the superfamily. 
 All components from each PDB, such as protein chains, ligands and metals, are 
additionally stored in separate PDB files. For example, structure 1BSX will be stored in five 
different files: 1) the complete structure including protein and ligand chains, 2) two separate 
protein chain files, one containing protein chain A and one containing chain B, 3) two 
separate ligand files, one containing ligand chain A and one containing chain B. The newly 
reoriented structures are used as basis for the split PDB files which therefore also use the 
common orientation.
2.4.5 Determine Structural Conservation
The amount of structural conservation differs between regions of the superfamily structures. 
To determine the common structural core, all superfamily members are compared with the 
master template using WHAT IF (fig. 1.7, a2 & fig. 2.5). Structural conservation is defined 
as three consecutive residues in both structures for which the distance between the Cα atoms 
of each pair is less than 2.5Å. When three consecutive residues are found that match these 
criteria, WHAT IF checks if additional residues can be added without violating the RMSD 
constraints. 
2.4.6 Select Subfamily Templates
Proteins for which no structure data are available are included into 3DM systems using 
sequence alignments. These sequences are grouped into subfamilies based on subfamily 
templates. Subfamily templates are selected based on sequence similarity. All superfamily 
PDB structures are examined in order. The first structure, usually the master template used 
for the superposition, is automatically selected as a subfamily template. For each subsequent 
structure the sequence similarity is determined with the list of selected subfamily templates. 
Structures are added as subfamily templates when they are less than 80% similar to all 
currently selected subfamily templates. The selection of subfamily templates therefore 
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depends largely on the order in which the structures are compared. A proper selection of 
subfamily templates probably requires a phylogenetic tree, evaluation of structure properties 
such as resolution, and in-depth knowledge of the superfamily. Smarter subfamily template 
selection will soon become necessary as more and more sequence and structure data become 
available and the list of potential subfamily templates continues to grow. 
2.4.7 Expand Common Core
The initial common structural core is determined using a single superposition based on the 
master template. This common core is relatively conservative due to structural divergence 
and the flexibility of structural elements. Conformational changes in the loops connecting 
secondary structure elements, crystallization artefacts, or contaminations can shift structural 
elements beyond the 2.5Å cut-off used for the determination of common core residues. 
Additionally, hinges sometimes allow for much larger conformational changes without 
requiring large insertions or deletions of sequence. In the Nuclear Receptor family for 
example, helix 12 changes confirmation depending on activation or inhibition of the ligand 
binding domain. The composition of the helix itself is conserved, only the location in the 
structure is variable due to the hinge. Helix 12 can therefore be included in the common 
core based on sequence similarities despite the divergence in structural location. To expand 
the conserved regions determined in step 2.4.5 the common core is determined again using 
the subfamily templates structures selected previously. 
2.4.8 Subfamily Alignments
Subfamily alignments are created for each of the templates selected in step 2.4.6 using a 
profile based iterative method (fig. 1.7b). These alignments are used to align proteins to the 
Figure 2.6: Partial alignment profile. Columns show the residue number (position 3-40 not shown), residue, 
gap open penalty, gap elongation penalty, position weight, score for each amino acid (some scores omitted), and 
alignment position numbers. The gap open and elongation scores are adjusted for positions 43-49, and 51-52, 
as these positions are part of the common core. These regions are used as anchors in the sequence alignment and 
therefore the scores have been adjusted to prefer insertions and deletions in variable regions. 
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closest related template structure in the superfamily. BLAST searches against the UniProt 
and PDB databases are used to preselect sequences which can potentially be aligned to the 
subfamily template. A subset of sequences is used for the alignment procedure instead of 
all sequences from PDB and UniProt to speed up the alignment procedure. The alignment 
procedure is profile based and iterates through multiple rounds. Using the template sequence 
an initial profile is created (fig. 2.6) for the first alignment round. Profiles for the 2nd, 3rd, 
and 4th rounds are based on the results of the previous iteration. After the first alignment 
is complete, a profile is created for the 2nd round using all sequences which were aligned to 
the profile in the first round with at least 70% identity. Profiles for the 3rd and 4th round 
are created using sequences 55% and 45% similar to the profile of the previous round. 
Several modifications are made to the profiles to improve the alignments. Common core 
regions in the template are used as anchors in the alignments. Insertions and deletions in 
Figure 2.7: Alignment data of an alpha amylase protein. The superfamily consensus is shown at the top 
together with the subfamily consensus and template sequence of subfamily 2FH8A. Alignments for the protein 
against several subfamily templates are shown in the table. Each line contains the alignment of the protein against 
a subfamily profile. The alignments are ordered by profile iteration and similarity. Each line shows the subfamily, 
profile iteration, similarity and aligned common core regions of the protein. Common core regions are numbered 
at the top. The numbers between the common core regions indicate the number of variable residues. The selected 
alignment used in 3DM is shown in green. The other alignments are only used for quality control. Alignment 
positions that do not match the selected alignment are highlighted in red.
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common core regions are less likely as these regions are structurally conserved. Therefore the 
alignments are tuned to favour insertions and deletions in variable regions by adjusting the 
gap open and gap elongation penalties. The iterative profile based alignment procedure is 
performed twice for each subfamily. The first run consists of three iterations and the second 
run of four. Superfamily statistics such as conservation and hydrophobicity are determined 
for all positions of the common core after the first three iterations. During the second set 
of alignments the superfamily statistics are used to tune the profiles. For example, a highly 
conserved serine at a structurally conserved position will get a positive bonus score and 
hydrophobic residues receive a small bonus score on predominantly hydrophobic positions. 
Due to differences in length of the sequences in the variable regions these regions cannot be 
properly aligned during the profile alignment phase. MUSCLE [7] is therefore used to align 
the sequences of each variable part of each subfamily separately using 4 iterations. 
2.4.9 Alignment Quality Control
A sequence can be aligned to several templates in the superfamily due to sequence and 
structure similarities between templates (fig. 2.7). For each protein in the 3DM superfamily 
only one alignment is used. Proteins with ambiguous alignments are therefore checked to 
obtain the highest quality alignment for each protein. An alignment is initially selected 
for each protein based on profile iteration and similarity. In figure 2.7 for example, the 
alignment against profile iteration 4 of subfamily template 2FH8A is preferred over the 
other alignments as the similarity is higher. All proteins for which the selected alignment 
has a profile similarity over 50% are assumed to be correct. The alignment consistencies of 
proteins with a selected alignment with a similarity below 50% are checked and if necessary 
adjusted using the alternative alignments. If only one alignment is available for a protein and 
the similarity of that alignment with its profile is below 50% the protein is removed from the 
database as its alignment cannot be verified. The 50% similarity cut-off was chosen due to 
the high number of comparisons the alignment consistency check requires for each protein, 
and the low rate of inconsistently aligned sequences with similarities over 50%.
 To check the quality of a proteins alignment the alterantive alignments for each 
region of the common core are compared with each other. A consistent alignment is not 
necessarily an indication of a high-quality alignment. Inconsistent alignments however, 
indicate regions for which multiple alignment solutions were available that scored evenly. 
The alignments of these regions are less certain then the unambiguously aligned regions and 
have to be checked to ensure the alignment is correct. To check the alignment consistency of 
a common core region the alternatives for each region are determined and evaluated using 
the subfamily and superfamily consensus sequences. A similarity score is determined for 
each of the common core regions with the subfamily template and superfamily consensus 
and used to selected the best alignment for each region. The final sequence for a protein can 
thus consist of common core regions from alignments against different subfamily templates. 
After assembly, the overall score of the alignment is calculated and used to determine if 
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the alignment passes quality control. Proteins for which the alignment does not score high 
enough on this final test are removed from the database. 
 The alignment of a common core region is considered correct and left unchanged 
when it is consistent between different subfamilies. In the example shown in figure 2.7 this 
is the case for common core regions 3 and 4 which are essentially aligned unambiguously. 
Common core regions that have been aligned inconsistently are evaluated using the alternative 
alignments (fig. 2.7, regions 1, 2 and 5). For each inconsistently aligned common core 
region, the alternative alignments are selected based on frequency of occurrence. Six possible 
alignments are available for region 1 in figure 2.7: SAAGKNF 9 times, FVLTDRF 4 times, 
DIVGAPF, DKNDHGF and KNFYFVL twice and SALPRYF once. Only SAAGKNF and 
FVLTDRF occur more than the occurrence cut-off of 3 and are therefore considered as 
potentially correct alignments for this common core region. Both alignments are compared 
with the subfamily template and superfamily consensus sequence for common core region 
1 using a BLOSUM62 matrix. Additional points are awarded for alignments that result in 
the lengths of the variable regions upstream and downstream of the common core region 
to match the length of the corresponding variable regions in the subfamily template. In 
this case, the variable regions of the subfamily template sequence flanking common core 
region 1 are 262 and 22 residues in length. Neither of the two alternative alignments results 
in flanking variable regions of these lengths so no bonus points are added. The alignment 
with the highest score is used in the final alignment. For the example case the final score for 
SAAGKNF is -5 and the score for FVLTDRF is +5 meaning that the FVLTDRF alignment 
will be used for the first region of the common core in this alignment. After each core 
has been checked, and if necessary replaced, a final evaluation of the updated alignment 
is performed to check the quality of the complete alignment. The scores of the correct 
common core regions are checked and alignments for which more than 2 regions score 
negatively are removed.
2.4.10 Assemble Superfamily Alignment
To construct a superfamily alignment the subfamily alignments must be combined as 
described in figure 1.7. The common core regions of all subfamily templates are already 
aligned automatically because of the superfamily superpositioning. The common core of 
each superfamily is based on structure conservation resulting from evolutionary pressure. 
The common core residues are therefore present in most aligned proteins. Residues aligned 
to the common core positions in the subfamily templates are extracted for each protein 
and used to construct a core alignment. A numbering scheme based on these core regions 
is applied to facilitate the transfer of information between structurally equivalent residues. 
2.4.11 Integrate Heterogeneous Data Types
A large number of different data types and datasets can be integrated in a 3DM system using 
the MSA as basis. This ranges from additional descriptions of the proteins in the superfamily 
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to correlations between different alignment positions. Data types that can be integrated 
into 3DM systems include: mutations and variants, protein and residue annotations, 
inter- and intra-molecular contacts, ligand-, ion-, and, metal-contacts, genomic sequences, 
charge clamps, hydrophobicity, accessibility, RMSD of positions in the common core, 
B-Factor, cross-references, etc.
1) Publications. Articles are used as reference in 3DM systems whenever possible. Annotations 
retrieved from external databases for example, are sometimes linked to articles. Mutator, the 
3DM tool used to extract mutations from literature also provides mutations annotated with 
articles. These articles themselves are not stored in 3DM systems, however a reference is 
stored for each articles linked to an annotation or variant. For each article the title, authors, 
PubMed identifier, and reftag are stored. Mutator (chapter 2.6) and the GenBank and 
UniProt parsers insert the literature data in the database whenever a referenced annotation 
or variant is stored. 
2) Structures. Structures are incorporated into the alignment and stored as proteins in the 
Protein table. PDB files, however, contain more than just proteins. Compounds commonly 
found in PDB files include ions, metals, solvents, water molecules, ligands, DNA/RNA 
strains, and drugs. The rules used to identify the various compounds are listed in table 2.3. 
Compound Identification rule
Protein Compound name starts with ‘Protein’
Water Compound name contains ‘water’
Oxygens Compound name contains ‘O2’
DNA/RNA Compound name is ‘DNA/RNA’
Ions Predefined list of ions including ‘BA’, ‘BR’, ‘CA’, ‘CD’, etc.
Metals Predefined list of metals including ‘AU’, ‘CO’, ‘FE’, ‘HG’, etc.
Solvent Compound name is any of ‘EOH’, ‘GOA’, ‘GOL’, or ‘SO4’
Ligand Compound is composed of 7 or more HETATMs
Unknown Everything else not matched by any of the other rules
All compounds from the PDB file are stored in the 3DM database except water molecules, 
solvents, and unknown compounds. Additionally, each residue of each protein chain is 
stored separately to be able to link residues in PDBs with amino acids in the alignment 
Table 2.3: Identification rules for compounds in PDB files. Rules for the identification of compounds 
commonly found in PDB files in the order they are used to identify compounds.
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and link structure specific data to the PDB residues. These structure specific data include 
3D-coordinates, secondary structure, b-factor, RMSD, accessibility, and the number of 
the residue in the PDB file. The complete PDB file is analysed and inserted using a PHP 
script. Each structure is loaded into WHAT IF to determine the individual components 
using the SHOSOU option. A second script parses the split PDB files generated after the 
superpositioning and inserts each residue from the PDB file linked to an amino acid from the 
alignment. Extraction and determination of structure specific data is described separately.
3) Mutations and variants. Mutation data is available from several sources such as literature 
and mutation databases. Mutator was developed for the selection and retrieval of relevant 
articles, scanning for mutations and grounding these mutations to residues in the database 
(chapter 1.4 and 2.6). UniProt and GenBank records of superfamily proteins also often 
contain mutations and sequence variants. XML formatted files containing all data on each 
protein are available for all entries from these two databases. Mutations and variants are 
extracted from these files and stored in the database as a feature linked to the relevant amino 
acid. A PHP [8] script has been written that uses SimpleXML data structures and XPath [9] 
queries to retrieve the variants from the XML files. UniProt records are available in XML 
format using a webservice. GenBank records are retrieved using the EFetch facility of the 
Entrez suite [10]. Records from both UniProt and GenBank are cached for one month to 
prevent excessive network traffic. 
 An additional source of mutation and variant data are custom databases containing 
datasets for species or diseases. A growing number of databases containing natural variants 
are also available due to the rapidly decreasing costs of sequencers. Hospitals and universities 
are increasingly participating in genome, or exome sequencing projects to diagnose patients 
or to create natural variant databases. These databases are intended for SNP detection and 
variation studies, and are an important source to study the natural variations in the human 
genome. For some high-profile diseases, specific mutation databases are available such as the 
iARC [11] database that contains mutations related to cancer. Aggregate databases for entire 
species are also available such as the HGMD for human and the Sacharomyces Genome 
Database for yeast [12]. These custom mutation databases are available for a limited number 
of species, diseases, and superfamilies as assembling, curating, and maintaining these 
databases takes a lot of manual work. Free public access to these databases is therefore not 
always available, and access methods and data formats differ significantly due to a lack of 
common standards. An often used file format to export data from databases and spread sheets 
is the Comma-Separated Values (CSV) format [13]. A PHP script was written for 3DM to 
parse CSV files, convert the mutation data, and store the data in the 3DM database. The 
mutations are processed by providing the script the location where the data can be retrieved 
and a description of the format. Databases which do not offer CSV or XML output are 
scripted individually. 
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4) Protein and residue annotations. Many annotations are available from the UniProt and 
Genbank records discussed in the previous paragraph. These annotations describe residues, 
domains, and proteins and include post-translational modifications, species, gene names, 
synonyms, binding sites, active sites, NCBI taxonomy id, taxonomic lineage, trans-membrane 
regions, etc. Annotations are linked either to individual amino acids or to complete proteins 
depending on their type. The script described in the previous paragraph is also used to 
extract annotations from UniProt and GenBank records, link the annotations to a protein 
or amino acid, and store the annotations in the 3DM database. A separate PHP script was 
made to extract annotations such as species, secondary structure, or mutations from PDB 
structure files. In contrast to the scripts used to determine for example contacts from PDB 
files, the extraction of annotations from PDB records does not require the coordinates of 
all atoms. Partial XML formatted records which lack the coordinate section are therefore 
used rather than complete PDB files for extraction of PDB data. XML records are more 
consistently structured then regular PDB files, and it is therefore much easier to retrieve data 
from these records compared to PDB raw files. XML formatted records containing only the 
PDB header are available from PDBe [14].
5) Contacts. Many types of contacts are formed between different amino acids and between 
amino acids and other molecules. Example contacts are hydrogen bonds, ligand contacts, 
disulfide bridges, and intra-molecular contacts. WHAT IF is used to determine these contacts 
using the SHOHBO, SHOCYS, and CONTACT options [15]. A WHAT IF macro to 
determine contacts is generated by a PHP script. The macro instructs WHAT IF to load one 
or more structures one by one, determine the contacts, and store the results in a separate 
file for each structure. The files containing the contacts are subsequently parsed to extract 
the raw data. The PHP script matches the residues in the structure with the residues in the 
database and stores the contacts. Hydrogen bonds, intra-molecular contacts, and cysteine 
bridges are linked to both amino acids involved in the contact. Ligand contacts are linked 
to an amino acid and to a PDB compound. The compounds can be anything co-crystallized 
with the protein in the PDB file such as hemes, activators, drugs, etc. Contact data such 
as cysteine bridges and binding sites are also available from UniProt and GenBank protein 
records. The parser described in the mutations and variants paragraph of this chapter is also 
used to extract contacts from GenBank and UniProt and store them in the 3DM database.
6) Genomic data. The PICR webservice [16] hosted by the EBI is used to match proteins 
in the 3DM database to gene sequences from RefSeq. RefSeq entries include the full gene 
transcript that consists of the promoter, coding sequence, poly-A tail, and 3’-UTR region. 
Unfortunately, a single UniProt accession code may return multiple RefSeq entries due to 
isoforms. RefSeq stores each transcript separately, UniProt however combines all isoforms 
of a protein in one record. As the numbering of isoforms between the databases is not 
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consistent, an amino acid translation of the transcript sequence is used to determine the 
correct match. A custom PHP script is used to invoke the PICR webservice, determine the 
correct isoform, and insert the data into the 3DM database.
7) Correlated mutations. Residue positions that appear correlated in alignments are 
potentially functionally related. Comulator is used to determine which residue pairs are 
actually correlated. The evolutionary basis of correlated mutations is described in chapter 
1.3 and the implementation of the algorithm used to determine correlations in chapter 2.5.
8) Charge clamps. Charge clamps are commonly determined by investigating charged 
residues in close proximity of each other in structures. However, since most sequences do 
not have structural data associated with them, and we require an automated method to 
determine charge clamps we decided to use alignments instead to predict possible charge 
clamps. Charge clamps are defined as two residues in close proximity which contain an 
opposite charge. We defined lysine and arginine as positively charged, aspartic acid and 
glutamic acid as negatively charged, and all other amino acids as neutral. A script was written 
which for each pair of alignment positions determines the residue pairs that occur. A score 
is calculated based on the categories the occurring residues fall into. Pairs of residues with 
opposite charge are indicative of a possible charge clamp and score positively. Positions 
which have combinations of a neutral and a charged residue, and combinations with 
identically charged residues are indicative of non-charge clamped pairs and score negatively. 
Pairs of neutral residues are used to normalize the score. As the common core residues in the 
sequence alignments are linked directly to the structural alignment, a future expansion of 
the charge clamp code will include the distance between the residues in the structures in the 
formula to attempt to validate predicted charge clamps.
9) Hydrophobicity. The average hydrophobicity of alignment positions can be calculated 
using the amino acids that occur at the position. Many different scales are available to 
determine the hydrophobicity of an alignment position aimed at different situations and 
purposes. We decided to use a simple generic scheme in which each amino acid is either 
hydrophobic or hydrophillic determined by the amino acid type. A hydrophobicity score 
is determined for each alignment position by adding a point for each hydrophobic residue 
(WFALYIVM) and subtracting a point for each hydrophilic residue. Finally, the score for 
each position is normalized to 100 using the number of sequences available at that position.
10) Accessibility. Solvent accessibility of each alignment position is determined using 
WHAT IF. A PHP script creates a WHAT IF macro that passes all structure files from the 
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superfamily to WHAT IF one after the other. WHAT IF determines the vacuum accessibility 
of each atom of each residue using the custom VAC3DM option. The results are stored in 
an easily usable format in a separate file for each structure. The PHP script parses all output 
files, determines the total accessibility in percentages of the side chain of each residue, and 
averages the side chain accessibility for all residues on an alignment position. Both the 
individual accessibility scores for each residue of each structure, and the average accessibility 
score of each alignment position are stored in the 3DM database.
11) RMSD. The RMSD of an alignment position can be used as an indication of its 
flexibility and freedom of movement. To determine the RMSD of an alignment position, 
the coordinates of the C-Alpha atoms from the structures are used. A PHP script parses 
the structure files for a superfamily and extracts the ATOM records for all CA atoms. The 
RMSD is determined by a second PHP script using the atom coordinates. The RMSD of 
each PDB residue is stored in the 3DM database. An averaged RMSD is also stored for each 
alignment position.
 
12) B-Factor. The B-Factor is stored in PDB files in a separate data column. A PHP script is 
used to extract the data for each residue of each PDB file and store this data in the database. 
An averaged B-Factor value for each alignment position is also determined and stored.
13) Cross-references. Databases containing data, references, and annotations for all sorts 
of biological entities are scatter over the internet. To include all of this data in 3DM is not 
practical due to size and time constraints. Most of the available data has only a very small range 
of applications, and storing all data would mean enormous datasets. 3DM therefore includes 
references to many external databases to offer as complete an overview and description of 
each protein and amino acid as possible. References to external databases can be retrieved 
using PICR, or from the UniProt, GenBank and PDB records. Example references included 
in 3DM are: InterPro, Gene3D, PDBSum, ProSite, and PFam. In addition to the identifier, 
a description of the remote record is also stored to facilitate searching and data clustering. 
The PHP scripts used to retrieve the references from the various sources are described in the 
previous paragraphs.
14) Accession status. UniProt protein records contain not only information on proteins but 
also include updates and deprecations of the record themselves. Proteins in UniProt are not 
static and may be replaced, or removed over time. Several possibilities lead to the removal 
of accession codes from UniProt, these are: the merger of separate isoform records into a 
single record, retraction of the underlying genomic dataset, and removal of predicted ORFs 
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which after curation are found not to encode for proteins. Retrieving a record for a UniProt 
accession code using the webservices therefore has three possible outcomes: the record itself 
is returned, the record has been deprecated and a different record into which the entry has 
been merged is returned, or the record has been removed entirely and an empty record is 
returned. To keep the 3DM systems as up-to-date as possible the churn of accession codes is 
handled automatically by the UniProt retrieval script. When a different record was returned 
then was requested, the original accession entry is not removed from the database directly. 
Instead, the record is changed into an alias of the UniProt accession code into which it has 
been merged. When the webservice returns an empty record a second record in RDF format 
is retrieved to check the records status. If an accession code has been removed from the 
UniProt database this is reflected in the RDF record with an “obsolete” tag. These proteins 
are removed from the 3DM database completely as they do no longer exist.
2.4.12 Visualize Superfamily Data
Data in 3DM systems can be visualized using either the interactive website or the YASARA 
structure viewer (fig. 2.1). The website allows users to view the alignment, alignment statistics, 
correlations, protein and amino acid annotations, phylogeny trees, mutations, contacts, 
taxonomy trees, etc. Various tools are also provided to search data, analyse mutants, create 
homology models, and view data in structures. Most data can be visualized and retrieved 
from multiple different starting points. For example, mutations are listed on amino acid, 
protein, and alignment position detail pages. Export options are also available for various 
data types to allow the user to process data in external programs. Filters can be used to create 
subsets of the superfamily alignment based on a variety of options. These subsets can be used 
to limit the data visualised on the website to allow for more in-depth study of parts of the 
superfamily. 
 Data from the 3DM system can be mapped onto structures using the view data 
in structure tool (fig. 2.8). An arbitrary selection can be made of structures and homology 
models and 3DM data can be mapped on the residues in the structures. The orientation 
of structures and models is identical due to the reorientation of structure files during the 
creating of the 3DM system. Using the alignment position numbering in the structures and 
models ensures residues can be compared with each other and with the data on the website 
easily. A 3DM plugin is available for YASARA which can retrieve data from the database 
and plot these data interactively in the scene. The python plugin communicates with a series 
of XML producing PHP scripts on the 3DM webserver to obtain the requested data. The 
plugin allows users to map alignment position data such as conservation and correlations 
onto the structures, colour the structures based on various properties, and add structures and 
drugs to the scene on the fly. Protein and amino acid annotation data can also be retrieved 
and visualized using the plugin.
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Figure 2.8: 3DM generated YASARA scene containing several examples of 3DM data plotted into structures. 
Scene contains Nuclear Receptor structure 1A28 chain A combined with ligands from 1BSX, 1DKF, 1ERE, 
and 1FBY superposed in the active site. Ligands are shown in atom sphere representation, residues in tube 
representation. Residues of interest have their side chains shown in atom sphere and are labeled with the alignment 
numbering. Common core regions are colored in a gradient from green to blue. Residues in variable regions are 
colored grey. Coloring of residue side chains based on plotted data: red) charge clamps, blue) intramolecular 
contacts, green) ligand contacts, yellow) conservation, magenta) correlated mutations.
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2.5 Correlated Mutations
A Correlated Mutation Analysis (CMA) score is determined for each pair of alignment 
positions (formula 1). The CMA algorithm uses a double loop over the alignment positions 
to compare each position with all other positions. CMA scores are calculated bi-directionally 
and subsequently averaged for each pair of positions. The CMA scores are calculated using 
a custom developed C++ program (fig. 2.1, comulator). The CMA score is normalized by 
assigning the highest correlating pair a score of 1 and scaling the other scores correspondingly. 
Both the absolute and relative CMA scores are stored in the 3DM database. CMA scores 
are not comparable between different protein superfamilies as the outcome of the algorithm 
depends heavily on the number of sequences in the alignment.
CMA scores are visualized in the 3DM websites using heatmaps. A PHP script was written 
to generate the images using the precalculated CMA scores. Heatmaps containing all 
available datapoints for a superfamily are very large. The Nuclear Receptor superfamily 
for example, has 157 positions in the common structural core which results in a heatmap 
containing 24,649 datapoints ( 157 * 157 ). A condensed overview image of the correlations 
is therefore also included. This condensed overview contains only those positions for which 
any of the correlations exceeds the relative CMA score cut-off of 0.8. For the NR this results 
in 33 positions being included leading to a much more manageable heatmap consisting 
of 1,089 datapoints. Amino acid abundances can be visualized for each pair of correlating 
alignment positions. These abundances are displayed in a table with the amino acids of the 
two positions on the axes and the percentage of superfamily sequences that contains that 
amino acid pair in the cells.
2.6 Mutation Information
Mutator was developed to extract mutations from the literature. The aim was to automatically 
retrieve text from articles that describes possible amino acid or nucleotide mutations and to 
link these mutants to the correct proteins. Mutator consists of a series of python scripts 
designed to retrieve scientific articles from PubMed, to convert the articles to a computer-
readable format, to extract the mutations, to ground the mutations to proteins (grounding 
Formula 1: CMA scoring algorithm. The CMA score is determined for each pair of alignment positions. The 
absolute fraction difference (F) is multiplied by the observed frequency of the amino acid pair (Nxy) for each pair 
of amino acids at an alignment position. The results are summed to determine the CMA score for the position. 
The fraction differences are determined using the total number of sequences in the alignment (Ntot) and the total 
number of sequences that have amino acid x (Nx) or amino acid y (Ny) at that position.
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is the process that associates a mutation with the corresponding gene), to validate the 
mutations and discard false-positives, and to store the mutations in the 3DM database. 
Therefore the design criteria for Mutator are strongly influenced by the requirements of the 
3DM platform. The main criteria for the design of Mutator were: applicability to complete 
superfamilies consisting of thousands of proteins, applicability to all superfamilies without 
requiring superfamily specific logic, and full-text article support. Mutator additionally has to 
be over 99% automated to be able to keep up with the rate of publication of new articles. At 
the time work on Mutator began in 2006, a number of tools where already available to deal 
with one or more parts of the mutation retrieval process (table 2.2). An overview of these 
tools, and additional tools available today is presented in the next section. The strong and 
weak points of the various tools will be listed together with the lessons we took from them.
2.6.1 Tools
Several tools have been developed to automate one or more steps of the mutation retrieval 
process (table 2.2). These tools work on different databases, use different technologies, 
and different levels of automation and user interaction. MuteXt [17] uses a computational 
method that identifies and extracts mutation data from scientific literature related to two 
specific protein families. MEMA [18] was developed to extract mutations and gene names 
from MEDLINE. Yip et al. [19] describe a method to update Swiss-Prot variants with new 
literature references. CoagMDB [20] is a database of mutations for five serine proteases 
involved in blood coagulation. MutationGrab [21] explores the use of network graphs to 
ground ambiguous mutations and MuGeX [22] retrieves mutations from MEDLINE that 
are related to a specific disease. Vtag [23] and Mtag [24] are applications for finding and 
highlighting biomedical entities in a text. Vtag looks for mutations and Mtag for cancer 
related objects and concepts.
 Each of these tools has been developed with a specific goal in mind. Some tools 
focus on just one aspect of the mutation extraction process, while others are targeted at 
specific proteins, or showcase a novel technique for one of the steps of the mutation retrieval 
process. Most tools are able to retrieve articles, extract mutations, and ground the mutations 
to a protein. MEMA and MuteXt for example, offer a complete workflow that ranges from 
searching and retrieving articles to mutation extraction and validation. Vtag and Mtag instead 
focus on highlighting mutations in articles for manual extraction. The mutation source of the 
tools also varies, some use MEDLINE and others use PubMed. Most tools support data 
extraction from abstracts while some also have additional support for extracting data from 
full-text articles. The target proteins for which the applications were designed differ widely. 
CoagMDB and MuteXt have been designed to retrieve mutations for specific superfamilies 
while MuGeX is targeted at proteins related to a specific disease. Despite these differences, 
these tools all solve several parts of the mutation extraction process similarly. Almost all tools, 
for example, use regular expressions to extraction mutations from text. We have studied the 
available tools to determine which aspects could be incorporated into Mutator.
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Tool Database Options Year Reference
MuteXt MEDLINE KRGVF 2004 [17]
MEMA MEDLINE RGV 2004 [18]
Swiss-Prot PubMed KRGV 2007 [19]
CoagMDB PubMed KRGV 2008 [20]
Mutation Grab PubMed GVF 2007 [21]
MuGeX MEDLINE RG 2007 [22]
Vtag NA - 2004 [23]
Mtag NA KR 2006 [24]
OSIRISv1.2 MEDLINE RGV 2006 [25,26]
MutationFinder PubMed - 2007 [27]
EnzyMiner PubMed KR 2009 [28]
Mutator PubMed KRGVF 2010 [29]
1) MuteXt is part of the Molecular Class Specific Information System (MCSIS) platform, 
and offers an automated pipeline for retrieval of mutations for a complete protein 
superfamily. MuteXt was developed in close cooperation with the authors of the NuclearDB 
and GPCRDB MCSISes. The MCSIS database, used as backend, contains proteins and 
keywords of the target superfamily. The MEDLINE database is queried for relevant articles 
using query terms obtained from the MCSIS. Queries are generated by combining the 
protein family names with ‘mutagenesis’, ‘mutant’, and ‘mutation’. MuteXt uses PubMed 
facilities to obtain full-text articles when possible. Mutations, gene names, and organism 
data are extracted from the articles using regular expressions. The first step in the grounding 
process is the selection of candidate sequences from the MCSIS database that match the 
sequence motif of the extracted mutation(s). Subsequently the corresponding sequence is 
determined by using the gene names and organism data extracted from the article. When 
multiple candidate sequences remain, the distance in words in the original text between 
the extracted terms and the mutation is used to select a sequence. The original design of 
MuteXt facilitates mutation retrieval for complete superfamilies. However MuteXt was 
designed to work with an MCSIS database as backend, and contains a lot of superfamily 
specific code. Therefore, MuteXt can only be used for the Nuclear Receptor and GPCR 
Table 2.2: List of mutation analyses tools. First two columns list the name of the tool and the database from 
which articles or abstracts for searching and scanning are retrieved. The following 5 columns list the capabilities 
of the tool: generation of lists for keyword searching, automatic retrieval of articles, grounding of mutations to 
proteins, validation of the grounding algorithm, and applicable to superfamilies. The publication date of the 
article accompanying the initial release of the tool and the reference are shown in the final 2 columns. Options: 
(K) Keyword searches, (R) Retrieval of articles, (G) Grounding of mutants to proteins, (V) Validation of mutants, 
(F) Support for protein or gene families.
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superfamilies. MuteXt is no longer actively developed, but serves as a major inspiration for 
Mutator, similarly to the MCSISes serving as main inspiration for the 3DM platform at 
large. MuteXt was the first tool to utilize a superfamily system as backend for data storage. 
Many ideas from MuteXt are incorporated into Mutator such as the keyword generation, 
full-text article retrieval, usage of gene names, and organism data for grounding, and 
pre-selection of candidate sequences. 
2) MEMA has been designed to extract protein and DNA mutations from all MEDLINE 
abstracts. MEDLINE contains only abstracts of articles classified as ‘medical’, which largely 
limits the application of MEMA to disease related proteins. Additionally, only abstracts 
which contain a HUGO [30] protein name were retrieved and processed. For Mutator 
we do not use HUGO but rely on protein names available through the UniProt and 
GenBank databases. Records from these databases contain lists of synonyms which generally 
include the main HUGO identifier in addition to other often used identifiers. Using the 
lists therefore increase the chances of recognizing protein identifiers in articles. MEMA 
assigns mutations retrieved from abstracts that contain only one gene directly to that gene. 
When multiple protein identifiers are observed, the corresponding protein is determined 
by evaluation of the text surrounding the mutation term. The MEMA authors validated 
and tested their method on several sets of articles. Recall and precision of the extraction of 
mutations and mutation-gene pairs from text was evaluated using a test set of 100 articles. 
Protein identifiers and mutations were manually extracted from these articles and compared 
with the results of MEMA. Extraction of mutations gave a recall of ~74% with a precision 
of 99% and for mutation-gene pairs a recall of only 35% with a precision of 93%. 
3) Yip et. al describe a method to automatically update the references for variants in the 
Swiss-Prot database. All variants in the Swiss-Prot database have been manually extracted 
from the literature when available the effect of the mutant is also extracted. To keep the 
reference lists for each variant as up-to-date as possible a method was developed to validate 
existing, and retrieve new references for novel and existing variants from the literature. 
Protein names, gene names, and synonyms from the Swiss-Prot record are used to query 
PubMed for relevant articles. Any article that is already referenced by an existing variant is 
discarded. The abstracts and titles of the remaining articles are scanned using three regular 
expressions to extract mutations (table 2.3). A rudimentary sentence parser is also used to 
extract mutations: “For pattern 4, a sentence was considered as a match if it contained all 
of the following information: (1) a number (position of the variant); (2) a term describing 
the variation (e.g. variant, mutation, or polymorphism); (3) an amino acid in full letters, 
3-letter code, or codon notation; and (4) a term descriptive of the position in the amino 
acid chain (e.g. position, located, situated). A sentence containing no term on position but 
mentioning two different amino acids was also considered as a match.” Full-text articles 
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were used for preliminary tests to check if the workflow could be extended to include full-
text articles. Although the tests indicated that full-text articles could be used the method 
proved to slow for inclusion in the regular workflow. New references for existing variants 
have been added automatically to the Swiss-Prot database, but novel variants could not be 
added automatically as the quality of detected mutations did not live up to Swiss-Prot’s high 
accuracy standard. Articles containing novel variants were however tagged for later manual 
inspection. Unlike Mutator, Yip’s method focuses on a high precision rate whereas Mutator 
values recall over precision. The regular expressions and search criteria used by Yip’s et al. 
were studied and partially included in Mutator.
1 Single character abbreviations with position number L45H, L-45-H, L(45)H
2 Three character abbreviations with position number Leu45->His, Leu(45)His, CTT(45)CAT
3 Position number with three character abbreviations 45Leu->His, 45CTT>CAT, 45Leu→His
4) CoagMDB is a mutation database designed specifically for five sequentially highly similar 
serine proteases involved in blood coagulation. The keywords used to search PubMed for 
articles are based on Entrez gene names, alternative protein names and diseases from OMIM 
records associated to the genes. Articles that could not be retrieved automatically where 
retrieved manually. Mutations are not entered into the database automatically. Candidate 
sequences for mutation grounding are selected based on gene and protein names found 
in the text. The software uses regular expressions to locate sentences containing amino 
acids and residue positions. These sentences are extracted and parsed for mutation entities 
consisting of a wild type, mutant, and position. The wild type residues are matched with the 
candidate sequences to determine the most likely protein. CoagMDB uses three different 
numbering schemes for sequence selection: regular sequence numbering with or without 
the signal peptide, a chymotrypsin specific numbering scheme, and a sliding window 
approach. Regular sequence numbering checks if the wild type amino acid is present at the 
specified position in the sequence. As signal peptides can be included or excluded from the 
numbering at the discretion of the authors of the paper, the position is compensated for 
both possibilities. The chymotrypsin numbering of the proteases is also used to check if the 
wild type residue matches any of the candidate sequences. Alternatively, a sliding window 
is used to determine whether all mutations have a common offset in one of the candidate 
proteases. A web interface is used to show the results from the parser to an administrator 
who can either accept or discard the mutation(s). Using alternative superfamily specific 
numbering schemes will be added to Mutator in the future. To prevent having to include 
superfamily specific code into Mutator the numbering schemes will be stored in the 3DM 
database and be editable by the user. A sliding window to find mutations in sequences will 
Table 2.3: Regular expressions used by Yip et. al to extract mutations from articles.
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not be incorporated into Mutator in the foreseeable future as using a sliding window with 
the vast amount of sequences available in the backend database would significantly increase 
the number of false-positives.
5) Mutation Grab was tested on three protein families: G protein-coupled receptors, tyrosine 
kinases, and ion channel transporters. These three families were selected as they are the three 
major targets for drug development, Mutation Grab has been designed to be applicable to 
all superfamilies. Articles were selected differently for the superfamilies. The tGRAP [31] 
database was used to identify articles for the GPCR family. For the other two families the 
family name in combination with “protein mutation” was used as PubMed query. In all 
three cases the articles were curated manually and 100 articles were selected to be used 
as training set, and 100 articles were selected as test set. The remaining articles were not 
used for the analyses. Mutations, protein names, and organism names were extracted using 
regular expressions. Regular expressions to extract protein and organism names where based 
on dictionaries assembled from Swiss-Prot and Entrez gene proteins related to the protein 
family. Candidate sequences were retrieved from Swiss-Prot using the organism and protein 
name. Further selections have been made by fitting the wild type residues from the mutation 
on the sequence. Isoforms and signal peptides were taken into account. When only one 
candidate protein remained the mutation was assigned to that protein. When multiple 
candidates remained a graph bigram metric was used. Graph bigram is a distance metric to 
determine the likelihood two words are connected. Graph bigrams include frequency and 
positional data for all terms extracted from a text. For example, if “human GLA” is found at 
the beginning of the article and GLA itself is found close to the location of the mutant in the 
text, the graph bigram metric will associate human with the mutation in addition to GLA. 
Both terms can then be used to select a protein.
6) MuGeX retrieves all abstracts from MEDLINE that contain either the word “mutation” 
or “polymorphism” and extracts amino acid mutations from these abstracts. A preprocessing 
step is used to extract authors, title, and journal from the abstract and store them in an easily 
retrievable format. The title and content from the abstract are first split into sentences and 
subsequently into words for later processing. A set of 20 regular expressions all based on the 
[amino acid][position][amino acid] format are used to extract mutations. Machine learning 
techniques are used to filter out nucleotide mutations, strain names, and cell lines from the 
results that matched any of the regular expressions. For the grounding step a dictionary is 
created using HUGO gene names and aliases. Because a standard nomenclature for gene 
names is lacking the terms in the dictionary are preprocessed in order to normalize the gene 
names. For gene symbols all hyphens are replaced by white space, and all parenthesized 
material is removed. For gene names, all parenthesized materials are also removed, all 
punctuation characters are replaced by white space, and all uppercase characters are lower 
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cased. Grounding of mutations to genes follows 4 simple rules based on the method used by 
MEMA: The gene selection rules are: 1) the abstract contains only one gene; 2) the sentence 
the mutation was found in contains only one gene; 3) the closest gene based on proximity in 
the text when multiple genes are found in the sentence containing the mutation; 4) the first 
sentence of the abstract; Testing of the MuGeX method on a selected set of 231 MEDLINE 
abstracts containing 472 mutations revealed recall and precision rates of over 85%. The 
filtering of false-positives using the machine learning based disambiguation module resulted 
in a higher precision at a slight cost to the recall. An overall test of MuGeX performance was 
done using Alzheimer’s disease. Alzheimer’s was selected as several databases with mutation 
are available allowing for validation of the results. The tested showed that MuGeX misses 
most mutations due to the gene names not being available from HUGO. A website was 
made available to search for mutations in predefined enzyme classes using MuGeX. Using 
a test set of 231 articles containing 334 distinct gene names the MuGeX algorithm had 
a recall rate of only 56%. Most missed gene names are simply lacking from the HUGO 
database, the remaining cases are mainly spelling variants that could not be resolved by 
the normalization algorithm. The authors suggest the use of extended dictionaries with all 
possible versions of the HUGO gene names to increase recall. Mutator does not solely use 
the HUGO gene names for precisely this reason. A website is available were the MuGeX 
results can be queries for mutations by gene or disease.
7) VTag and MTag are named entity taggers. VTag targets mutation and deletions, called 
“variation events” in the article hence VTag, whereas MTag was designed to tag malignant 
cancer references such as neuroblastoma. Named entity tagging is a process where predefined 
entities are located and highlighted (tagged) in a text. Both tools use the machine-learning 
method Conditional Random Fields (CRF) that recognizes text entities. CRF is used to 
assign types and weights to tokens retrieved from abstracts. For example, VTag annotates 
several tokens from the sentence, “All cases with K-ras codon 12 mutations were found to 
be G to T transversion”: type: transversion, location: codon 12, wildtype: G, mutation: T. 
Rather than retrieving articles and extracting mutations, both tools are restricted to tagging 
occurrences for manual reviewers. Neither VTag nor MTag contains article retrieval or 
mutation grounding functionality which is left to curators or other tools. 
8) OSIRIS uses a Named Entity Recognition (NER) module to extract variants from bio-
medical literature. These variants are mapped on dbSNP entries with the use of a custom 
mutation database, HgenetInfoDB.   Every MEDLINE abstract is retrieved from a local 
MEDLINE mirror and annotated using the ProMiner [32] NER by default. OSIRIS has 
however been designed to work with any NER capable of grounding proteins to NCBI 
Gene identifiers. Results from both steps are stored in a local database and available from a 
website. Search options are available using both genes and MESH terms.
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9) MutationFinder. Caporaso et. al aimed at providing a freely available implementation 
of a mutation extraction tool and a dataset of annotated abstracts which could be used 
as reference for validation. A partial reimplementation of MuteXt was used as basis for 
MutationFinder. The authors of MutationFinder decided not to include the sequence 
verification step in the grounding algorithm to increase recall at the expense of precision. 
Six changes were made to the mutation extraction module as compared to MuteXt. 
1) wNm format mentions with one-letter abbreviations must have N > 9; 2) wNm format 
mentions with one-letter abbreviations must appear in upper-case letters; 3) Wild-type 
and mutant residue/base identities must not be the same; 4) MutationFinder specifies 
patterns incorporating non-alphanumeric characters, whereas the baseline system removes 
non-alphanumerics; 5) MutationFinder identifies mutations described in natural language 
(as opposed to completely abbreviated formats) with specific patterns, whereas the baseline 
system uses a heuristic to match these mentions; 6) MutationFinder splits text on sentences 
and applies its regular expressions to each sentence, whereas the baseline system splits both 
on words and sentences and applies different regular expressions to each; Several of these 
updates to the MuteXt algorithm were also integrated into Mutator. Mutations on the first 
9 positions of a protein receive a penalty score in the grounding algorithm of Mutator. Like 
MutationFinder non-alpha numerical characters are preserved. However, the conversion 
process of PDF documents to text in Mutator converts most non-alpha numerical characters 
to ASCII equivalents. Extracting mutations from natural language is also implemented in 
Mutator. The capitalization of wildtype and mutant as specified in adaptation 2, and the 
skipping of silent mutations in adaptation 3 are not included in Mutator as we focus on 
recall over precision. Abstracts of 813 articles were annotated with in total 1,515 mutations. 
508 abstracts were used as test set, and 305 as reference set. The entire set of annotated 
abstracts was made publically available to be used as golden standard set for the validation of 
mutation extraction tools. MutationFinder is freely available in three different programming 
languages: python, perl, and java.
10) EnzyMiner was developed to extract and classify protein mutations from PubMed 
abstracts. A PubMed query using the enzyme name and “mutation” is used to find relevant 
articles. The Mutation Extraction module from MuGeX [22] is used to retrieve mutations 
from these abstracts. As EnzyMiner only handles protein mutations, the Disambiguation 
module from MuGeX is used to discard abstracts containing only genetic mutations, or 
terms wrongly identified as mutations such as strain names. Three separate classifiers are 
constructed using RainBow [33] to separate the abstracts into classes. The first classifier 
distinguishes between diseases and non-diseases related abstracts. The non-diseases related 
abstracts are separated into change and no change classes by the second classifier. The final 
classifier is used for the change abstracts which are divided into stability and catalytic classes. All 
classifiers use a Probabilistic Indexing algorithm although different stemming and tokenizers 
were selected for each classifier. A set of 194 abstracts containing mutation for the amylase or 
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lipase enzyme classes was used to train the classifiers. 155 abstracts were used as training set 
with the remaining 39 abstracts used as test set. To test if training the classifiers on a single 
enzyme family results in a generic classifier the classifiers were retrained and test on different 
enzyme classes. The results indicated a high accuracy from which the authors concluded 
that abstracts from the target enzyme class do not have to be part of the intial training set 
for EnzyMiner to perform accurately. EnzyMiner has several drawbacks such as the inability 
to assign type or direction to mutations in the change classes. For example, EnzyMiner 
cannot determine whether a mutation has an effect on Ph or temperature resistance and if so 
whether the mutation increases or decreases the stability. Additionally, EnzyMiner does not 
contain a grounding algorithm. A distinction can therefore not be made between mutations 
from different proteins in the same abstract. Results from EnzyMiner are visualized using 
a website. A selection can be made between disease or non-disease mutations for a number 
of enzyme classes. For each mutation a sentence with highlighted keywords selected by the 
classifier is shown together with the PubMedID and mutation(s) and publication year.
11) Mutator is mainly inspired by MuteXt. The MCSIS platform is the predecessor of 3DM 
with MuteXt similarly being the predecessor of Mutator. Mutator uses a similar architecture 
and workflow compared to MuteXt. A superfamily database serves as backend for storage 
of sequences and mutations. Keyword lists are generated using protein and amino acid 
annotations from the database. Article retrieval is automated and regular expressions are 
used to extract mutations from text. The grounding algorithm used in Mutator is also based 
heavily on the MuteXt implementation. From the other tools we incorporated additional 
regular expressions to extract more mutations. OMIM was added as a source for PubMed 
search keywords to find relevant articles. A future addition to Mutator will be the usage of 
custom numbering schemes defined in the 3DM database for the selection of candidate 
sequences. The following chapter describes the various steps in the mutation retrieval process 
as implemented by Mutator in more detail.
2.6.2 Challenges
Mutation related data can be valuable in the study of protein function. Obtaining a relevant 
set of articles and mutations for a protein of interest is a time consuming process. Articles 
must be selected, retrieved, and parsed to extract mutations. Mutations must be linked to 
the correct protein, a process called grounding. Each step in the retrieval process is faced 
with challenges. In Mutator we recognize six distinct steps that will be described in the 
following sections.
1) Article selection. PubMed is the main publicly available online source for articles, currently 
containing over 20 million references. Only a small fraction of these articles are related to 
a protein or superfamily of interest and an even smaller fraction contains mutation data. 
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The list of articles to process should be as small as possible since retrieving, converting, and 
scanning articles is a time-consuming process. Articles are selected by querying the PubMed 
database using the NCBI Entrez Programming Utilities [10]. Protein names, gene names, 
functional names, diseases, and superfamily keywords are used to restrict the set to articles 
concerning the superfamily of interest. Mutation related search keywords, such as “mutant”, 
“mutagenesis”, and “mutational” are used to limit the number of articles that are linked to 
the field of interest but do not contain any mutational data.
2) Article retrieval. PubMed search results contain links to websites of publishers or journals 
from which the article can be retrieved. The links often do not direct the user to the article 
itself but rather to the website of a publisher or journal. Fully automatic retrieval of articles 
from these websites is a difficult process. Publisher websites often use javascript obfuscation 
to hide files, redirect the user several times, or try to open the article in the browser itself. 
Additionally the website layout and steps required for the download process are redesigned 
often. Several options are available to retrieve the full-text PDF file. The location of the PDF 
file itself is determined from the HTML code of the page. Depending on the publisher website 
either a web-browser, or downloader will be used to obtain the file. Manual download of 
articles will almost always succeed, however this is not a viable option as hundreds of articles 
might be relevant for the protein or superfamily of interest. Due to the constant redesign of 
web-sites article retrieval requires occasional manual supervision and intervention to remain 
able to obtain all required articles. A further limited for the electronic availability of articles 
are age and subscriptions. Older articles are often only available through libraries whereas 
newer articles may not be accessible due to missing journal subscriptions.
3) Article conversion. Before mutations can be extracted from articles a conversion step is 
required for all non-text formats. Most articles are available in PDF format [34] which was 
a proprietary Adobe format until 2008. Several tools are available for the conversion of PDF 
to text. Either open source tools such as pdftotext (xpdf http://www.foolabs.com/xpdf ), 
poppler (http://poppler.freedesktop.org/), and utopia documents [3] or commercial tools 
such as simpo pdf converter (http://www.simpopdf.com/). Common conversion problems 
of these programs are the conversion of non-standard characters such as Greek letters used 
in gene names and the contents of tables and images. Any information present in images is 
currently unavailable as none of the tools is capable of converting images to text. Data in 
tables can be used but tables may be placed either horizontally or vertically and the column 
and row structure is often lost in conversion. Mutator uses the pdftotext utility from the 
poppler suite. 
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4) Mutation detection. The terminology used to describe a mutation varies between journals 
and research fields due to a lack of commonly accepted nomenclature. A mutation may 
be written in short form such as A23F, p.A23F, or Ala23Phe, or in a more descriptive 
format such as “the alanine to phenylalanine mutation on position 23” or “resulting in 
a phenylalanine on position 23”. The sequence numbering used to indicate the position 
of the mutant in the protein also differs from article to article. Initiator methionine and 
signal peptide may or may not be included in the numbering scheme and different isoforms 
often have different lengths and numbering schemes. Additional obfuscation results 
from numbering schemes commonly used in some superfamilies. Antibody sequences, 
for example, are often numbered using Kabat [35], Chotia [36], or a derived numbering 
scheme [37]. These schemes define numbers for conserved residues in the antibody family. 
Insertions required for antibodies with longer sequences are specified with the addition of a 
character to the position after which the insertion occurs. L82cA is therefore a valid identifier 
for a leucene to alanine mutation of the third residue between positions 82 and 83. The 
possible numbering schemes and amino acid identifiers result in an almost infinite number 
of combinations. Using a combination of numbering schemes and identifiers most terms 
can therefore be interpreted as a valid mutation. An additional problem is the ambiguity of 
some of these terms. For example, a C23G mutation may either indicate an amino acid or a 
nucleotide mutation. Some journals enforce rules on mutation formats such as an obligatory 
prefix indicating whether the mutation is an amino acid (p.) or nucleotide (c.). However, 
these rules themselves have not been standardized and differ from journal to journal. Even 
apparently valid and straight forward terms such as 3A-G may indicate different entities e.g. 
a mutation at position three or the abbreviation of 3-(arylmethylidene)aminoxy-(3a-g, 4a-g) 
acid. Additional false positives might even occur from the name of the superfamily. Mutator 
results for the P450 superfamily contained an abnormally high number of proline mutants 
on position 450. These mutations were almost invariably variations on the name of the 
superfamily which had been mistaken for mutations and ground successfully to sequences 
which actually do contain a proline on position 450.
 To retrieve mutations from full-text articles two methods have been commonly 
used: regular expressions and Natural Language Parsing (NLP). Regular expressions are 
structured search terms that can be used to find and retrieve sections from text that match 
the expression. For example, the expression [A-Z][0-9]+[A-Z] will search for a capitalized 
character followed by one or more digits, indicated by the plus, followed by another 
capitalized character. Regular expressions can be structured to match a wide variety of 
mutation formats. However, the expressions are rigidly evaluated. For example, the given 
expression will not match mutations when a space is inserted between the amino acids and 
the position, when the amino acids are written using their three letter abbreviations or when 
lower case characters have been used. All of these problems can be solved by adapting the 
expressions to allow spaces, mixed characters or various other exceptions. This however leads 
to an ever growing set of expressions to allow for increasingly obscure corner cases. The 
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number of retrieved mutations will increase at the expense of an increased number of false-
positives. An alternative method for mutation retrieval is Natural Language Parsing. NLP 
based methods ‘read’ the text and attempt to extract the meaning by analysing sentences. 
NLP has been a promising technique for at least 20 years but actual applications in mutation 
retrieval are scarce [38]. The main problem hampering the wider adoption of NLP is the 
incredible diversity of human languages. A sentence describing a mutation in a gene can 
be written in hundreds of different ways. Even splitting text into sentences is difficult as 
not every dot indicates a new sentence, and not every sentence is necessarily finished with 
a dot. A technique which may solve both the rigidity problem of regular expressions and 
the interpretative problem of NLP is RDF. RDF parses text and creates triples which assign 
meaning to words. For example GLA [is a] gene, where GLA is the term retrieved from the 
article which is linked to the gene keyword with which it has an “is a” relationship. RDF 
is somewhere midway between NLP and regular expressions in complexity. An increasing 
number of public databases are offering RDF annotated versions of their data. In the future, 
RDF might therefore be used to obtain data or annotations of data for usage in text mining.
 Mutator uses a series of regular expressions to extract the mutations from text. 
These expressions are partially taken from publications on other mutation extraction tools 
such as Yip et al. and partially developed and adapted from missed mutations in manually 
verified articles.
5) Mutation grounding. The protein in which a mutation was found is not always mentioned 
explicitly in the article. Instead of a protein identifier such as a UniProt accession code, only 
a gene name or function in combination with a species is often used to indicate the protein. 
Changes and updates in the protein databases affect identifiers used in (especially older) 
articles when the submitted sequences are updated, or removed entirely. Proteins in UniProt 
that are obtained by translating nucleotide sequences in, for example, GenBank are updated 
or removed when the original genomic sequence is found incorrect or incomplete. Formerly 
popular databases may also have disappeared due to lack of funding, or public interest [39]. 
 Mutator uses dictionary based searches to retrieve organism- and gene name data 
from articles to assist mutation grounding. An initial selection of sequences is made based 
on sequence motif searches using the wild type residues from the mutations obtained from 
the articles. For example, if mutation A23D and F24E were retrieved from the article text, 
all sentences with motif 23A,24F are retrieved from the 3DM database. Dictionaries are 
created based on the organism name and on the gene name data available for the selected 
candidate sequences. Both the scientific and the common name are used for the organism 
dictionary. To ground the mutation, all candidate sequences are evaluated individually and 
graded using a scoring scheme. For each of the mutants found in the text that matches with 
the candidate sequence, one point is added. An additional point is added for matching 
organism or gene names, with 0.5 points added when the organism or gene name is found 
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in the title. When only the genus of the organism is found 0.5 is added to the score instead 
of 1.0. A penalty score is subtracted when more then 15 mutants were found in the text to 
prevent that articles with many mutations match a sequence by chance alone. This penalty 
is the number of mutations divided by 15. Articles also often contain molecular formulas 
of various compounds or abbreviations of genes or species which can easily be mistaken for 
mutations because numbers in these strings are often below 10. Mutations in the first 10 
positions of a sequence therefore, receive a penalty of one point. When multiple candidate 
sequences are available for a mutation the score is calculated individually for each candidate. 
A minimum score of 3.5 is required for a candidate sequence to prevent false-positives 
matches. When multiple candidate sequences are available the mutation is grounded to the 
highest scoring candidate. When the score is a tie, Mutator cannot determine which of the 
candidate sequences is the actual sequence used in the original study. Rather than selecting 
one of the sequences arbitrarily, the mutation is grounded to all candidate sequences. The 
task of curator is left to the user of the system who will have to disambiguate the grounding. 
This is in line with the 3DM wide strategy to always include data even when this might 
impact accuracy.
6) Superfamilies. Manual mutation retrieval for a single protein of interest could in principle 
be performed in an acceptable time-frame. However, single protein PubMed queries will 
miss many articles that do not describe the protein itself but instead deal with closely-
related superfamily members. These articles are also relevant for the single-protein case as 
data related to these mutations can often be transferred to the protein of interest. This 
greatly increases the list of articles that potentially contain useful mutational information. 
The size of protein superfamilies ranges from a few hundred to tens of thousands of distinct 
proteins, which means thousands of articles may match the query terms. Manual retrieval 
of mutation from relevant articles is therefore infeasible due to the time required to retrieve, 
scan, ground, and verify mutations from so many articles.
2.7 DNA Diagnostics
Many diseases of many different types are known. Diseases for which a genetic origin has 
been established are called genetic disorders. The human genome contains at least 10,000 
protein coding genes leading to many potential candidates for deleterious mutations. The 
total number of genetic disorders is affected both by genes with a duplicate function since 
defects in one gene can be compensated for by another gene, and composite genes where 
defects in different regions of a single gene give rise to separate genetic disorders. OMIM lists 
over 3,000 disorders with a known molecular basis as of spring 2012. Diagnosing patients 
suffering from genetic diseases however remains difficult for several reasons: the overlap in 
phenotypes between different diseases, the large amount of variance found in the human 
genome, and the lack of a one-to-one mapping between diseases and genes. The research 
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field of DNA diagnostics focusses on diagnosing (and treating) patients suffering from 
genetic diseases. For diagnosis the underlying genetic defect must be located. Treatment 
of genetic disorders requires determining the effects of the disorder on the protein. The 
following sections will discuss datatypes, databases and tools that can potentially be used for 
diagnosing genetic disorders.
2.7.1 Diagnostic Data Types
Many different data types can be used to determine the pathogenicity of unknown variants 
(UVs) such as solvent accessibility, bumps, conservation, and active site residues. The scripts 
used to obtain this data are described in section 2.4.11 unless indicated otherwise. Some of 
the available data types for variant analysis are: 
1) Genetic variants. Many different projects study genetic variants such as mutagenesis 
experiments, GWAS studies, patient trials, etc. Variants can be used for two purposes: 1) 
when an effect is available, a direct link can be made between the variant and a phenotype; 
2) variants can be used to determine the conservation of genomic locations. Discovered 
variants are often published using articles and sometimes deposited in variant databases (see 
chapter 2.7.2 for an overview). We designed Mutator (chapter 1.4 & 2.6) to automatically 
retrieve mutations from articles. Variants stored in databases are retrieved using custom 
scripts. 
2) Contacts. Ligand contacts, dimer interfaces, salt-bridges, and charge clamps are vital for 
the stability, folding, and functional properties of proteins. Disrupting these contacts often 
results in unstable or inactive proteins. Variants at such positions are therefore more likely 
to be pathogenic than variants at positions that are not involved in functionally important 
contacts. Ligand contacts and dimer interfaces are retrieved using WHAT IF; charge clamps 
are determined using a custom script. 
3) Amino acid variability and conservation. Amino acid variability and hence conservation 
can be determined using alignments. Alignments are constructed of naturally occurring 
proteins and therefore reflect the variability allowed in nature. The occurrence of an amino 
acid at a position can therefore be used as an indication of the viability of the variant. 
Alignments often reflect millions of years of trial and error and therefore variants that do 
not occur in natural proteins are most likely detrimental. These variants are thus more likely 
pathogenic compared to variants that do occur in nature. Alignments can also be used to 
determine the conservation of a position. Highly conserved positions are often involved in 
important structural of functional properties of the protein. Variants at conserved positions 
are therefore more likely to be pathogenic then variants at non-conserved positions. 
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4) Solvent accessibility. Solvent accessibility is the degree to which a residue is exposed 
to solvents. Solvent accessibility can be determined using protein structures. Inaccessible 
residues are often buried within the protein, and potentially involved in intramolecular 
contacts such as hydrogen bonds. Variants at buried positions rarely fit in the available space 
due to differences in size, charge, and preferred side-chain orientation. Additionally, smaller 
variants that do fit might disrupt intra-molecular contacts required for folding. For Fabry’s 
disease, for example, Garman [40] has shown a strong correlation between pathogenic 
mutations and buried residues in the corresponding GLA gene. 
5) The number of bumps caused by a variant. A bump is defined as atoms from two residues 
taking up the same space in the protein. This usually results from buried mutations where 
a smaller residue is replaced with a larger residue which does not fit in the available space. 
Bumps in a protein will either force a different folding, or disrupt folding entirely. The 
number and severity of bumps caused by a variant is therefore related to the likelihood the 
variants effect will be pathogenic. 
6) Amino acid annotations. Amino acids can be involved in many functions in the mature 
protein such as active sites, post-translation modifications, trans-membrane regions etc. 
Variants at these positions often disrupt the function or regulation of the protein. Annotations 
of interest are phosphorylation sites, glycosylation sites, active sites, domains, etc.
7) Structural location. The location of a variant can also be used to determine pathogenicity. 
An amino acid can be located in a helix or beta-sheet or be part of a trans-membrane 
domain. Different amino acids are preferred in these regions and some variants would result 
in disruption of the secondary structure.
8) Amino Acid substitution matrices. Manyn different amino acid substitution matrices are 
available, such as BOLSUM and Dayhoff (see chapter 1.2). The matrices are constructed by 
observing the frequency of mutations from each amino acid to all other amino acids. Amino 
acid mutations which occur more frequently are given a lower penalty compared to mutations 
which occur more rarely. Example matrices are Grantham [41] and BLOSUM [42]. Scores 
from these matrices are used to indicate the magnitude of the amino acid substitution and 
thereby the chance that the mutant causes a genetic disease. These matrices however, only 
reflect the magnitude of a specific substitution without taking the environment of the 
amino acid into account. Therefore, these matrices are much less predictive of pathogenicity 
compared to the sequence and protein environment based criteria, and should only be used 
as a last resort if other data yield ambiguous results.
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2.7.2 Variant Databases
Prior data on UVs can be used to assist in determining variant pathogenicity. Several 
databases are available containing data on known protein and DNA variants. Examples of 
such databases that contain generic human variants are OMIM [43], dbSNP [44], HGVBase 
[45], HGMD [46], and Swiss-Prot [47]. Specialized variant databases are available for some 
proteins or diseases, such as the tumor linked p53 gene [11].
1) OMIM. The Online Mendelian Inheritance in Man (OMIM) database contains data on 
diseases in humans. OMIM lists all known Mendelian diseases and contains data on over 
12.000 genes. For each disease the relevant articles are listed and, if available, the genetic 
background is described. Population and demographic data on disease severity and impact 
are also included. Variant data is manually retrieved from literature, an automatic article 
scanner selects publications for review. OMIM can be accessed through the NCBI search 
website and  is available both in academic and commercial versions.
2) dbSNP. dbSNP is a database that contains both natural and pathogenic variants for several 
species including human, chicken, and mouse. The population where the variant was found 
and occurrence in the population are available for some SNPs. Variants linked to disease 
related genes are linked with the corresponding OMIM entries. Variant data can be entered 
into dbSNP via external submission methods.
3) HGVBase. The Human Genome Variation database (HGVBase) is a central repository for 
mutation collection efforts by members of the Human Genome Variation Society (HGVS). 
The database aims to provide a non-redundant overview of all known and suspected variants 
in the human genome. High quality of the database contents is guaranteed by extensive 
manual curation of submitted sequences. Publically available SNP databases such as dbSNP 
are scanned and variants passing quality control are incorporated into the system. In 2011 the 
database was renamed to GWASCentral to emphasize the shift in focus towards collection of 
variants from genome wide association studies (GWAS).
4) HGMD. The Human Gene Mutation Database contains a collection of pathogenic 
variants in human. Variants are retrieved from literature manually. The manual extraction 
allows for additional data on variants such as phenotype to be incorporated into the database. 
Variants in transcription regions are also included. Publications are linked for each variant, 
however each unique variant is only reference once. The HGMD is run by the University 
of Cardiff and commercially exploited by Biobase. Access to the complete database is only 
available for users with a paid subscription.
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5) Swiss-Prot. Swiss-Prot records list both natural and pathogenic variants. Separate variant 
pages are available which list the variants with their effect: disease, polymorphism or 
unclassified. 3D models are generated whenever possible.
2.7.3 Variant Calling Tools
Variant databases are primarily useful for the study of known variants and cannot be used to 
predict the effects of UVs. Several tools have been developed to assist in variant analysis and 
pathogenicity prediction. Examples of these tools are ProCMD [48], HOPE [49], mSTRAP 
[50], SIFT [51], PolyPhen [52] and Alamut [53].
1) ProCMD. ProCMD, the Protein C Mutation Database, focuses on mutations in protein 
C. Protein C is an anticoagulant plasma serine protease that plays an important role in 
controlling inflammation and cell proliferations. Mutations in protein C have been linked 
to venous thrombosis. The database contained a total of 195 mutations upon publication: 
21 variants were retrieved directly from in-house patient data, the remaining mutations 
were obtained from the HGMD, Swiss-Prot Variants, and an existing database of protein 
C gene mutations. Alignments with paralogues and homologues sequences are used to 
determine amino acid conservation. A structural model can be generated for most mutants 
for additional study. ProCMD does not address the fitness or pathogenicity of mutated 
proteins, is only applicable to protein C, and the database does not appear to have been 
updated with new mutations since its inaugural publication in 2007.
2) The mutation extraction and STRucture Annotation Pipeline, mSTRAP, is an automatic 
workflow to collect mutations from articles and visualize the mutations in a structure. 
Articles are retrieved from PubMed using user provided keywords as search terms. mSTRAP 
automatically downloads and converts the articles to plain text before extracting mutations 
and protein names. A single regular expression is used to extract mutation formatted as 
A23G while allowing for the use of three-letter amino acid abbreviations, and a dash between 
the wildtype amino acid and position. A list of all protein names available from Swiss-Prot 
is used to extract protein identifiers from the text. Mutations and proteins are matched 
based on occurrence in the same sentence. BLAST searches are used to determine the closest 
structural homolog for each protein. At most three homology models are built and evaluated 
using a scoring algorithm. jMol is used to present the user with the selected structure. All 
mutations mapped to the protein are visualized in the structure and the sentence from which 
the mutant was extracted is shown.
3) SIFT can be used to Sort Tolerant From Intolerant mutations in proteins or genes. For 
a given input sequence SIFT uses PSI-BLAST to construct an alignment of homologous 
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sequences. Additional precautions are made to prevent the alignment consisting of very 
close homologs which might occur for example for viral strains which are often sequenced 
with only one or two mismatches multiple times. A prediction on whether the mutation 
is damaging is made solely on the conservation of the position in the alignment. Highly 
conserved positions are deemed evolutionary important and therefore unlikely to allow 
substitutions. Validation of SIFT results on a test set of patient data resulted in ~70% of 
mutants correctly predicted as damaging.
4) PolyPhen predicts mutant pathogenicity using a combination of eight sequential and 
three structural parameters. The parameters include the number of residues in the generated 
alignment, the change in residue side chain volume, and the change in accessible surface 
of buried residues. An alignment is automatically generated using sequences selected by 
a clustering algorithm. For each mutation a Naïve Bayes posterior probability that the 
mutation is damaging is calculated. An estimate of the false positive and true positive rates 
for the variant are also determined. PolyPhen2 was evaluated using two training sets, both 
consisting of annotated benign and pathogenic mutations. Pathogenic mutations were 
retrieved from OMIM and UniProt and benign sequence variants were retrieved from 
UniProt. Testing PolyPhen2 on these training sets showed a good to average true positive 
rate of 92% and 73% for the test sets but a false positive rate of 20%. 
5) Alamut is a knowledgebase system similar to 3DM but mainly focussed on genes instead 
of proteins. Variants are retrieved from external databases such as HGVBase and presented 
using a standardized nomenclature. Alamut integrates with several external databases and 
tools such as PubMed, Ensembl, and Uniprot. Mutations can be evaluated using external 
prediction tools such as SIFT and Ployphen. A search engine is available to query PubMed 
abstracts for mutations, however no complete text-mining tool is incorporated in Alamut.
6) HOPE, our own pathogenicity predictor is aimed at biomedical researchers. A website 
is available where a sequence and mutant can be entered for analysis. Data for the protein 
of interest is gathered from UniProt and PDB, and calculated using WHAT IF and DAS 
using webservices. The advantage of webservices is the distributed nature which results in 
relatively few in-house tools that need to be maintained. Together with the analysis, HOPE 
also provides snapshots and movies of the variant in the structure or a homology model 
when possible. Project Hope is described in more detail in chapter 4.
2.8 Wrap-up
The various subdisciplines of the life-sciences are producing an impressive amount of data 
on a daily basis. A lot of this data is published and made publicly available for reuse in 
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other projects. Large public database offer access to structures, genes, proteins, annotations, 
literature, and many other data types. Many specialized data-sets are also available such 
as a large number of transcriptomics experiments on genes with a multitude of different 
variables. New research projects often start by collecting the literature available for the 
protein/gene/function/disease of interest. A thorough literature study however might result 
in hundreds of articles which might be relevant for the new project. A similar problem arises 
in the next phase of the project: obtaining relevant existing data. Obtaining both literature 
and data is complicated by the ambiguity of data relevance. Data which is not directly 
related to the field of research or the protein of interest may be invaluable in solving the 
original hypothesis. 
 Bioinformatics and systems biology are fields that aim at incorporating all available 
data into databases which can be queries easily by biologists. A choice must however 
always be made between the capabilities of the hard- and software, breadth of data to store, 
maintainability, and ease of use. Specialized systems, such as 3DM, focus on a subset of all 
data and try to solve a limited number of problems rather than trying to be the swiss-army 
knife of the life sciences. Such an army knife would have so many functions and utensils 
it would probably be unpractical in actual day-to-day use. 3DM systems for example are 
not aimed at solving genomics or transcriptomics problems, and (currently) do not even 
store most of the data that would be necessary to do this. The previous two chapters have 
described the scientific and technological background, some applications, and evolution of 
the 3DM platform. Several examples have been presented to show the generic capabilities 
or highlight distinctive features of the platform. The following chapters give a more detailed 
overview of 3DM itself and the techniques used, the kind of problems 3DM can be used to 
solve, and the applications it has been put to.
90
Chapter 2
References
1. G. Vriend, WHAT IF: a molecular modeling and drug design program, J Mol Graph, 8 (1990) 
52–56, 29.
2. E. Krieger, YASARA, n.d.
3. T.K. Attwood, D.B. Kell, P. McDermott, J. Marsh, S.R. Pettifer, D. Thorne, Utopia documents: 
linking scholarly literature with research data, Bioinformatics, 26 (2010) i568–574.
4. A.L. Cuff, I. Sillitoe, T. Lewis, A.B. Clegg, R. Rentzsch, N. Furnham, M. Pellegrini-Calace, 
D. Jones, J. Thornton, C.A. Orengo, Extending CATH: increasing coverage of the protein 
structure universe and linking structure with function, Nucleic Acids Res., 39 (2011) D420–
426.
5. R.P. Joosten, T.A.H. te Beek, E. Krieger, M.L. Hekkelman, R.W.W. Hooft, R. Schneider, C. 
Sander, G. Vriend, A series of PDB related databases for everyday needs, Nucleic Acids Res., 
39 (2011) D411–419.
6. G. Vriend, C. Sander, Detection of common three-dimensional substructures in proteins, 
Proteins, 11 (1991) 52–58.
7. R.C. Edgar, MUSCLE: multiple sequence alignment with high accuracy and high throughput, 
Nucleic Acids Research, 32 (2004) 1792–1797.
8. The PHP Group, PHP, (n.d.).
9. World Wide Web Consortium (W3C), XML Path Language (XPath) 20, (n.d.).
10. E.W. Sayers, T. Barrett, D.A. Benson, E. Bolton, S.H. Bryant, K. Canese, V. Chetvernin, 
D.M. Church, M. Dicuccio, S. Federhen, M. Feolo, L.Y. Geer, W. Helmberg, Y. Kapustin, 
D. Landsman, D.J. Lipman, Z. Lu, T.L. Madden, T. Madej, D.R. Maglott, et al., Database 
resources of the National Center for Biotechnology Information, Nucleic Acids Res., 38 (2010) 
D5–16.
11. M. Olivier, R. Eeles, M. Hollstein, M.A. Khan, C.C. Harris, P. Hainaut, The IARC TP53 
database: new online mutation analysis and recommendations to users, Hum. Mutat, 19 
(2002) 607–614.
12. S.R. Engel, R. Balakrishnan, G. Binkley, K.R. Christie, M.C. Costanzo, S.S. Dwight, D.G. 
Fisk, J.E. Hirschman, B.C. Hitz, E.L. Hong, C.J. Krieger, M.S. Livstone, S.R. Miyasato, 
R. Nash, R. Oughtred, J. Park, M.S. Skrzypek, S. Weng, E.D. Wong, K. Dolinski, et al., 
Saccharomyces Genome Database provides mutant phenotype data, Nucleic Acids Res., 38 
(2010) D433–436.
13. Network Working Group, RFC 4180: Common Format and MIME Type for Comma-
Separated Values (CSV) Files, (n.d.).
14. S. Velankar, G.J. Kleywegt, The Protein Data Bank in Europe (PDBe): bringing structure to 
biology, Acta Crystallographica Section D Biological Crystallography, 67 (2011) 324–330.
15. R. Hooft, G. Vriend, WHAT IF Manual, (n.d.).
16. R.G. Cote, P. Jones, L. Martens, S. Kerrien, F. Reisinger, Q. Lin, R. Leinonen, R. Apweiler, 
H. Hermjakob, The Protein Identifier Cross-Reference (PICR) service: reconciling protein 
identifiers across multiple source databases, BMC Bioinformatics, 8 (2007) 401.
17. F. Horn, A.L. Lau, F.E. Cohen, Automated extraction of mutation data from the literature: 
application of MuteXt to G protein-coupled receptors and nuclear hormone receptors, 
Bioinformatics, 20 (2004) 557–568.
18. D. Rebholz-Schuhmann, S. Marcel, S. Albert, R. Tolle, G. Casari, H. Kirsch, Automatic 
extraction of mutations from Medline and cross-validation with OMIM, Nucleic Acids Res, 
32 (2004) 135–142.
91
Technical Background
19. Y.L. Yip, N. Lachenal, V. Pillet, A.-L. Veuthey, Retrieving mutation-specific information for 
human proteins in UniProt/Swiss-Prot Knowledgebase, J Bioinform Comput Biol, 5 (2007) 
1215–1231.
20. R.E. Saunders, S.J. Perkins, CoagMDB: a database analysis of missense mutations within four 
conserved domains in five vitamin K-dependent coagulation serine proteases using a text-
mining tool, Hum. Mutat, 29 (2008) 333–344.
21. L.C. Lee, F. Horn, F.E. Cohen, Automatic extraction of protein point mutations using a graph 
bigram association, PLoS Comput. Biol, 3 (2007) e16.
22. M. Erdogmus, O.U. Sezerman, Application of automatic mutation-gene pair extraction to 
diseases, J Bioinform Comput Biol, 5 (2007) 1261–1275.
23. R.T. McDonald, R.S. Winters, M. Mandel, Y. Jin, P.S. White, F. Pereira, An entity tagger 
for recognizing acquired genomic variations in cancer literature, Bioinformatics, 20 (2004) 
3249–3251.
24. Y. Jin, R.T. McDonald, K. Lerman, M.A. Mandel, S. Carroll, M.Y. Liberman, F.C. Pereira, R.S. 
Winters, P.S. White, Automated recognition of malignancy mentions in biomedical literature, 
BMC Bioinformatics, 7 (2006) 492.
25. J. Bonis, L.I. Furlong, F. Sanz, OSIRIS: a tool for retrieving literature about sequence variants, 
Bioinformatics, 22 (2006) 2567–2569.
26. L.I. Furlong, H. Dach, M. Hofmann-Apitius, F. Sanz, OSIRISv12: a named entity recognition 
system for sequence variants of genes in biomedical literature, BMC Bioinformatics, 9 (2008) 
84.
27. J.G. Caporaso, W.A. Baumgartner Jr, D.A. Randolph, K.B. Cohen, L. Hunter, MutationFinder: 
a high-performance system for extracting point mutation mentions from text, Bioinformatics, 
23 (2007) 1862–1865.
28. S. Yeniterzi, U. Sezerman, EnzyMiner: automatic identification of protein level mutations and 
their impact on target enzymes from PubMed abstracts, BMC Bioinformatics, 10 Suppl 8 
(2009) S2.
29. R.K. Kuipers, H.-J. Joosten, R.H. Lekanne dit Deprez, M.M. Mannens, P.J. Schaap, Novel 
tools for extraction and validation of disease-related mutations applied to Fabry disease, Hum. 
Mutat, 31 (2010) 1026–1032.
30. T.A. Eyre, F. Ducluzeau, T.P. Sneddon, S. Povey, E.A. Bruford, M.J. Lush, The HUGO Gene 
Nomenclature Database, 2006 updates, Nucleic Acids Research, 34 (2006) D319–D321.
31. O. Edvardsen, A.L. Reiersen, M.W. Beukers, K. Kristiansen, tGRAP, the G-protein coupled 
receptors mutant database, Nucleic Acids Res., 30 (2002) 361–363.
32. D. Hanisch, K. Fundel, H.-T. Mevissen, R. Zimmer, J. Fluck, ProMiner: rule-based protein 
and gene entity recognition, BMC Bioinformatics, 6 Suppl 1 (2005) S14.
33. A.K. McCallum, Bow: A toolkit for statistical language modeling, text retrieval, classification 
and clustering, 1996.
34. ISO 32000-1:2008, (n.d.).
35. E.A. Kabat, T.T. Wu, H. Bilofsky, M. Reid-Miller, H. Perry, Sequence of Proteins of 
Immunological Interest, 1983.
36. B. Al-Lazikani, Standard conformations for the canonical structures of immunoglobulins, 
Journal of Molecular Biology, 273 (1997) 927–948.
37. K.R. Abhinandan, A.C.R. Martin, Analysis and improvements to Kabat and structurally 
correct numbering of antibody variable domains, Mol. Immunol., 45 (2008) 3832–3839.
92
Chapter 2
38. W.W. Chapman, P.M. Nadkarni, L. Hirschman, L.W. D’Avolio, G.K. Savova, O. Uzuner, 
Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for 
additional creative solutions, Journal of the American Medical Informatics Association, 18 
(2011) 540–543.
39. Access denied?, Nature, 462 (2009) 252–252.
40. S.C. Garman, Structure-function relationships in alpha-galactosidase A, Acta Paediatr Suppl, 
96 (2007) 6–16.
41. R. Grantham, Amino acid difference formula to help explain protein evolution, Science, 185 
(1974) 862–864.
42. S. Henikoff, J.G. Henikoff, Amino acid substitution matrices from protein blocks, Proc. Natl. 
Acad. Sci. U.S.A, 89 (1992) 10915–10919.
43. J. Amberger, C.A. Bocchini, A.F. Scott, A. Hamosh, McKusick’s Online Mendelian Inheritance 
in Man (OMIM), Nucleic Acids Res, 37 (2009) D793–796.
44. S.T. Sherry, M.H. Ward, M. Kholodov, J. Baker, L. Phan, E.M. Smigielski, K. Sirotkin, dbSNP: 
the NCBI database of genetic variation, Nucleic Acids Res, 29 (2001) 308–311.
45. D. Fredman, M. Siegfried, Y.P. Yuan, P. Bork, H. Lehväslaiho, A.J. Brookes, HGVbase: a 
human sequence variation database emphasizing data quality and a broad spectrum of data 
sources, Nucleic Acids Res., 30 (2002) 387–391.
46. P.D. Stenson, E.V. Ball, K. Howells, A.D. Phillips, M. Mort, D.N. Cooper, The Human 
Gene Mutation Database: providing a comprehensive central mutation database for molecular 
diagnostics and personalized genomics, Hum. Genomics, 4 (2009) 69–72.
47. Y.L. Yip, H. Scheib, A.V. Diemand, A. Gattiker, L.M. Famiglietti, E. Gasteiger, A. Bairoch, 
The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure 
information on human protein variants, Hum. Mutat, 23 (2004) 464–470.
48. P. D’Ursi, F. Marino, A. Caprera, L. Milanesi, E.M. Faioni, E. Rovida, ProCMD: a database 
and 3D web resource for protein C mutants, BMC Bioinformatics, 8 Suppl 1 (2007) S11.
49. H. Venselaar, T.A.H. Te Beek, R.K.P. Kuipers, M.L. Hekkelman, G. Vriend, Protein structure 
analysis of mutations causing inheritable diseases An e-Science approach with life scientist 
friendly interfaces, BMC Bioinformatics, 11 (2010) 548.
50. R. Kanagasabai, K.H. Choo, S. Ranganathan, C.J.O. Baker, A workflow for mutation 
extraction and structure annotation, J Bioinform Comput Biol, 5 (2007) 1319–1337.
51. P. Kumar, S. Henikoff, P.C. Ng, Predicting the effects of coding non-synonymous variants on 
protein function using the SIFT algorithm, Nat Protoc, 4 (2009) 1073–1081.
52. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. 
Kondrashov, S.R. Sunyaev, A method and server for predicting damaging missense mutations, 
Nat. Methods, 7 (2010) 248–249.
53. Interactive Biosoftware, Alamut, Interactive Biosoftware, n.d.


3DM: systematic analysis of heterogeneous 
super-family data to discover protein functionalities
  
Remko Kuipers, Henk-Jan Joosten, Willem van Berkel, 
Nicole Leferink, Erik Rooijen, Erik Ittmann, 
Frank van Zimmeren, Helge Jochens, Uwe Bornscheuer, 
Gert Vriend, Vitor Martins dos Santos, Peter Schaap
96
Chapter 3
Abstract 
Ten years of experience with Molecular Class Specific Information Systems (MCSIS) such 
as with the hand-curated G protein-coupled receptor database (GPCRDB), or the semi-
automatically generated nuclear receptor database (NRDB) has made clear that a wide 
variety of questions can be answered when protein related data from many different origins 
can be flexibly combined. MCSISes revolve around a multiple sequence alignment that 
includes “all” available sequences from the entire super-family, and it has been shown at 
many occasions that the quality of these alignments is the most crucial aspect of the MCSIS 
approach. 
 We describe here a system, called 3DM that can automatically build an entire 
MCSIS. 3DM bases the multiple sequence alignment on a multiple structure alignment, 
which implies that the availability of a large number of super-family members with a known 
three-dimensional structure is a requirement for 3DM to succeed well.
 Thirteen MCSISes were constructed and placed on the Internet for examination. 
These systems have been instrumental in a large series of research projects related to enzyme 
activity or the understanding and engineering of specificity, protein stability engineering, 
DNA-diagnostics, drug design, etcetera.
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Introduction
Due to new high-throughput DNA sequencing, protein crystallization technologies, and 
efficient large scale mutant generation techniques such as chemical gene synthesis, there is 
an exponential growth of the amount of data submitted to databases such as the PDB [1], 
UniProt [2] and PubMed [3]. Data deposition rates are getting so high that screening new 
database depositions just for molecules of one family of interest already requires specialized 
software. 
 Each protein related data type can be a powerful information source in itself, but 
combined, they can become true eye-openers. A good example is probably the combination 
of protein sequences and structures into structure-based multiple sequence alignments. 
These alignments contain a wealth of evolutionary fingerprints such as correlated mutations 
or amino acid conservation and variability patterns that can be used to get clues about the 
function of individual amino acids. Alignments can be used in combination with many 
other, often heterogeneous, protein data types. Mutation information, for instance, can be 
successfully transferred between proteins using an alignment. A mutation that influences 
antagonist binding in one nuclear hormone receptor (NR), for example, is likely to have a 
similar effect in other NRs. Another example is the combination of keywords in PDB files 
with the presence of specific amino acids at specific positions in an alignment. This latter 
concept was published in 2004 when Folkertsma et al. used this approach to detect a residue 
responsible for antagonist binding in the NR super-family. 
 The above examples show that, when studying individual members of a protein 
family, much can be gained when all available information about all individual members 
of the super-family is available concurrently. This is often difficult to achieve because the 
processes of data collection, validation, storage, and the subsequent determination of 
correlations between heterogeneous data types can be technically complicated, laborious, and 
very time consuming. The data collection and storage process suffers from a large number 
of technical complications such as the existence of protein isoforms, or different numbering 
schemes used for homologous proteins. Other data available at the amino acids level such 
as mutation data, ligand binding data, etc., can also have their own nomenclatures and 
numbering schemes. Especially the residue numbering problem must be solved rigorously 
before correlations between the various data types can be studied. 
 For an easy comparison of heterogeneous super-family data several web-interfaced 
Molecular-Class-Specific Information Systems (MCSIS) have been developed that store, 
combine, validate, give structure, and present data about protein super-families. The 
GPCRDB [4] is a MCSIS for G protein-coupled receptors. This system, originally designed 
in 1993, has been used as a model system for the nuclear hormone receptors (NuclearDB) 
[4], potassium channels (KchanelDB) and prions (PrionDB) MCSIS. An important lesson 
learned from the design and use of these MCSISes was that the quality of the MSA is the most 
important aspect of any subsequent research performed, and indeed, the curators of these 
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MCSISes have spent many months or even years on obtaining the best possible alignments. 
In this process new profile-based sequence alignment methods were designed that would 
allow for user interaction; mutation collections were made and used to obtain information 
about particularly hard to align sequence sections, ligand binding studies were used to reveal 
whether residues in different proteins were, or were not likely to be at equivalent locations 
in their structures. These systems thus relied on extensive manual curation, which makes it 
difficult to keep them up-to-date. Nevertheless, the power of having so much heterogeneous 
data at one’s disposal in one coherent system allows for a wide variety of theoretical and 
applied scientific questions to be addressed [5-18].
 The 3DM system provides a generic framework to exploit heterogeneous protein 
related data, and facilitates a broad range of tasks needed to automatically create and update 
the next generation of MCSISes. It generates a highly accurate multiple sequence alignment 
(MSA) of a protein super-family by using a multiple structure alignment (3D-MSA) to guide 
the construction of the (much larger) MSA. From the 3D-MSA it generates a unified 3D 
numbering scheme, which is subsequently used for all protein related data types including 
aligned structures and sequences, homology models, and mutational and computationally 
derived data. This unified numbering also enables the easy construction of homology models. 
Most data types are automatically mapped onto the alignment and can also be visualized in 
the 3D-models and structures of individual proteins. 
 Here we present the 3DM framework that is at the basis of a series of MCSIS systems 
and illustrate the possibilities with a series of highly successful experiments performed in the 
fields of protein engineering, drug design, and DNA diagnostics.
Materials & Methods
Definitions
Within a 3DM system a super-family is defined as a group of structures with a common 
structural fold. A sub-family is the smallest building block of the alignment and is a profile 
based alignment starting from a single structure. Families are groups of related sub-families.
Data Collection
Data collection (Fig 1. Step 1) is performed by a series of scripts – one script per data source. 
Scripts have been written to extract information from Swiss-Prot (http://www.expasy.org/ 
sprot/), NCBI (http://www.ncbi.nlm.nih.gov/), literature, etc. In addition, the flexible set 
up of 3DM facilitates easy extraction of data from specific sources. For example, 3DM 
contains scripts to extract data from two public p53 mutation databases (http://www-p53.
iarc.fr/, http://p53.free.fr/). 
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Figure 1. The 3DM generic framework at a glance. Step 1 Data collection. 1A: Sequences and structures 
are automatically inserted into the 3DM database. 1B: Features related to amino acids, such as mutational 
information from the literature, are collected, and automatically inserted in the database. Step 2 Creation of 
the 3D-MSA. Step 2a1 Superposing of the structures. Step 2a2 Deletion of structural variable regions and (2a3) 
core determination. Step 2b illustrates the iterative profile based alignment procedure to create the individual 
subfamily alignments in four (default value) successive alignment rounds. In step 2c the separate subfamilies are 
aligned to one large super-family alignment using core data. (step 2a for details see materials and methods). Note 
that some individual sequences can be confidently aligned to different structures here indicated by the arrow 
showing a sequence aligned in both subfamily alignments. These sequences are used for alignment quality control 
(see materials and methods). Correlated data can be visualized by the user via HTML pages (step 3)
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Structural information was obtained by extracting family members from SCOP [19] and 
running BLAST [20] against the PDB database using as queries representative members 
from each SCOP subfamily. Representative structures show less than 80% (3DM default 
cut-off) pair-wise sequence identity. BLAST searches were also performed with these same 
sequences to extract all super-family sequences from the Swiss-Prot and Trembl databases. 
Multiple Sequence alignment
3DM uses a three-step procedure (Fig. 1, step 2) to create a super-family alignment. In the 
first step (Fig. 1, step 2a1), all collected structures of a super-family are superposed [21] and 
a common core of structurally equivalent positions (called core positions) is determined 
(Fig. 1, step 2a2). The WHAT IF structure superposition method was described already in 
1991 [21], and will here be described very briefly. WHAT IF collects from both structures 
all fragments of 15 amino acids or longer and does an all-against-all comparison on these 
fragments. This is done in distance space rather than Cartesian space, which makes this 
process very fast. Each pair of matching fragments between the two structures is related 
via a superposition matrix, and when two pairs of matrices have a similar trace, it is highly 
likely that the two pairs of fragments can be superposed together. This is tried in Cartesian 
space. This process is fast enough so that it can be repeated for all possible clusters of pairs of 
fragments, and the 10 largest clusters are refined using an optimized version of the algorithm 
of Rossmann and Rao [22]. As the Rao and Rossmann method is known to occasionally 
find the wrong local minimum, we restart the best cluster 25 times; each time using a 
global superposition matrix that is randomly rotated 5-15 degrees in a random direction. 
The quality of this method has be described in an article in which a series of methods was 
compared [23]. The conclusion was that the WHAT IF method is especially suitable for 
the accurate detection of superpositions of large numbers of non-contiguous fragments that 
fit well. This is the main reason why this method was selected as Oliveira et al. found that 
the quality of alignments is crucial for a series of follow-up calculations such as correlated 
mutation analyses [12,13].
 The core is typically defined as the collection of residue positions where at least 
three consecutive residues have their alpha carbon located within 2.5 Ångstrøm of the 
average position in at least 90% of the superposed structures. Cores can differ depending 
on the order in which the structures are superposed. For example, starting with structure A, 
a structurally conserved helix might be detected in structure B, but, even when present in 
structure C, this helix might just fall outside the cut-off. Starting with structure B, however, 
the helix in C might be detected and then it is missed in A. If in B it is positioned in-
between the helices of A and C, then the structure alignment order A, C, B will allow us 
to find all three helices as structure mates. 3DM therefore repeats step 2a starting with one 
representative structure of each distinct subfamily. For completeness all obtained core files 
are then merged into one super-family core.
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In the second step (Fig. 1, 2b), separate subfamily alignments are created by aligning to each 
of the representative structures all sequences with more than typically 30% (3DM default 
value) sequence identity. The alignments are created by WHAT IF [24] using the sequence-
to-structure iterative profile based alignment procedure as described by Oliveira et al. [25]. 
 In the third step (Fig. 1, 2c), the resulting single-structure-based subfamily 
alignments are merged into one large alignment guided by the structure alignments from 
step one. Each subfamily alignment comprises all residue positions present in its parent 
structure, whereas the combined alignment only contains ‘core’ residue positions.
Alignment quality
In the 3DM approach, correctness of the alignment is more important than completeness. 
Therefore, 3DM uses several alignment quality checks before a sequence is included in the 
alignment (Fig. 1 step 2c). All sequences that can be aligned to one of the representative 
structures with a sequence identity above a threshold (inclusion-cut-off; present 3DM 
default value = 55%) are automatically included in the alignment. If a sequence is aligned 
against more than one structure with the inclusion-cut-off above the threshold, then the 
alignment with the highest sequence identity is used. We have observed that mapping of 
sequences onto the core is independent of the choice of structure against which a sequence 
is aligned, as long as the inclusion-cut-off of 55% is met. In our experience small cores are 
more difficult to align and demand a higher inclusion-cut-off.
 Sequences that show upon alignment a percentage identity between the lower cut-
off (present 3DM default value = 30%) and the inclusion-cut-off are only included if they 
can be aligned against two representative structures and if both alignments are consistent in 
terms of core assignments. If a sequence is aligned against three or more structures the most 
abundant core assignment is used. 
Parameter choices
3DM provides a series of user-adjustable parameters like sequence identity cut-off, percentage 
of structures that must participate at any residue position in the superposition for acceptance, 
gap open and elongation penalties for each of the alignment procedures, minimally required 
sequence identity percentages, etc. Plausible default values were selected for each parameter 
based on our experience with building a dozen 3DM systems. Systematic optimization of 
these parameters is still beyond the realm of possibilities of today’s computers. 
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3DM -numbering scheme
A semi-arbitrary sequence numbering scheme is applied in which residues are numbered 
sequentially starting at 1 for the most N-terminal core position. These numbers are 
referred to as 3D-numbers. These 3D-numbers are used throughout all alignments and are 
incorporated in all structure files and homology models. 
Correlated mutations
3DM contains a newly developed tool, Comulator, for correlated mutation analyses (CMA), 
of large structure-based multiple sequence alignments. The tool and results obtained by 
Comulator are published elsewhere [9]. The CMA scores that result from Comulator are 
stored in the 3DM database connected to the 3D-numbers. This makes the CMA scores 
easy to relate to the other data types. The correlations are visualized in hyperlinked heatmaps 
enabling the selection of a subset of sequences that contain a certain amino acid couple at 
a correlating position pair. These subsets can be used to create a filter (see the section on 
filters) from which a new 3DM (sub)system can be generated automatically. 
Ligand contacts
3DM uses WHAT IF for the extraction of contact data between co-crystallized compounds 
(ligands) and protein molecules from all super-family PDB files using a method similar to 
ARES [26]. The 3DM definition of a ligand is a molecule with more than 6 atoms that is not 
a solvent molecule commonly used in protein crystallization (e.g. sulphate, glycerol, etc). All 
contacts are stored in the 3DM database connected to the 3D-numbers. They are visualized 
in the context of other data in the alignment detail pages and in the protein structures.
Mutations and other amino acid features
3DM contains a literature mutation extraction tool, Mutator, which is modelled after 
MuteXt [27]. Mutator uses the protein descriptions from a super-family as keyword searches 
in the PubMed database and extracts all mutations from the resulting literature. Mutator and 
results obtained by Mutator are published elsewhere [28]. Swiss-Prot holds many data about 
protein features such as post-translational modifications, mutations, and natural variants, 
metal binding, etc. 3DM collects and stores these features. The p53 MCSIS (manuscript 
in preparation), for instance, illustrates the flexibility of 3DM because additional mutation 
information could be collected from two large mutation databases (the IARC TP53 
Mutation Database29 and the UMD-p53 database [30]) and simply incorporated and used 
in the MCSIS with all other (mutation) data.
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Filters and subsystems
3DM contains several filter methods to obtain a sub-selection of proteins from the 3DM 
database. This filtering system enables the automatically generation of a new MCSIS for 
a subset of sequences. This subset system remains fully connected to the complete super-
family MCSIS. All 3DM features, such as alignment, correlated mutations, alignment detail 
graphs, visualisation in structures, etc., are also available for a subset MCSIS. 3DM provides 
multiple filters to select a subset of the proteins. For instance, a subset can be generated 
that contains sequences only from just one or more subfamilies. A subset can be retrieved 
using BLAST searches, sequence motifs, selection of a sub-branch of the phylogenetic tree, 
by keyword searches in PDB files, protein names, organism names, etc. Separate subsets of 
sequences that result from different selection options can be logically combined. The search 
filters of 3DM were used, for example, to query structure files in the nuclear receptor 3DM 
in order to generate two different subsets of sequences related to a) PDB files with an agonist 
in the ligand binding domain and b) PDB files with an antagonist. 
3DM  Interface
Usage of a 3DM database is organized via interactive web pages that interact with the 
underlying database (Fig. 1, step 3). The homepage of 3DM is directly linked to the 
collection of alignments. An alignment is the main point of access to the data underlying 
each 3DM, such as sequences, mutation data, 3D structures, etc., and to derived results 
such as CMA scores, 3D models, contact information, variability, and conservation in the 
alignment, etc. The first method for navigation through the 3DM information is provided 
from the alignments via links to four different types of secondary pages: 
1. Protein detail pages, which can be retrieved via the protein names. The protein detail 
pages provide information about the similarity of the sequence aligned against different 
structures, the 3D models (superposed on the ‘core’ and numbered as desired), raw sequence 
data, and a collection of all mutations that 3DM has collected for the protein. 
2. Amino acid detail pages. These are linked to the amino acids in the main alignment. 
The amino acid detail pages provide amino acid features, such as mutational data and 
the corresponding links to the literature. Additionally, structure models can be retrieved 
from these amino acid detail pages in which computationally modelled mutations have 
been introduced. These structure models, which contain the 3D-numbers, are visualized 
with a sphere around the in silico introduced amino acid to indicate possible bumps with 
surrounding amino acids. 
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3. Position detail pages. These can be retrieved via the consensus sequence on top of 
the alignment. The position detail pages provide CMA results, amino acid distribution 
histograms, integrated positional mutation information from all sequences in the alignment, 
integrated contact information from all structure files, etc. 
4. (Sub)-family detail pages. These can be retrieved from the scroll down button at the top of 
each sub-family. The family detail pages are separate 3DM systems within the super-family 
3DM. A family contains a selection of sub-families that are evolutionary close together. A 
3DM family is similar to a filter with one important difference: In contrast to a filter the core 
of a 3DM family contains more residues than the core of the super-family. The sub-family 
detail pages provide an alignment of full length sequences. The alignment of the non-core 
regions of the sequences is done by Muscle [31]. At the subfamily detail pages mutational 
information is also visualized in these regions. 
The second method of navigation through the 3DM data is via the scroll down menus 
which are present in all 3DM web pages. The ‘Families’ scroll down menu is hyperlinked 
to the available 3DM (super)-families. The ‘Alignment’ menu provides links to the various 
different alignment views, the correlation data, a page to insert data in the 3DM database 
(only for administrator users), and alignment statistics for data comparison (see section 
comparison of data types). With the ‘Filter’ option filters can be generated and updated (see 
section filters). The ‘Search’ option provides various options to query the 3DM data and 
to generate a sub-selection of sequences which can be used to generate a filter. The ‘View’ 
option provides links to the alignment detail pages, the correlation data, a protein structure 
detail page, a taxonomy page, and to pages for data visualisation in protein structures.
Homology models
3DM uses YASARA (www.yasara.org) to visualize the super-family protein structures and 
3DM homology models. The ‘VIEW->Data in Structure’ option of 3DM enables the user 
to select multiple protein structures (these are all superimposed), multiple co-crystallized 
compounds (even from different protein structures than those selected) and different data 
types, such as correlated mutations, contact information, charge clamps, conservation, etc. 
All selected data will be written in a so-called YASARA scene file that can be read by the 
free YASARA viewer available from www.yasara.org. All selected homology models use the 
3D-numbering scheme, which make it easy to compare them with the 3DM alignment and 
the underlying data. 
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Availability
The 3DM systems discussed here are available at http://3dmcsis.systemsbiology.nl and 
http://3dmcsis.systemsbiology.nl/FMDB/ The alignment-related software, especially the 
3D-MSA part is performed using the WHAT IF software (free for academic use). WHATIF 
macro’s used to produce an example MSA are available from http://3dmcsis.systemsbiology.
nl/software/ 
Results and Discussion
Implementation
An introduction into the technology behind 3DM is given in fig. 1. Sequences and 
structures of a target super-family are automatically extracted from the public repositories 
and inserted into the 3DM database. Input structures are used to create a superposed 
coordinate file. An iterative profile-based sequence alignment procedure is used to create 
the individual subfamily alignments. The separate subfamily alignments are aligned guided 
by the superposed coordinate file. Features related to individual amino acids of individual 
Figure 2. Superposing of the agonistic (pdb code 1XDK) and antagonistic (pdb code 1L2J) of the ligand 
binding domain of a nuclear receptor. A co-crystallized ligand is shown in ball representation. Residues at 
positions with high CMA scores are purple (3D-numbering scheme) Most of these residues are located at the rim 
of the ligand binding pocket. Highly conserved residues (>85%, yellow) are located at the co-factor binding site. 
In the agonistic conformation is helix 12 close to the ligand binding pocket and the conserved glutamate 155 is 
positioned to bind the cofactor for activation (here depicted in red). The positions of helix 12 and its glutamate 
in antagonistic conformation are in blue. 
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sequences, such as mutational information are also automatically extracted from the 
literature. It has proven difficult to quantify the quality and completeness of automatically 
extracted data. The collection of structure files, for example, is complicated because none 
of the currently available tools for obtaining similar 3D structures (e.g., SCOP, Structure 
Matching tool [32], BLAST, etc.) provides a complete collection. Some of these systems 
look only in non-redundant subsets of the PDB, others have algorithmic features that 
exclude certain structures, and yet others are not based on the latest version of the PDB. 
Therefore several structure extraction methods were implemented and used in parallel 
to obtain as many structure files as possible, even though this could result in duplicated 
structure information, which must be removed later. Superposing is done automatically 
using WHAT IF software. Unfortunately sometimes many highly similar superposition 
solutions exist and not always all structure files can be used because they contain too many 
syntactic errors for automatic superposing. The collection of primary sequences, on the 
other hand, is much simpler because software like BLAST can easily be parameterized to 
include every possible homolog. In the 3DM approach, correctness of the 3D-MSA is much 
more important than completeness. Some remote homologs therefore are not (yet) included 
because the structures required for a reliable alignment are not available.
 The definition of the core set of structurally superposed residue positions 
(fig. 1 step IIa) depends to some degree on the cut-off parameters chosen by the operator. The 
3DM automatic superposition and alignment module was benchmarked against a manually 
created structure-based multiple sequence alignment of the nuclear receptors [26]. The 
manually created NR alignment resulted in a ‘core set’ of 183 positions. 3DM automatically 
detected a core of 158 residues. Most of the core positions that were not automatically detected 
are involved in movement of helix I and helix XII (fig. 2). These residues were manually added 
to the core by Folkertsma et al. even though they did not superpose at all. 3DM does allow 
the curator to manually extend the core between steps IIa and IIb (fig. 1). In 2004 Folkertsma 
et al. collected 1,577 NR sequences, 468 of which they could reliably align. Using the same 
set of input sequences, 3DM could automatically align 752 sequences. Although this increase 
is mainly a result of the larger number of structures available it also demonstrates the need 
for automation. In just two years the number of “alignable” NR sequences in the 3D-MSA 
increased by 37%. This increase in number of alignable sequences resulted in a concomitant 
increase in usable information. For example, in 2004, no mutation information was available 
for 38 of the 158 core positions, whereas currently mutation information is available for 
150 core positions. In nine cases, this gain of information was due to the increased number 
of aligned sequences. In 21 cases this was due to new mutational information automatically 
extracted from the literature. For instance in 2004, no mutation information was available for 
a conserved alanine in the WAK motif in helix III and contradicting predictions were made 
for the role of this residue. A recently published mutation of this alanine to a lysine in the 
androgen receptor [33] was automatically extracted from the literature. As the high preference 
for an alanine residue at the particular residue position in the 3D-MSA already suggested, 
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this mutation had an effect on ligand binding. The last update of the NR (February 2009) 
contains 2152 sequences. From the literature 3DM automatically extracted 2,539 mutations 
covering 98% of the structural core.
Limitations
Today, structure information can be found for at least one detectable homolog for about 
40% of all known sequences. Obviously, 3DM can work without structures, but in that case 
the multiple sequence alignment will be no better than the HSSP-based profile alignment 
method that we use for multiple sequence alignment purposes, and all advantages of the 
structure based approach will be lost. Correlated mutations analyses tend to work best when 
the alignment contains hundreds till thousands of sequences [12,13]. However, if the signal 
is clear, i.e., the alignment is correct and the spread in the sequences is adequate, then even 
a small number of sequences can already reveal useful information. As an example we made 
a 3DM for the very small family of crambin-like proteins. The PDB database holds some 
30 structures of crambin variants while the total number of unique sequences that can 
be extracted from UniProt is currently about 50. Most crambin-like molecules have three 
conserved cysteine bridges. The highest 3DM CMA score is between residue positions 12 
and 29, positions which in a few of the family members form a fourth cysteine bridge.
Figure 3. Conserved and highly correlated positions in the model structure of oxaloacetate hydrolase from 
A. niger.  The 3D-numbering system is used. Residues at conserved alignment positions (>98%) of the PEPM/
ICL super-family are yellow. Most of these residues are located near the conserved oxalate moiety of the substrate 
and the conserved metal ion (blue). Residues at alignment positions having a high CMA score are in purple. Most 
of these residues form a network located near the substrates substituent group (S) in green.
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Use Cases
3DM was initially designed for the purpose of guiding protein engineering projects. Protein 
engineering projects are usually focussed on increasing enzyme activity or on changing or 
modifying enzyme specificity. Despite many computational efforts, it still proves difficult 
to consistently predict the specific mutations needed to achieve such goals. Most protein 
engineering project therefore still rely on random mutagenesis approaches, where thousands 
or even hundreds of thousands mutants are generated and screened for the desired effects. 
Nowadays, with chemical techniques for gene synthesis, mutant libraries can be generated 
with combinational changes at only a few specific positions in the protein. Narrowing 
down the library size to specific positions makes subsequent screening much more efficient. 
Correct selection of these protein engineering hot spots and selection of the amino acid 
residues that should be introduced at these positions is then crucial. Below we demonstrate 
how the 3DM framework was used to predict such hot spots for protein specificity, protein 
activity and for thermostability.
Substrate Specificity
The PEPM/ICL super-family consists of a variety of enzymes that can break carbon-carbon 
bonds, such as lyases (isocitrate lyase), hydrolases (oxaloacetate hydrolase OAH), and mutases 
(phosphoenolpyruvate mutase). All these enzymes act on a bond between a carbon and an 
oxalate-like moiety that is always bound to an Mg2+ or Mn2+ metal ion in the active-site cleft 
(fig. 3). 3DM detected a network of nine positions 43, 49, 75, 139, 147, 149, 150, 155, and 
157 (3D-numbering) with high CMA scores located in the active-site cleft in the area where 
the substituent group of the substrate binds (fig. 3). This strongly suggested that this part 
of the active site is involved in substrate specificity. To test this hypothesis we have mutated 
one of these positions in OAH of Botrytis cinerea [34]. Position 157, a serine in OAH, was 
selected since this position is closest to the substituent group of the substrate (Fig. 3). Three 
mutations were made: S157T, S157P, and S157A, since these three residues are the most 
abundant residues at position 157 (42%, 38%, and 11% respectively). As expected, these 
mutations did not significantly decrease activity of the protein, but they did have a drastic 
effects on the affinity of OAH for its substrate oxaloacetate [34]. This suggested that this 
position could be considered as a hot spot for changing substrate specificity. To test this 
hypothesis, mutations were made at the same position in two structurally related proteins. 
The first protein that was mutated was the petal death protein (PDP) which can convert 
multiple substrates including oxaloacetate. Like OAH, PDP [35] has a serine at 3D number 
157. The same S157T and S157P mutations were introduced in PDP, which specifically 
eliminated OAH activity from PDP while retaining all others [34]. 
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The second protein that was mutated at position 157 was methyl isocitrate lyase (MICL) 
which has a threonine at this position. In order to introduce OAH activity in MICL the 
complementary T157S mutation was made in MICL from E. coli (data not shown). 
Although this mutant could not convert oxaloacetate in oxalate and acetate, the T157S 
mutation, again had a drastic effect on the affinity of MICL for its natural substrate whereas 
the activity was virtually unchanged. This example shows that mutational information can 
successfully be transferred between different proteins, even though these proteins belong to 
different sub-families. From the fact that mutating position 157 in different subfamilies leads 
to the same effect we can conclude that this position is correctly aligned. This is especially 
rewarding because the region around position 157 is sequentially highly variable. 
 To demonstrate the connectivity of heterogeneous data types in a 3DM and to 
show the usability of the 3DM filtering system, a subset of OAH-like proteins from known 
oxalate producing fungi was generated. For each filter a graph is automatically generated 
that highlight residues specifically conserved in the corresponding subset of sequences. 
These “filter specific conservation” graphs can be retrieved from the position detail pages 
(see section 3DM interface of M&M). Not surprisingly, the OAH specific serine was the 
number one residue in this “filter specific conservation” graph of oxalate producing fungi. 
This example demonstrates the power of combining heterogeneous data. The multiple 
sequence alignment, the CMA, together with the possibility of rapidly determining the 
correlation between a physiological trait, residue type, and enzyme class brought position 
157 forcefully to our attention.
Figure 4. Tube representation of the 3D structure of PfPGI from P. furiosus (PDB accession code 1X82). 
The 3D-numbering scheme is used. The two conserved histidine residues are in yellow, the seven positions with 
high CM scores are in purple. 
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Enzyme activity I
The proteins that belong to the RmlC-like cupin super-family are functionally diverse [36], 
but most are enzymes of which the active site is located within the β-barrel. This active site 
often contains two histidines on core positions 10 and 31 that are conserved in approximately 
80% of all 2,035 sequences (fig. 4: magenta residues). The 3DM Comulator tool revealed a 
network of highly correlating positions (3D-numbers 12, 19, 25, 26, 27 and 28), of which 
the highest pair-wise CM score was detected for position pair 27 and 28. This pair is located 
in a structurally conserved surface loop far away from the active site histidines (fig. 4). We 
have studied how the relationship of the two positions affects enzyme activity in Pyrococcus 
furiosus PGI (PfPGI) [9]. PfPGI has a tyrosine at position 28 and first we introduced a 
glycine since, with 42%, this is the most prevalent amino acid at this position in the cupin 
super-family. The Y28G mutant (residue Y133G in PfPGI sequence) resulted in a 2.6 fold 
reduction of the activity. The most abundant residue at position 27 is also a glycine which 
is present in 26% of the aligned sequences. PfPGI however has a proline at this position. 
Analysis of the Comulator heat-map reveals that the PfPGI combination P27-Y28 occurs 
rarely (1.1%), whereas P27-G28 occurs in 4.4% of all sequences. However, when a glycine 
is present at position 28, by far the most prevalent residue at position 27 is an alanine (23%) 
followed by a glutamate (18%) and an arginine (18%). The double mutant P27A/Y28G 
not only regained the activity lost by the Y28G mutant, but even became twice as active as 
the wild-type enzyme. Also both the P27E/Y28G and P27R/Y28G double mutants could 
compensate for the loss of activity of Y28G, regaining near WT activity. It should be noted 
that in practice these results can not be obtained with a random mutagenesis and screening 
approach. 
Enzyme activity II
Members of the vanillyl-alcohol oxidase (VAO) flavoprotein family catalyze a wide variety of 
oxidation-reduction reactions and share a characteristic domain topology, with a conserved 
N-terminal FAD-binding domain and a less well conserved C-terminal cap domain. Most 
VAO-family members are oxidases that bind the FAD cofactor in a covalent manner [37]. 
To rationalize these properties with only few protein structures available, a 3DM alignment 
of the N-terminal domain using 1152 sequences of (putative) VAO-family members was 
constructed. It turned out that position 36 (a histidine in members with a covalently bound 
flavin) correlates well with positions 78, 91 and 929. Glycines are favoured at positions 
78, 91 and 92, and they are all located in the vicinity of the FAD. L-galactono-g-lactone 
dehydrogenase (GALDH), a VAO-family member lacking oxidase activity, contains a 
leucine at position 36 (Leu56), an alanine at position 78 (Ala113), and a valine at position 
91 (Val126). Ala113 was identified as a potential key residue, as it is predicted to be near the 
reactive flavin-C4a position creating a steric block that prevents oxygen from approaching 
the enzyme active site. Mutation of Ala113 to Gly generated an enzyme with 400-fold 
higher oxygen reactivity than wild-type GALDH, similar to that of other VAO family 
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members [38]. In the wild-type enzyme Ala113 acts as a gatekeeper, preventing oxygen to 
access the isoalloxazine nucleus. The pr esence of such an oxygen access gate seems to 
be a key factor for the prevention of oxidase activity within the VAO family, and is absent 
in members that act as oxidases. This study together with results from molecular dynamics 
simulations [39] provides an important advance in our understanding of the selective 
reactivity of flavoproteins toward oxygen.
Thermostability
A 3DM alignment consisting of 2,813 α/β-hydrolase super-family members including 
esterases, dehalogenases and epoxide hydrolases was used to increase the thermostability of 
an esterase from Pseudomonas fluorescens. Three positions were determined to be effective 
towards thermostability using B-FITTER (http://www.mpi-muelheim.mpg.de/kofo/
institut/arbeitsbereiche/reetz/reetz_e.html). From the determination of the amino acid 
Figure 5. 3DM contact data plots from the nuclear receptor ligand binding domain. Horizontal axes; 
alignment positions (3D-numbering scheme). The green bars indicate the number of contacts per position 
retrieved from PDB structure files. Upper panel; number of contacts retrieved from all relevant PDB files. Middle 
panel; contacts retrieved from PDB files with an agonistic compound. Lower panel; contacts retrieved from 
PDB files with an antagonistic compound. Alignment position 26 (boxed) makes only contacts with antagonistic 
compounds. 
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distribution at these three positions using the 3DM software, codons were elucidated that 
incorporate only those residues that are frequently present in the natural set of enzymes. 
By using this strategy, the library size could be substantially reduced from ~100,000 to 
only 3,450 variants to cover 95% of all possible combinations in a simultaneous saturation 
experiment. After preparation and screening of this library, the best mutant showed a melting 
point 8°C higher than the wild-type enzyme. To further support the quality of the mutant 
library, two additional libraries were created in which either all 20 natural amino acids or 
only those that appear very rarely at these positions were incorporated and representative 
numbers of variants were screened for activity and thermostability. The comparison of all 
three libraries concerning the hit rate and the average quality of hits (higher thermostability 
while maintaining wild-type activity) clearly showed that beside the advantage of less 
screening effort, the quality of the smaller, 3DM driven library, is much better compared to 
the incorporation of all 20 amino acids and even more if only seldom residues are introduced 
(Jochens, H., Bornscheuer, U.T., manuscript in preparation).
3DM in drug design
Drug design is a very elaborate project, and when a new drug hits the market one can be 
almost certain that thousands of scientists have thrown in the skills of their specialism to 
come to the final result. The early stages of a drug design pipeline are characterized by a 
massive collection and generation of heterogeneous data. Sequence – structure – function 
relation studies are a crucial early step necessary to obtain the information needed to guide, 
for example, small molecule library design, lead optimisation, or toxicogenomics studies.
 Folkerstma et al. were especially interested in in silico discrimination of agonistic 
and antagonistic small molecules [8]. They manually created an MCSIS for the nuclear 
receptor (NR) ligand binding domain, and described a correlation method that allowed 
them to find residues that explain the binding and mechanistic differences of agonists and 
antagonists. Their study was quite laborious because it involved; i) manual generation of a 
high quality structure-based multiple sequence alignment; ii) extraction from the structure 
files of contact data for agonistic and antagonistic ligands; iii) correlating contact data, etc., 
with the sequences in the alignment. It took Folkertsma et al., more then a year to make 
the MCSIS and to do the analyses. The 3DM NR required one month, of which most time 
was simply a computer crunching through the thousands of sequences, structures, articles 
with mutation data, etc. Correlation studies like the one performed by Folkertsma et al., 
today only take minutes to complete, since all different data types are fully connected in the 
3DM system and generation of the graphs (fig. 5) that form the bases of such studies is fully 
automated. Actually, the only limit on the possible correlation studies lies in our ability to 
think of new hypotheses when thinking about what can be done with the available data.
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DNA diagnostics
The 1,000-dollar genome [40] will be generating more problems than it solves. Even if 
only the coding regions are sequenced of the genome of a person with a genetic disorder we 
can still expect thousands of deviations from the generic, ‘wild-type’ human genome. Such 
studies will have to be combined with powerful computational methods that can prioritize 
the observed differences in terms of likelihood of being involved in that disorder. The role of 
P53 in cancer is an example. P53s are transcription factors involved in tumour repression. 
P53 mutations are found in more than 50% of all cancer patients [41] and in 580 different 
kinds of tumours [42]. However, if among the thousands of mutations observed in the 
sequenced genome of a patient a mutation is detected in P53, we can still only make a strong 
prediction if that particular mutation has been proven correlated to cancer in previous 
studies. With over 60,000 observed mutations, the P53 3DM is the largest P53 mutation 
database available on the Internet. The phenotype (type of cancer) is known for almost all 
of these mutations, allowing for completely new areas of research. One striking observation 
is that 93.2% of the P53 cancer related mutations are observed in the 229 structurally 
conserved positions while only 6.8% are observed in the remaining 112 positions of the 
human P53 (results not shown).
 The alpha-amylase 3DM contains more than 40 amylase sub-families, including 
the human alpha-galactosidase (hGLA). Fabry disease is a monogenetic X-linked lysosomal 
storage disease caused by mutations in hGLA. A deficiency in hGLA causes substrate 
accumulation, which ultimately leads to disease symptoms such as chronic pain, vascular 
degeneration and cardiac impairment. The diagnostics of Fabry (specifically the mild forms) 
can be difficult since the symptoms are similar for other diseases such as diabetics. The hGLA 
gene of a suspect patient is therefore sequenced to confirm the diagnosis. However, even if 
the gene indeed contains a non synonymous mutation, it still might be an uncommon non-
pathogenic variant. In previous work (Kuipers et al., manuscript in preparation) we have 
shown how the 3DM framework can assist in this type of DNA-diagnostics by correlating 
residue plasticity of core positions with specific mutations related to Fabry disease. The first 
major conclusion of this work is that 3DM could automatically collect more mutations from 
the literature then currently is stored in the conventional, mostly human curated, databases. 
3DM collected 1,369 mutations (371 unique mutations) from the literature, whereas the 
human gene mutation database (HGMD [43]), which is the most complete database of 
Fabry related mutations, contains only 301 unique mutations. The second major conclusion 
was that there is a very strong correlation between the alignment derived information and a 
pathogenic Fabry mutations. First, like in P53, 75% of the reported Fabry mutations were 
associated with core positions. Second, there is a strong correlation between a disease related 
hGLA amino acid change and the occurrence of the changed residue at the corresponding 
alignment position in the alpha amylase 3D-MSA. For example, only 3% of the in total 
1,034 reported hGLA mutations at core positions mutate to a residue that is present at 
the corresponding alignment position in more then 25% of the aligned alpha-amylase 
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sequences. Vice versa, 85% of all reported Fabry mutations located at core positions are 
mutated into amino acids which are present in the corresponding alignment position in less 
then 7% of the aligned alpha-amylase sequences. Clearly, introducing residues that are not 
frequently observed at the corresponding alignment position have a higher probability to be 
pathogenic.
Conclusions
The technologies of the omics era allow us to gather large volumes of data for many, often 
very different data types. These data must all be collected, validated, curated, and put in 
a common nomenclature and numbering scheme before they can be harvested through 
correlation techniques or other methods that have their basis in data integration. 
 The 3DM systems that were constructed so far have helped specialists in a series 
of research fields answer questions related to topics as diverse as protein stability, enzyme 
activity and specificity, the design of novel agonists or antagonists, and phenotype genotype 
correlations in humans with a genetic disorder. 
 These technologies will allow us to obtain and integrate all the time larger volumes 
of more data types. The subsequent deepening and widening of 3DM systems, in turn, will 
allow us to answer all the time more but also more complicated biological questions.
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Abstract 
Background
Many newly detected point mutations are located in protein-coding regions of the human 
genome. Knowledge of their effects on the protein’s 3D structure provides insight into the 
protein’s mechanism, can aid the design of further experiments, and eventually can lead to 
the development of new medicines and diagnostic tools. 
Results
In this article we describe HOPE, a fully automatic program that analyzes the structural 
and functional effects of point mutations. HOPE collects information from a wide range of 
information sources including calculations on the 3D coordinates of the protein by using 
WHAT IF Web services, sequence annotations from the UniProt database, and predictions 
by DAS services. Homology models are built with YASARA. Data is stored in a database and 
used in a decision scheme to identify the effects of a mutation on the protein’s 3D structure 
and function. HOPE builds a report with text, figures, and animations that is easy to use 
and understandable for (bio)medical researchers.
Conclusions
We tested HOPE by comparing its output to the results of manually performed projects. In 
all straightforward cases HOPE performed similar to a trained bioinformatician. The use of 
3D structures helps optimize the results in terms of reliability and details. HOPE’s results 
are easy to understand and are presented in a way that is attractive for researchers without an 
extensive bioinformatics background.
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Background 
The omics-revolution has led to a rapid increase in detected disease-related human mutations. 
A considerable fraction of these mutations is located in protein-coding regions of the genome 
and thus can affect the structure and function of that protein, thereby causing a phenotypic 
effect. Knowledge of these structural and functional effects can aid the design of further 
experiments and can eventually lead to the development of better disease diagnostics or even 
medicines to help cure patients. The analysis of mutations that cause the EEC syndrome, 
for example, revealed that some patients carry a mutation that disturbs dimerisation of 
the affected P63 protein [1]. This information has triggered a search for drugs (www.
epistem.eu; [2]). In another case, the study of a mutation in the human hemochromatosis 
protein (HFE), which causes hereditary hemochromatosis, resulted in new insights that 
are now being used to develop novel diagnostic methods [3]. These and numerous other 
examples have highlighted the importance of using heterogeneous data, especially structure 
information, in the study of human disease-linked protein variants.
 The data that can aid our understanding of the underlying mechanism of disease 
related mutations can range from the protein’s three-dimensional (3D) structure to its 
role in biological pathways, or from information generated by mutagenesis experiments to 
predicted functional motifs. Collecting all available information related to the protein of 
interest can be challenging and time-consuming. It is a difficult task to extract exactly those 
pieces of information that can lead to a conclusion about the effects of a mutation. Several 
online Web servers exist that offer help to the (bio)medical researcher in predicting these 
effects. These servers use information from a wide range of sources to reach conclusions 
about the pathogenicity of a mutation. The PolyPhen server, for example, is widely used 
by researchers to predict the possible impact of an amino acid substitution on the structure 
and function of human proteins [4]. PolyPhen combines a subset of the UniProt sequence 
features, structural information (when available), and multiple sequence alignments in order 
to draw conclusions about the impact of a mutation [4]. SIFT, on the other hand, bases its 
mutation analysis purely on a multiple sequence alignment [5]. This server gives probability 
scores for each amino acid type at the position of interest to separate the harmless mutations 
from disease-causing ones. The ALAMUT software (http://www.interactive-biosoftware.
com/) is widely used in human genetics research groups. It focuses on making many forms 
of software and databases available to their users. The ALAMUT system also automatically 
calls the PolyPhen Web server as part of its decision process. ALAMUT is not available as a 
Web server. PolyPhen, Sift and Alamut all have an excellent track-record make existing data 
accessible for (bio)medical scientist to aid them with the interpretation of mutational effects. 
We built on their strengths to produce the HOPE software that was written to optimally use 
the advantages of the novel tools of the e-Science era.
 The recent increase in data types and data volumes has gone hand-in-hand with 
large efforts in bioinformatics that have led to numerous new databases and computational 
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methods, and in this era of e-Science, Web services provide on-demand access to these 
facilities [6-8]. The development of Web services facilitates the usage of external databases and 
methods in in-house developed software and eases software maintenance and development 
by out-sourcing logic to Web services. Web services have a series of advantages for the 
software developers:
•	 They save time by reusing program code;
•	 They tend to always be up-to-date;
•	 They are executed remotely, which gives access to large amounts of (free) CPU time, 
thus not overloading the local machine;
•	 No need to maintain in-house data and software collections.
Web services also have disadvantages:
•	 Source code of Web services often is not available;
•	 Web services are not guaranteed to always be available.
HOPE (Have (y)Our Protein Explained) is a next-generation web application for automatic 
mutant analysis. We have designed HOPE to explain the molecular origin of a disease 
related phenotype caused by mutations in human proteins. In this aspect HOPE resembles 
the aforementioned systems (PolyPhen, SIFT, ALAMUT). With HOPE we have taken the 
logical next step in the e-Science era in that the data gathering is done using Web services and 
DAS servers. Additionally, in HOPE we have taken a protein 3D structure centred approach. 
HOPE collects information from data sources such as the protein’s 3D structure and the 
UniProt database of well-annotated protein sequences. For each protein this data is stored in 
a PostgreSQL-based information system. A decision scheme is used to process these data and 
to predict the effects of the mutation on the 3D structure and the function of the protein. A 
life-scientist friendly report is produced that explains and illustrates the effects of the mutation. 
This report is presented using an interface that is designed specifically for the intended user 
community of human genetics researchers. The report is enriched with figures that illustrate 
the effects of the mutation, while any residual bioinformatics jargon is linked to our in-house, 
online dictionary of bioinformatics jargon. The conclusions drawn in the report can be used to 
design follow-up experiments and eventually can lead to the development of better diagnostics 
or even medicines. Figure 1 illustrates the major steps of HOPE. We have tested HOPE on 
a series of mutations that we have previously analyzed manually. In all straightforward cases 
HOPE performed equally well as a trained protein structure bioinformatician. 
 
Availability. 
The HOPE Web server is freely available on http://www.cmbi.ru.nl/hope/.
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Results and discussion
Input 
The intended users of HOPE are life scientists who neither routinely use protein structures 
nor bioinformatics in their research. Therefore, both HOPE’s input and its results are 
designed to be intuitive and simple, and all software used will run with default settings so 
Figure 1. Overview of HOPE’s process flow. The user submits a sequence and a mutation. HOPE will first 
collect information from a wide range of information sources. These sources include: WHAT IF for structural 
calculations on either the PDB file or a homology model that was build by YASARA, HSSP for conservation 
scores, DAS-servers for sequence-based predictions and Uniprot for sequence annotations. The data is stored in 
HOPE’s information system. The data is combined with the known properties of the amino acids in a decision 
schedule. The result is a report shown on the HOPE website that will focus on the effect of the submitted 
mutation on the 3D-structure of the protein. The text and figures can be used in articles and publications.
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that the user neither needs to set parameters nor needs to read documentation. Actually, the 
user will not even know which software runs in the background. The interface of HOPE is a 
website that enables the user to submit a sequence and a mutation. The user can indicate the 
mutated residue and the new residue type by simple mouse-clicks. Figure 2 shows the input 
screen, filled with an example protein sequence and a mutation. 
Information retrieval
HOPE uses the submitted sequence as query for BLAST [9] searches against both the 
UniProt database [10] and the Protein Data Bank [11]. The search against the UniProt 
database identifies the protein’s UniProt entry and the accession code of the protein, 
unique identifier that is used later in the process to obtain DAS-predictions. Alternatively, 
it is possible to submit this accession code directly. The BLAST search against the PDB 
is required to find the protein’s structure or a possible template for homology modelling. 
HOPE uses the actual PDB-file when it contains the residue that is to be mutated and when 
it is 100% identical with the submitted sequence. HOPE identifies among multiple 100% 
hits the best structure for analysis based on resolution, experimental method, and length of 
the protein covered in the PDB (a full protein is preferred over a fragment). Nowadays, 20% 
of the human sequences available from SwissProt have a (partly) known structure and for 
another 30% a homology model can be build. To be able to build a homology model, the 
BLAST results should contain the equivalent location of the mutation and the percentage 
sequence identity should fall above the Sander and Schneider curve shown in Figure 3. 
Figure 2. HOPE’s input 
screen. The user can submit 
a sequence of interest 
and indicate the mutated 
residue with two simple 
mouse-clicks. In this 
example HOPE will analyze 
a leucine to aspartic acid 
mutation on position 25 of 
the plant protein Crambin.
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Homology modelling is performed using the Twinset version of YASARA which contains 
an automatic homology modelling script that requires only a sequence as input [12]. The 
script fully automatically performs the modelling process including sequence alignment, 
loop building, side chain modelling, and energy minimization. This script was the top 
contestant in the CASP8 modelling competition in terms of model detail accuracy [13]. 
 The structure of the protein of interest, either a PDB-file or a homology model, 
is analyzed using WHAT IF Web services [7]. These services can calculate a wide range of 
structural features (e.g. accessibility, hydrogen bonds, salt bridges, ligand or ion interactions, 
mutability, variability, etc). When neither a 3D structure nor a possible modelling template 
is available, HOPE cannot use structural information and will instead base its conclusions 
only on the sequence related data, and published mutation and variation results. 
 The UniProt database (http://www.uniprot.org/) is used for the retrieval of features 
that can be mapped on the sequence [14]. This information includes the location of active sites, 
transmembrane domains, secondary structure, domains, motifs, experimental information, 
and sequence variants. The UniProt accession code is used to retrieve data from a series of 
DAS-servers for sequence based predictions such as possible phosphorylation sites. The DAS-
servers form a widely used system for biological sequence annotation [15]. The conservation 
score of the mutated residue is calculated from a HSSP multiple sequence alignment [16].
Figure 3. The two zones of sequence alignment identity that indicate the likelihood of adopting similar 
structures. Two aligned sequences are highly likely to have similar folds if their length and percentage sequence 
identity fall in the region above the threshold (black line). HOPE will build a homology model when the identity 
between the template and submitted sequence falls in this zone. In case the sequence identity is less than 5% 
above this threshold (grey line) HOPE will build a model but will also warn that the model is based on a template 
with low identity. The region below the threshold (indicated with a cross) indicates the zone where inference of 
structural similarity cannot be made, thus making it difficult to determine if model building will be possible. 
(Figure free after Sander and Schneider [25])
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Data storage in HOPE
Information obtained from the protein structure or model, the UniProt record, and the 
DAS-predictions is stored in a protein-specific information system based on the PostgreSQL 
database system. One new information system is produced for each submitted protein. 
Differences in the protein sequence might exist between data sources, for example sequences 
from UniProt often contain the signal peptide while the sequences stored in the PDB tend 
to lack these residues. Therefore, sequences obtained from different sources are aligned using 
ClustalW. This enables us to transfer information to the residue of interest without the need 
to deal with the residue numbering problem that results from these sequence differences. 
Protein features are stored in the information system on a per-residue basis, and can have 
one of the following four data-types: 
•	 Contacts: Interaction of the residue with another entity; for example DNA, a metal-ion, 
a ligand, hydrogen bond, disulfide bond, salt bridge;
•	 Variable features: Type with a value: for example, accessibility or torsion angle;
•	 Fixed features: Labels a residue (or stretch of residues) with a feature without a value. 
This indicates that the residue is located in a domain or motif (for example a residue can 
be part of the active site or in a transmembrane region);
•	 Variants: Mutations or other variations in sequence known at this position; for example 
splice variants, mutagenesis sites, SNPs.
After a user request has triggered the generation of an information system for the protein 
of interest, the system for this protein is kept on disk for one month just in case the same 
user (or another user for that matter) requests information about other mutations in the 
same molecule. After one month every system is thrown away to ensure that conclusions are 
never based on outdated information. So, there does not really exist a HOPE database as all 
HOPE’s data is, in total agreement with e-Science paradigms, scattered over the internet, 
and is each time combined upon request.
Decision scheme
The decision scheme in HOPE uses all collected information combined with known 
properties of the wild-type and mutated amino acid, such as size, charge, and hydrophobicity, 
to predict the effect of the mutation on the protein’s structure and function. The scheme 
consists of six parts that each correspond to a paragraph in the output. Each part analyzes 
the effect of the mutation on one of the following aspects of the residue: 
•	 Contacts. Any interaction with other molecules or atoms, like DNA, ligans, metals, etc, 
but also hydrogen bonds, disulfide bridges, ionic interactions, etc;
•	 Structural domain. Any part of the protein with a specific name (and often function), 
such as domains, motifs, regions, transmembrane domains, repeats, zinc fingers, etc;
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•	 Modifications. Features that do not directly influence the structure of the protein but 
might influence post-translational processes like phosphorylation.
•	 Variants. Known polymorphisms, mutagenesis sites, splice variants, etc;
•	 Conservation: The relative frequency of an amino acid type at each position taken from 
a multiple sequence alignment.
•	 Amino acid properties: The differences in the known properties of the wild-type and 
mutant residue (size, charge, hydrophobicity).
 
HOPE will produce its conclusions for each of these six aspects separately. For example, 
a residue can be located in a transmembrane domain and also be important for ligand 
interaction. HOPE will in this case produce a paragraph about the effect of the mutation on 
the contacts and a separate paragraph describing the effect of the mutation on the structural 
location, in this example the transmembrane domain.
 Some types of information can be obtained from multiple sources, which are not 
equally reliable. Experimentally determined features and calculations performed on the 3D 
coordinates are more likely to be correct than any prediction. For example, transmembrane 
domains can be predicted by a DAS-server which normally will produce less reliable results 
than the annotations in UniProt. Therefore, HOPE ranks the information and uses the most 
accurate source available for its conclusions. WHAT IF calculations are preferred, followed 
by UniProt annotations, and DAS predictions are used only when neither WHAT IF nor 
UniProt data are available. In case no information about the mutated residue is found, 
HOPE will show a conclusion based only on biophysical characteristics between the wild 
type and mutant amino acid type. The conservation score is obtained either from the HSSP 
database that holds multiple sequence alignments for all proteins in the PDB, or through the 
HSSP Web services if a PDB file is not available [16].
Output
The report focuses on the effect of the mutation on the 3D-structure, and is aimed at a 
specific audience in the field of (bio)medical science. It shows the methods used and the 
sources of the combined information. This can either be an analysis of the real structure or 
homology model, or a prediction based on the sequence. The results of the mutation analyses 
are illustrated with figures of the amino acids and, if available, figures and animations of the 
mutation in the structure. The HOPE output is rather extensive and way too large to put in 
print, in figure 4 we just show a small part of one mutation report. A series of examples of 
HOPE output is available at the “about” section of the HOPE pages. 
 A HOPE result consists of one HTML page that contains all results. This makes 
it easy for users to print the results, or to make their own Web-page with HOPE results for 
long-term storage.
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Test cases
HOPE was validated in a series of collaborations with scientists from different fields of life 
sciences. Experiences from these real-world examples where used to design and adjust the 
decision scheme. So far, most mutation studies involved non-sense and missense mutations. 
Descriptions of these projects can be found at the HOPE website. The resulting reports 
often contain a molecular explanation of the observed phenotype that can suggest further 
experiments. The majority of these projects included the building of a homology model as 
in most cases no 3D-structure of the protein of interest was available.
 We also validated HOPE’s conclusions by comparing them with the output of 
PolyPhen and SIFT. Even though it is very difficult to compare the results from PolyPhen, 
SIFT, and HOPE, we can still draw a few general conclusions, that will be elaborated on in 
the following paragraphs.
Figure 4. Example of HOPE’s output. A simplified example of HOPE’s output. A) Explanation of the used 
method (structure, modelling or predictions) and links to the relevant databases. B) Text and pictures that explain 
the differences between the wild-type and mutant residue. (Text is left out of this figure for clarity.) C) Paragraph 
of the report explaining the effect of the mutation on contacts made by the residue, a disulfid bond in this case. 
It contains a link to the wiki-entry “cysteine” and “disulfid bond”. D) Images/animations that show the effect of 
the mutation on the structure.
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Structure adds value
The use of a protein’s 3D-structure or homology model increases the prediction quality 
in terms of reliability and detail. The possibility offered by the YASARA software to fully 
automatically build high quality homology models increases the number of sequences for 
which HOPE can use structure data. The protein structure, either a PDB-file or a homology 
model, can reveal information that currently cannot be predicted accurately from sequence 
alone, such as ionic interactions, ligand-contacts, etc. 
 The value of the extra information that HOPE can extract from a protein’s structure 
or model is illustrated, for example, by the L320P and L347P mutations in ESRBB (see 
the “about” section of the HOPE website). All Web servers correctly predict the effect of 
these mutations as damaging for the protein. However, HOPE completes the story by an 
extensive explanation of the disturbing effect of prolines on alpha-helices. In cases for which 
no 3D structure data is available, the three Web servers seem to perform similarly albeit that 
Polyphen’s output often tends to be scarce and a bit cryptic and SIFT’s output is limited to 
conservation scores. 
Biomedicist understandable results
HOPE’s interface was designed especially for users that work in the (bio)medical sciences. 
Instead of displaying data in the form of detailed tables and numerical values, HOPE 
writes human readable reports that explain the structural and functional effects of the 
mutation, and illustrates this with figures and animations. When other Web servers list 
the effects of a mutation as “Hydrophobicity change at buried site; normed accessibility: 0.00, 
hydrophobicity change: -2.7”. HOPE will instead report that “the mutation introduces a less 
hydrophobic residue in the core of the protein which can destabilize the structure”. Many more 
examples of HOPE’s readable output can be found at the “about” section of the HOPE 
website. HOPE’s comprehensibility is improved by the Help-function that links difficult 
bioinformatics keywords to our own in-house dictionary based on Wikipedia’s software. 
In this dictionary the user can find text, illustrations, and sometimes a short video-clip that 
explains the keyword. 
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Conclusions
Upon running 24 test cases, listed on the website, we realised that the present version of 
HOPE is useful and reliable in analysing point mutations. The next generation of HOPE 
will, however, need to reach a higher level of data integration to address more complicated 
cases. Some answer might be found only by combining the calculations with literature data 
and general knowledge of the protein’s structure function relations. For example, PolyPhen 
predicts the N255D mutation in Kv1.1 (discussed in [17]) as being benign, while SIFT shows 
that this residue is 100% conserved. Combination of the conservation information with the 
fact that this residue is located in the voltage sensor of the channel can result in the hypothesis 
that the mutation disturbs the channel’s voltage sensing mechanism. Such conclusions are still 
beyond the capabilities of today’s Web servers, but the software design of HOPE will one day 
allow us to introduce the features needed to deal which these more complicated cases.
HOPE is an example of the new way of doing data- and software-intensive research 
in the era of eScience. Nowadays, the ongoing developments in experimental techniques 
like high-throughput sequencing will continue to produce large amounts of data and will 
therefore demand new, further automated approaches towards the analysis of these data. The 
eScience approach used will allow us to easily extend HOPE with more Web services, data 
sources, and DAS predictions when these become available. In the years to come HOPE 
can be extended with the possibility to analyze double-mutants, to quantitatively score the 
structural effects of the mutation and thereby provide the possibility to automatically rank 
candidate mutations that are the result of a sequence project, or to further improve the 
already user-friendly HOPE user interface.
Methods 
The HOPE system is schematically shown in figure 5. The individual elements of his schema 
are described in the remainder of this section.
 The HOPE website is implemented using the Wicket (http://wicket.
apache.org/) web framework, which allows us to provide a fluent and responsive user 
experience. The web application is deployed on the GlassFish web application container 
(https://glassfish.dev.java.net/).  
 HOPE obtains information from different sources beyond our control. Therefore, 
the data gathering is set up as fail-safe as possible to handle service unavailability. Data 
is cached to speed up the process, reduce dependencies and to put less strain on external 
resources. The data-retention time is 30 days, after which time the data is renewed at the 
moment someone runs an analysis on the same sequence. The database scheme (available 
at the “about” section of the HOPE pages) is the result of an iterative design process using 
both Java and Hibernate to manage all data and to create the database tables. The database 
engine is PostgreSQL version 8.4. 
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The MRS BLAST version 4 Web service is used for most database searches with an 
e-value cut-off of 1e-5 and the low-complexity filter switched off [18]. This Web service 
(http://mrs.cmbi.ru.nl/mrsws/blast/wsdl) is backed by an in-house implementation of the 
standard BLAST algorithm. ClustalW version 2.0.10  is used for sequence alignments [19]. 
ClustalW is also offered as a Web service through MRS (http://mrs.cmbi.ru.nl/mrsws/clustal/
wsdl).
 WHAT IF Web services, accessible via http://wiws.cmbi.ru.nl/wsdl/, are used 
to calculate secondary structure (using DSSP [20]), accessibility values, structural fits of 
mutations, contacts with ligands or ions, salt bridges, disulfide bridges,  and hydrogen 
bonds [21]. These calculations are performed either on the deposited PDB structure, or 
a homology model. Homology modelling is performed fully automatically using a locally 
installed WHAT IF & YASARA Twinset [12, 13]. This installation runs on a separate 
server, and is controlled through a Perl CGI script.
 Sequence annotations are obtained from the UniProt database (http://www.
uniprot.org/) [14] XML records. The obtained information includes sequence features such 
as active site, motifs, domains, variants and binding sites.
 
Figure 5. Detailed overview of HOPE’s components. HOPE’s input consists of the sequence and the mutation. 
The sequence is used for a BLAST search against the databases. Using the accession code (and PDB-file if 
available) HOPE can collect information from a series of information sources: WHAT IF calculations on the 
PDB-file or homology model built by YASARA, annotations in the Uniprot database, HSSP conservation scores 
and sequence-based predictions by DAS-servers. The information is combined in a decision scheme and a report 
is generated. This report is illustrated with pictures and animations and difficult keywords are linked to our own 
online dictionary. 
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Conservation scores are obtained from HSSP using the Web service for which the WSDL 
is available at http://mrs.cmbi.ru.nl/hsspsoap/wsdl. When a PDB deposited structure 
is available, the pre-calculated HSSP scores maintained at the CMBI are used. In case a 
homology model is available a DSSP file is generated for the homology model, which in 
turn is used to create a HSSP file. In case no structure or model is available, a HSSP file is 
generated using only the user sequence. 
 Distributed Annotation (DAS) servers [15, 22] are used to obtain predictions 
regarding transmembrane regions by Phobius [23], accessibilities by PHDacc [24], secondary 
structure by PHDsec  [24], and phosphorylation sites by NetPhos [22]. 
 The decision scheme is implemented in Groovy, a dynamic language that runs 
on the Java Virtual Machine (http://groovy.codehaus.org/). The simple Groovy language 
enables other users to design their own decision schemes and run a specific version of HOPE 
for their own purposes. The decision scheme is divided into separate branches targeted 
towards certain aspects of the mutant analysis, each producing a paragraph or sub-report. 
The decision scheme logic is separated from the phrases used to compose the report, for a 
cleaner separation in code and to allow for internationalization.
 The HOPE report is presented on a self-contained webpage, allowing the user 
to save the page without breaking links and images. The user can bookmark the URL to 
perform the same mutant analysis at a later point in time, incorporating any newly available 
data. The output web pages are intended to be free from bioinformatics jargon. An online 
dictionary based on MediaWiki’s software (http://www.mediawiki.org/) is used to explain 
bioinformatics-specific terms. JavaScript is used to link keywords on the webpage to articles 
present in the local MediaWiki instance. This functionality is available at any time via the 
omni-present blue help-button. Images and movies in the report are generated using the 
YASARA & WHAT IF Twinset. 
Availability and Requirements
The full description of the design and implementation of the HOPE server is available 
from the “about” section of the HOPE pages. HOPE can be used freely and no licenses 
are required. The source code has been made open source and can be freely obtained 
from the HOPE website. HOPE uses Java, Groovy, and PostgreSQL; it has been 
implemented on a Linux system while care has been taken to avoid system dependencies. 
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Abstract
Correlated mutation analyses (CMA) on multiple sequence alignments are widely used for 
the prediction of the function of amino acids. The accuracy of CMA-based predictions is 
mainly determined by the number of sequences, by their evolutionary distances, and by the 
quality of the alignments. These criteria are best met in structure-based sequence alignments 
of large super-families. So far, CMA-techniques have mainly been employed to study 
receptor interactions. The present work  shows how a novel CMA tool, called Comulator, 
can be used to determine networks of functionally related residues in enzymes. These 
analyses provide leads for protein engineering studies that are directed towards modification 
of enzyme specificity or activity. As proof of concept, Comulator has been applied to four 
enzyme super-families: the  isocitrate lyase/phoshoenol-pyruvate mutase superfamily, the 
hexokinase super-family, the RmlC-like cupin super-family, and the FAD-linked oxidases 
super-family. In each of those cases networks of functionally related residue positions were 
discovered that upon mutation influenced enzyme specificity and/or activity as predicted. 
We conclude that CMA is a powerful tool for redesigning enzyme activity and selectivity.
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Introduction
Proteins evolve within a framework of functional constraints that limit substitutions at 
individual positions in the sequence. The results of these constraints can be detected in 
large multiple sequence alignments as evolutionary fingerprints. Co-evolution of the amino 
acids at two distinct alignment positions, for example, is a result of functional constraints 
that force compensating mutations for specific residue changes. This co-evolution of residue 
positions can be detected by correlated mutation analyses (CMA) algorithms. Although 
the concept of correlated mutations is rather straightforward, their unambiguous detection 
proved more difficult. Therefore, several algorithms have been developed that are able to 
screen alignments for correlated mutations [1,2]. These methods are mostly used for the 
prediction of contacts between residues. Contact predictions can reveal inter-molecular 
protein-protein interactions [3-5], or intra-molecular interactions that in turn can be used 
for protein structure predictions [6]. In 1993 we introduced the idea that CMA is better 
suited for the detection of functionally related residues [7]. Later, using the GPCR protein 
super-family, we indeed showed that residue positions with common function tend to 
stay conserved, and when they do change they do so simultaneously [8]. Nevertheless, the 
number of articles that describe the utilization of CMA for detection of functionally related 
residues is still very limited. There are some examples where CMA was used to identify 
ligand-receptor interactions sites [8-10] and recently two papers appeared in which CMA 
was successfully used to detect residue positions important in multi-drug resistance of the 
HIV-1 protease [10,11]. 
 Unambiguous detection of functionally related residues by CMA requires a reliable, 
large super-family alignment. We have recently designed the 3DM software (manuscript 
in preparation) that can be used to rapidly produce structure-based super-family multiple 
sequence alignments (MSAs). The Comulator software is a novel extension of this 3DM 
software suite, and was specifically designed for analysis of very large MSAs. Here it was 
used in protein engineering experiments to analyze the alignments of four super-families: 
(1) the isocitrate lyase/phoshoenol-pyruvate mutase (ICL/PEPM) super-family, in which 
we could selectively remove the specificity for one of its substrates, (2) the hexokinase (HK) 
super-family, in which we could properly predict the allowed subset of allowed residues in 
a saturation mutagenesis experiment, (3) the FAD-linked oxidases (FAD-O) super-family 
in which we could predict compensating mutations for loss-of-function mutants, and (4) 
the RmlC-like cupin (cupin) super-family (nomenclature according to the SCOP database 
[12]), in which we could improve the activity by designing a double mutant. The former 
two super-family MSAs were used to detect residues involved in substrate specificity, the 
latter two to predict compensating mutations for mutations that either decreased protein 
activity or protein stability. The Comulator CMA results agree in all four cases well with 
experiments; the latter two sets of experiments were produced by us and are here published 
for the first time. 
140
Chapter 5
The Comulator is available at http://www.3dmcsis.systemsbiology.nl/comulator/; this 
most likely is the first CMA software that is freely available in the internet. All underlying 
structure and sequence alignments, CMA results, mutations mined from literature, etc., are 
available from http://www.3dmcsis.systemsbiology.nl/.
Materials and methods
Super-family sequence alignment.
Protein structures belonging to 4 super-families were collected using the SCOP database 
combined with BLAST [13] searches in the PDB database. Super-family sequences were 
collected by searches in the NCBI database using the sequences of the super-family structures 
as query sequences. The super-family alignments were generated using 3DM. This software 
is described elsewhere (manuscript in preparation)  and is only briefly described here. 3DM 
superposes the structures of proteins belonging to a super-family and so generates a structure-
based sequence alignment that contains all sequence positions that are structurally conserved 
throughout the super-family. These so-called core positions are numbered sequentially, and 
these numbers (called 3DM-numbers) are used throughout this study. For each structure 
a profile is built by iteratively aligning sequences that are related to that structure. Finally, 
all sequences are aligned against the profile they are most similar to. In the final step the 
structure-based alignment is used for the generation of one large super-family alignment. 
CM algorithm
The Comulator algorithm is derived from a method described for the detection of allosteric 
interactions in the nuclear receptor super-family [14]. The underlying method is known as 
the statistical coupling analysis method [15,16]. Equation 1 shows the similar method that 
was implemented in the Comulator.
                  with,      
In which x and y run over the residue positions in the MSA; CM(x,y) is the correlation score 
between the residue positions x and y; a and b run over the 20 amino acid types; N is the 
number of sequences in the MSA; N(y=b) is the frequency of residue type b at position y; N(x=a) 
is the frequency of residue type a at position x; and N(x=a^y=b) is the frequency of residue type b 
at position y in sequences where type a is observed at position x; |F(x,y,a,b)| is the absolute value 
of F(x,y,a,b). F will be negative if the amino acid b at position y is relatively more abundant in the 
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subset of sequences that has type a at position x (N(x=a^y=b)/ N(x=a)) than in the full alignment 
at position y (N(y=b)/N). If the amino acid pair is observed less often in the subset than in the 
whole alignment the score F will be positive. Due to the summation of absolute values, pairs 
of residue types contribute more to the score CM(x,y) when their frequency deviates more 
from the average. In other words, a high F score is obtained when the residues at positions x 
and y tend to mutate in tandem. Obviously, a pair of fully conserved positions gets a score of 
zero. Comulator calculates CM scores for all possible alignment position pairs. The resulting 
scores are visualized in heat-maps that are incorporated in interactive HTML pages (fig. 1) 
in which all squares are hyperlinked to the underlying raw data, including the alignment.
Comulator website
The WWW based version of Comulator accepts as input aligned sequences in Fasta or 
ClustalW format. The input alignments are visualized similarly as for 3DM derived 
alignments including an alignment positions numbering scheme. The same numbering 
scheme is applied to the CM heat-map. If a sequence file contains a Swiss-Prot ID then the 
results are also automatically linked to the corresponding Swiss-Prot data file. 
Figure 1. Heat-map of the ICL/PEPM  super-family. Only residue positions are shown that have at least one 
correlation score above a  cut-off (CMA score > 0.8). Squares are coloured from green (low correlation) to red 
(high correlation). The inset shows an example of hyperlinked information. In the insert the top-left corner of the 
residue pair frequency table is shown for the position pair (65,66).
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Mutation QuickChange primers
3DM PfPGI
P27A P132A FW: (5’- GTAGTTTATGTTCCCGCCTATTGGGCTCATAGG -3’)
RV: (5’- CCTATGAGCCCAATAGGCGGGAACATAAACTAC -3’)
Y28G Y133G FW: (5’- GTAGTTTATGTTCCCCCCGGTTGGGCTCATAGGACGG -3’)
RV: (5’- CCGTCCTATGAGCCCAACCGGGGGGAACATAAACTAC -3’)
P27A/
Y28G
P132A/
Y133G
FW: (5’- GTAGTTTATGTTCCCGCCGGTTGGGCTCATAGGACGG -3’)
RV: (5’-CCGTCCTATGAGCCCAACCGGCGGGAACATAAACTAC -3’)
P27E/
Y28G 
P132E/
Y133G 
FW: (5’- GTAGTTTATGTTCCCGAAGGTTGGGCTCATAGGACGG -3’)
RV: (5’- CCGTCCTATGAGCCCAACCTTCGGGAACATAAACTAC -5’)
P27R/
Y28G  
P132R/
Y133G
FW: (5’- GTAGTTTATGTTCCCCGCGGTTGGGCTCATAGGACGG -3’)
RV: (5’- CCGTCCTATGAGCCCAACCGCGGGGAACATAAACTAC -5’)
Mutagenesis, over-expression and purification of phospho-glucose isomerase from Pyrococcus 
furiosus.
The cloning of pgiA is described by Verhees et al. [17]. Mutants were generated with the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene, USA) following the manufacturer’s 
instructions with the following adaptations: 25 PCR cycles were applied, and the PCR 
mixture was incubated with DpnI for 4 to 8 hours at 37 °C. Mutants and primers used for 
mutagenesis are listed in table I. Mutants were verified by sequencing (Baseclear, Leiden, 
The Netherlands).
 E. coli strain BL21(DE3) containing the tRNA accessory plasmid pRIL (Stratagene) 
carrying the concerning plasmid was routinely grown in 1 liter  Luria Bertani medium 
(LB-medium) with kanamycin and chloramphenicol at 37 °C until an OD600 of 0.5 was 
obtained. Isopropyl-β-d-thiogalactopyranoside (IPTG) was added to a final concentration 
of 0.1 mM and the culture was further incubated for 8 hours under the same conditions. 
Cells were harvested by centrifugation (3,800 g at 4 °C for 20 min), resuspended in 10 ml 
lysis buffer (20 mM Tris.HCl, pH 8.0) and sonicated for 5 min at 4 °C. The cell extract was 
clarified by centrifugation (37,000 g at 4 °C for 20 min). E. coli proteins were denatured by 
incubating the cell extract at 70 °C for 30 min, and pelleted by centrifugation (37,000 g at 4 
°C for 20 min). PGI was purified to homogeneity using FPLC: the supernatant was loaded 
onto a Q-Sepharose Fast Flow column (GE Healthcare, USA) pre-equilibrated with 20 mM 
Tris.HCl (pH 8.0). Proteins were eluted by a linear gradient of 0.0 to 1.0 M NaCl in 20 
mM Tris.HCl (pH 8.0). Fractions containing PGI were pooled, concentrated, and loaded 
on a Superdex 200 GL column running in 20 mM Tris.HCl containing 125 mM NaCl. 
Table 1.  Primers used for the mutagenesis studies of pgiA. Both the 3DM alignment position numbering (1st 
column) and the number of the corresponding position in the ORF of  phoshoglucose isomerase from P. furiosus 
(2nd column) are indicated.
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Enzyme activity of the PGI mutants with fructose 6-phosphate was determined at 50°C as 
described previously17 with the following adaptations: 20 mM Tris.HCl pH 7.0 was used, 
and the protein samples were pre-incubated with 50 mM EDTA at 50 °C for 20 minutes 
to ensure complete metal depletion [18]. Activity was measured with MnCl2 in excess over 
EDTA to ensure enzyme saturation.
Mutation QuickChange primers
3DM AtGALDH
36 L56H FW: (5’-CCCGTTGGATCGGGTCACTCGCCTAATGGGATTG-3’)
RV: (5’-CAATCCCATTAGGCGAGTGACCCGATCCAACGGG-3’)
78 A113G FW: (5’-CTCTTCAGAACTTTGGCTCCATTAGAGAGCAG-3’)
RV: (5’-CTGCTCTCTAATGGAGCCAAAGTTCTGAAGAG-3’)
91 V126G FW: (5’-GGTGGTATTATTCAGGGTGGGGCACATGGGAC-3’)
RV: (5’-GTCCCATGTGCCCCACCCTGAATAATACCACC-3’)
Expression, purification, and mutagenesis of L-galactono-1,4-lactone dehydrogenase from 
Arabidopsis thaliana
The cDNA encoding mature L-galactono-1,4-lactone dehydrogenase (GALDH) from 
A. thaliana has been cloned previously to yield pET-GALDH-His6 [REF]. The GALDH 
mutants used in this study were constructed using pET-GALDH-His6 as template with the 
QuikChange method (Stratagene) using the primers listed in table 2. Successful mutagenesis 
was confirmed by automated sequencing.
 For enzyme production E. coli BL21(DE3) cells, harbouring a pET-GALDH 
plasmid, were grown in 1 l LB-medium supplemented with 100 mg/ml ampicillin at 37°C 
until an OD600
 
of 0.7 was reached. Expression was induced by addition of 0.4 mM IPTG and 
the incubation was continued for 16 h at 37°C. The cells were harvested by centrifugation, 
resuspended in 5 ml lysis buffer (50 mM sodium phosphate, 300 mM NaCl, pH 7.4) and 
passed twice through a pre-cooled French Press (SLM Aminco) at 10 000 PSI. The resulting 
homogenate was centrifuged at 25 000 g for 30 min at 4°C to remove cell debris and the 
supernatant was loaded onto a HisGraviTrap column (GE Healthcare), equilibrated with 50 
mM sodium phosphate, 300 mM NaCl, 45 mM imidazole, pH 7.4. Proteins were eluted with 
50 mM sodium phosphate, 300 mM NaCl, 300 mM imidazole, pH 7.4 and saturated with 
FAD. Excess FAD and salt were removed by Biogel P-6DG size exclusion chromatography 
(BioRad) in 20 mM sodium phosphate, 0.1 mM DTT, pH 7.4. The amount of protein-
bound FAD was determined from the ratio in absorbance at 280 and 450 nm (F-factor). 
Table 2. Primers used for the mutagenesis Studies of AtGALDH. Both the 3DM alignment position 
numbering (1st column) and the number of the corresponding position in the ORF of L-galactono-1,4-lactone 
dehydrogenase from Arabidopsis thaliana (2nd column) are indicated.
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GALDH activity was routinely assayed by following the reduction of cytochrome c at 550 
nm using a molar difference absorption coefficient (De550) of 21 mM
-1 cm-1 for reduced 
minus oxidized cytochrome c as described [19], with the modification that 1 mM FAD was 
included in the assay mixture. The thermal stability of GALDH was determined as reported 
earlier [19].
Results 
Isocitrate lyase-like/Phosphoenolpyruvate mutase super-family.
The isocitrate lyase/PEP mutase super-family alignment contains enzymes that cover 
three of the six main enzyme families (EC codes) that all break a carbon-carbon in an 
oxalate-containing compound. All enzymes in this super-family share an α-β-barrel fold. 
The structure-based multiple sequence alignment contains 375 unique sequences. A 
network of nine residue positions with high CM scores was detected. These nine residue 
positions are found mainly but not exclusively surrounding the active site cleft. The detailed 
function of many of these residues is not yet known. However, these CM scores led to the 
discovery of a serine that is very specific for the oxaloacetate hydrolase (OAH) sub-family 
[20]. Mutating this serine to alanine, threonine, or proline (the most prevalent residues in 
other sequences in the alignment) did not significantly decrease the activity (kcat), but had 
drastic effects on the affinity of  OAH for its substrate oxaloacetate. This serine was used 
as a marker for family members with OAH activity, distinguishing OAH’s from closely 
related paralogs that cannot convert oxaloacetate [20]. To show that this residue is indeed 
crucial for oxaloacetate recognition rather than for enzyme activity, we mutated this serine 
in the homologues petal death protein. This protein can convert a broad range of substrates 
including oxaloacetate. Indeed, when we mutated this serine we observed a 100 fold decrease 
in affinity for oxaloacetate, while the affinities for other substrates remained virtually 
unaffected [20]. Although OAH is very specific for oxaloacetate, it does have the potential 
to convert 2R,3S-2,3-dimethylmalate (DMM), albeit with poor efficiency. The S157A and 
S157P mutations in OAH actually improved the affinity of OAH for this substrate [20]. 
Recently we have isolated and characterized dimethyl-malate-lyase (DMML). DMML is 
closely related to OAH and has a proline instead of a serine at position 157. Mutating this 
proline to a serine shows the same behaviour with respect to kcat and affinity [21]. 
Hexokinase super-family
The sequences of the hexokinase super-family can be divided in two main groups: The 
hexokinases that can phosphorylate a wide range of hexo-sugars, and glucokinases that specifically 
phosphorylate glucose. The Comulator detected a network of six highly correlated residue 
positions (3DM-numbers 46, 47, 52, 67, 82, and 88) that surround the active site (Fig. 2). 
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In humans/mammals glucokinases are hexokinases that often function in the liver. They are 
highly specific for glucose and work at high glucose concentrations. The ‘other’ hexokinases 
tend to have a broad range of substrates (e.g. alose, mannose, or glucosamine) and are 
observed in a wide variety of cell-types. In contrast to glucokinases, they function well at 
low substrate concentrations.  
The Comulator found a network of highly correlated positions that contact the substrate. 
3DM-supported visual inspection of the 709 hexokinase sequences revealed that these six 
residue positions were conserved among the glucokinases. They were also conserved, but 
different among all ‘other’ hexokinases. The observed correlations almost perfectly separate the 
two main groups in the super-family. The fingerprints for these two groups are 46[A]47[C,G
,N]52[N]67[F]82[G]88[G] for the glucokinases, and  46[S]47[F,Y] 52[K]67[T]82[I]88[N] 
for the hexokinases. This clean separation suggests that these residue positions play a key 
role in determining the substrate specificities. Four of these positions (46, 47, 67, and 88) 
have been subject of a saturation mutagenesis experiment on the glucokinase of E. coli in 
a study by Miller [22]. In vivo selection in a glucokinase-deficient strain was used to find 
allowed substitutions at these positions. We analyzed all sequences in the MSA that have 
at least four of these six fingerprint residues in agreement with the glucokinase consensus 
(A,(CGN),N,F,G,G). Most of these sequences possess consensus residues at all six positions, 
but about ten percent differed at one or two positions. Despite the relatively low percentage 
of mutations, the results are still statistically meaningful because of the massive number 
Figure 2. Tube presentation of a hexo kinase complexed with glucose (PDB accession code: 1BDG). 
Conserved residues (>90%) are shown in yellow and the network of highly correlating residues is shown in purple. 
The numbers assigned to the correlating positions are according to the 3DM numbering scheme.  
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of sequences used in this study. Table 3 lists the residue types that were observed at these 
six fingerprint positions.  The saturation mutagenesis experiments that were performed for 
four of these six residues are shown too.  In 65 of 76 mutants we see that residues that are 
observed in the MSA also are detected in the saturation mutagenesis experiment and vice 
versa; in other words: residues not observed in the MSA were not observed experimentally.
 
Ali Screen Ali Screen Ali Screen Ali Screen Ali Ali
Nr. 46 47 67 88 52 82
A WT WT - - - - - - + +
C - + + + - + - - - -
D - - - + - - - - - -
E - - - - - - - - - -
F - - + + WT WT - - - -
G + + WT WT - - WT WT - WT
H - - + + - - - - - -
I - - + + + + - - - -
K - - - + - + - - + -
L - - + + + + - - - -
M - - + + + + - - - -
N - - + - - + - - WT -
P + + - - + + - - - -
Q - - - - - + - - - -
R - - - + - - - - - -
S + + + + + + - - - -
T - - + + + + - - - -
V - - + + + + - - - -
W - - - - - + - - - -
Y - - - + - - - - - -
Table 3. Residues observed at positions in the MSA that have at least four out of six glucokinase fingerprint 
residues according to the consensus, together with the results of saturation mutagenesis at four of these 
positions22. The residue numbers shown are 3DM-numbers. The corresponding numbers in the E. coli glucokinase 
are 64,65,101,140, 76,134,  respectively. The ‘Ali’ columns show a plus sign if the amino acid type was detected at 
least once in the MSA at that position. Plus signs in the ‘Screen’ columns indicate that the saturation mutagenesis 
experiment showed that this residue type at that position produced viable protein. Minus signs indicate non-
observed residue types. The colours green and red indicate whether CMA and experiment agreed or disagreed, 
respectively. WT indicates that that residue either is the consensus residue at that position, or is observed in the E 
coli wild type sequence. Not counting the WT cases, we observe agreement in 65 out of 76 cases.
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FAD-binding domain of the vanillyl alcohol oxidase super-family
The vanillyl alcohol oxidase (VAO) flavoprotein family (FAD-O in SCOP database) is a 
large group of enzymes that catalyze a wide variety of oxidation-reduction reactions [23,24]. 
Members of this family share a characteristic domain topology, with a conserved N-terminal 
FAD-binding domain and a less well conserved C-terminal cap domain that determines 
the substrate specificity (fig. 3). Most members of the VAO flavoprotein family contain 
a covalently bound FAD cofactor. L-Galactono-1,4-lactone dehydrogenase (GALDH; 
SwissProt ac=Q8GY16) is a VAO-family member that is involved in the vitamin C 
biosynthesis pathway in plants. Structural information is neither available for GALDH nor 
for any close homolog. Consequently little is known about GALDH’s active site or about the 
molecular basis for the non-covalent binding of the FAD cofactor, and a series of mutations 
was therefore made to obtain such information. Position 56 (36 in the 3DM alignment) 
is located in the so-called PP-loop that interacts with the pyrophosphate moiety of the 
FAD molecule [23]. In most family members with a covalently bound FAD, a histidine is 
observed at this position. Replacing the histidine at position 36 in covalent VAO-family 
members yielded either active proteins with non-covalently bound FAD, or inactive 
apo-proteins [25,26].
A 3DM alignment was constructed using 1152 sequences of (putative) VAO-family 
members. 3D protein structures are sparsely spread over this wide enzyme super-family. 
The 3DM alignment of the VAO-flavoprotein super-family comprises only the N-terminal 
FAD-binding domain due to a lack of structural conservation in the C-terminal cap domain. 
Alignment position 36 (a histidine in the VAO members with a covalently bound FAD) 
correlates well with positions 78, 91, and 92. Positions 78, 91 and 92 all are located in 
Figure 3. Crystal structure of 
6-hydroxy-D-nicotine oxidase 
(PDB accession code: 2BVF). The 
FAD-binding domain is in green, 
the cap-domain is in red, the 8a-N1-
histidyl-FAD cofactor is blue, and 
the residues with high CM scores are 
shown as grey ball models.
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the direct vicinity of the pyrophosphate moiety of the isoalloxazine ring of the flavin, with 
residue 78 being at hydrogen bonding distance of the reactive N5 locus (fig. 3).
 
Variant kcat
(s-1)
Km
(mM)
FAD binding
(F-factor)
Wild-typea 134 ± 5 0.17 ± 0.01 ++ (8.0)
L36Ha 32 ± 1 0.12 ± 0.01 ++ (7.9)
A78G 116 ± 5 0.45 ± 0.03 ++ (8.3)
V91G 62 ± 0.27 ± ± (14.1)
L36H/A78G 7.6 ± 0.2 0.15 ± 0.02 ++ (8.2)
L36H/V91G 21 ±  0.15 ± ± (14.6)
A78G/V91G 49 ± 2 0.31 ± 0.06 + (10.5)
L36H/A78G/V91G <0.1 ND -- (ND)
Among the VAO-family members with a covalently bound FAD, a histidine is favoured 
at position 36, and glycines are favoured at positions 78, 91, and 92. MurB reductases, 
which have a non-covalently bound FAD, favour a serine at position 36, and a leucine 
or alanine at position 78 and a methionine at position 91. GALDH contains a leucine 
at position 36 (Leu56), an alanine at position 78 (Ala113), and a valine at position 91 
(Val126). Throughout the super-family, glycine is the preferred residue type at position 
92 both for variants with a His at position 36 and for variants with a Leu at this position. 
Mutations studies were therefore started with the single mutants L36H, A78G, and V91G. 
These are three mutations that move the GALDH sequence in the direction of the consensus 
of family members with a covalently bound FAD. Covalently bound FAD was not observed 
in any of the GALDH variants. 
 Table 4 shows that the three single mutants have similar or worse Km and kcat 
values than the wild-type enzyme. Table 4 also shows that V91G poorly binds FAD. The 
Comulator residue type frequencies (table 5) indicate that all three single mutations led 
to situations with unfavourable amino acid combinations of the residue pairs shown to be 
important by the CMA. 
 With a His at position 36 the most abundant residue at position 78 is a Gly. When 
this Gly is added in the L36H/A78G double mutant, the catalytic rate is not improved, 
but the deteriorating effect on Km of the A78G mutant is compensated (table 4). Note that 
the loss in kcat in the L36H mutant is much stronger in the A78G background than in the 
Table 4. Catalytic and FAD-binding properties of GALDH variants. Values for the wildt-type and 
L36H adapted from Leferink et al. [24].  ND: Not determined.
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single mutant. With a His at position 36 the most abundant residue at position 91 is a 
Gly (table 5). When this Gly is added in the L36H/V91G double mutant, we see a similar 
effect as observed for the L36H/A78G double mutant, an improvement in the Km but a 
loss of kcat. With a Gly at position 91, the most abundant residue at position 78 is a Gly. 
When Gly78 was added in the A78G/V91G double mutant, a variant was obtained with 
catalytic properties comparable to both single mutants, but with much better FAD binding 
properties than V91G (table 4). Introducing a His at position 36 in the L36H/A78G/V91G 
triple mutant resulted in a mutant protein that is expressed as insoluble apo-protein that 
could not be purified in enough quantities to perform biochemical studies.
36 78 91 36/78 36/91 78/91
WT L A V L/A (0.26) L/V (0.09) A/V (0.09)
L36H H A V H/A (0.35) H/V (0.69) A/V (0.09)
A78G L G V L/G (0.17) L/V (0.09) G/V (0.26)
V91G L A G L/A (0.26) L/G (0.0) A/G (0.61)
L36H/A78G H G V H/G (19.9) H/V (0.69) G/V (0.26)
L36H/V91G H A G H/A (0.35) H/G (15.9) A/G (0.61)
A78G/V91G L G G L/G (0.17) L/G (0.0) G/G (15.4)
RmlC-like cupin super-family
The alignment of the cupin super-family is the largest of the four superfamilies studied and 
contains 2097 sequences. The RmlC-like cupin super-family consists of proteins possessing 
a common β-barrel structure also known as a jelly roll fold. Although the proteins in this 
super-family are functionally diverse [27], most are enzymes of which the active site is located 
within the β-barrel. This active site often contains two histidines (3DM-numbers 10 and 31) 
that are conserved in approximately 80% of all sequences (fig. 4: yellow residues). Comulator 
revealed a network of highly correlating positions consisting of the alignment positions with 
3DM-numbers 12, 19, 20, 26, 27,28, and 40 (fig. 4 magenta residues). The highest pair-wise 
CM score was detected for position pair 27 and 28. The alignment positions 26-28 form a 
structurally conserved surface loop in most members of the super-family.
 The 3DM software automatically extracted many hundreds of mutations for the 
cupin super-family from the literature and stored them in the database to allow for rapid 
inspection. Intriguingly, the network of correlated positions has barely been mutated by 
anybody yet. Mutagenesis of position 28 in flavonol synthase from Citrus unshiu (G261A) 
resulted in 95% reduction of enzyme activity. Introduction of a proline at this same position 
28 resulted in a completely inactive enzyme [29]. The residue at position 28 is located far 
away from the active site histidines (fig. 4) but nevertheless has been shown important for 
Table 5. Comulator 
residue type 
frequencies of GALDH 
variants
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activity. Because the residue positions 27 and 28 show the highest CMA value, we decided 
to study this pair of residues experimentally.
 One of the best characterized members of the cupin super-family is the Pyrococcus 
furiosus PGI (PfPGI) [18,28,30]. Several crystal structures of this protein have been 
elucidated [18,28,30,31] and the reaction mechanism has been analyzed by mutagenesis, 
NMR, and EPR studies [30]. PfPGI has a tyrosine at position 28 whereas glycine is the 
most prevalent amino acid at this position in the cupin super-family (42%, see Fig. 5). The 
Y28G mutant (Y133G in PfPGI numbering) results in a 2.6 fold reduction of the activity 
(fig. 6). The most abundant residue at position 27 (that is highly correlated with 28) is 
glycine (present in 26% of all sequences); in PfPGI it is a proline residue. Analysis of the 
Figure 4. Tube representation of the 
3D-structure of PfPGI from P. furiosus 
(PDB accession code: 1X82).  The two 
conserved histidines are shown in yellow and 
the core positions with high CM scores are 
in magenta. The inhibitor 5-phospho-D-
arabinonate represented as balls. 
Figure 5.  Bar graphs representing the amino acid distributions of positions 27 (left) and 28 (right). 
The x-axes lists the 20 different amino acids and the y-axes their percentages in the MSA.
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Comulator heat-map reveals that the combination P27-Y28 occurs rarely (1.1%), whereas 
P27-G28 occurs in 4.4% of all sequences. However, when a glycine is observed at position 
28, an alanine is by far the most prevalent residue at position 27 (23%). The double mutation 
P27A/Y28G not only regained the activity lost by the Y28G mutant, but even became twice 
as active as the wild-type enzyme. Obviously, if we had started with the P27A mutant and 
compensated it with Y28G, we would have obtained the same result (see fig 6).  
 Of the sequences with a glycine at position 28, 18.5% has a glutamate at position 
27 and 18.2% an arginine. Both P27E and P27R can compensate for the loss of activity of 
Y28G regaining near WT activity (fig. 6). 
Conclusions
Most enzyme engineering successes of the past decade have been accomplished via random 
mutagenesis, euphemistically called evolutionary approaches, while rational mutagenesis in 
terms of predicting one mutation at one position to achieve one phenotypic effect have 
lost terrain. The recent explosion in a series of high-throughput technologies, including 
sequencing, is enabling an even larger speed in the technical execution of these evolutionary 
approaches. It has often been observed, and this study adds one more observation, that optimal 
phenotypic effects tend to require a series of mutations to be introduced simultaneously, and 
many evolutionary approaches are optimized to achieve just that goal. Still, parallel random 
mutagenesis is technically limited to a handful of amino acid positions in the protein. 
It is therefore of paramount importance to select the positions well where these random 
mutations are going to be introduced. With CMA we can find groups of residues that are 
involved in the same function. And we have shown that this enables us to find combinations 
of mutations that improve catalysis rate or modify substrate specificity. It seems therefore 
that a major step forward can be made in enzyme engineering if the amino acid positions 
selected for combined randomisation are carefully selected from a CMA screen.
Figure. 6.  Bar graphs representing activity of single 
or double mutants of wild type PfPGI. Numbering 
according to the 3DM numbering. The numbers in 
the  amino acid sequence of  PfPGI are 132 and 133, 
respectively. 
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Our results also show that the combinatorial freedom at the positions detected by the CMA 
is limited so that full randomisation is not needed to harvest the complete combinatorial 
potential. Our mutation studies have shown that the combination of residues that can bring 
the desired phenotypic change in the enzyme often has already been tried in a different 
context, i.e. in another protein, so that the limited number of sequence finger prints obtained 
by CMA will be a good start for limited randomisation. Looking at the ease of today’s gene 
synthesis approaches, we can imagine that this might be a new path towards semi rational 
enzyme engineering.
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Abstract
Genetic disorders are often caused by non-synonymous nucleotide changes in one or more 
genes associated with the disease. Specific amino acid changes, however, can lead to large 
variability of phenotypic expression. For many genetic disorders this results in an increasing 
amount of publications describing phenotype associated mutations in disorder-related 
genes. Keeping up with this stream of publications is essential for molecular diagnostics and 
translational research purposes but often impossible due to time constraints: there are simply 
too many articles to read. To help solve this problem, we have created Mutator an automated 
method to extract mutations from full text articles. Extracted mutations are cross-referenced 
to sequence data and a scoring method is applied to distinguish false-positives. 
 To analyze stored and new mutation data for their (potential) effect we have 
developed Validator, a web-based tool specifically designed for DNA-diagnostics. Fabry 
disease, a monogenetic gene disorder of the GLA gene was used as a test case. A structure-
based sequence alignment of the alpha-amylase super-family was used to validate results. We 
have compared our data with existing Fabry mutation data-sets obtained from the HGMD 
and Swiss-Prot databases. Compared to these data sets Mutator extracted 30% additional 
mutations from the literature. 
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Introduction
Due to the ease of today’s gene sequencing methods, the relation between genes and 
corresponding diseases has been unraveled for several genetic disorders. Moreover, the 
specific sequencing of disease-related genes in patients has enormously increased the 
available mutation data in the literature. For some extensively investigated genes, gene 
specific mutation databases are generated by extraction of mutational information from the 
literature. Examples of such mutation databases are the IARC TP53 Mutation database [1] 
and UMD p53 database  for the tumor repressor gene TP53 [2]. For molecular diagnostics 
and translational research these databases are used as reference to distinguish between 
naturally occurring SNPs and (potentially) pathogenic mutations in patients. Populating 
these databases usually requires manual intervention which makes it difficult to generate and 
maintain mutation databases. Therefore, up to date mutational databases are only available 
for a select number of disease-related genes.
 In 2004, a tool MuteXt [3] was described for the automatic extraction of 
mutational information from literature. This tool was specifically designed for populating 
the nuclear receptor [4] and GPCR [5] Molecular Class-Specific Information Systems with 
mutation data. We have used the MuteXt method as basis for a new tool, Mutator, which 
can automatically extract and store mutational information from the literature for genes that 
are related to a genetic disorder. 
 Mutator was used to create a Fabry mutational database (FMDB). Fabry disease is 
an X-linked inborn error of glycosphingolipid catabolism that results from mutations in the 
alpha-galactosidase A (GLA; MIM# 300644) gene at Xq22.1. Currently two main Fabry 
disease related mutation data-sets exist; the Human Genome Mutation Database (HGMD) 
[6] and a collection of mutations automatically extracted from the UniProt databases [7]. 
The HGMD database is more complete since here mutational information is extracted 
from the literature. However, maintaining this database requires manual intervention. 
Our method extracts mutations from full text publications in a fully automated manner. 
The result shows an almost 100% coverage of mutations listed in the combined Uniprot 
and HGMD databases. Moreover, Mutator extracted from the literature 30% additional 
mutations covering 25% additional amino acid positions.
 Human alpha-galactosidase is a member of the alpha-amylase protein super-family. 
In the past, it was shown that protein super-family derived data contextually stored in a 
Molecular Class-Specific Information System (MCSIS) can be used to describe individual 
functions of residues in proteins [8]. This has led to the development of the 3DM suite, a 
new generation MCSIS builder, that can semi automatically generate protein super-family 
systems specifically designed for mutant prediction purposes [9-12]. A 3DM super-family 
system is a knowledge base that contains and connects many different super-family related 
data types, such as structures, sequences, structure-based multiple sequence alignments, 
protein-ligand interactions, mutational data, correlated mutation analysis results, and 
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residue conservation. Mutator is part of the 3DM suite. The 3DM mutational data that is 
extracted from literature is collected by Mutator. 
 3DM was used to collect alpha-amylase super-family data and to generate the 
structure-based super-family alignment (3D-MSA). Strong correlations were observed 
between the aggregated mutational data and 3D-MSA derived data, which suggested that 
alignment derived data can principally be used to predict the pathogenicity of individual 
mutations in GLA. 
 On these principles Validator, a 3DM web-based graphical user interface, was 
developed for retrieval of literature extracted mutations and for validation of (new) amino 
acid variants (see supplementary figure S1). Validator uses various different information 
types, such as alignment information (e.g. amino acid conservation) and structural 
information (e.g. solvent accessibility, secondary structure information) that are stored in 
the 3DM database for variant validation. The predictability of each information type is pre-
determined by examining how all known Fabry mutations relate to each specific information 
type. Furthermore, Validator generates a structure model for each variant in which bumps 
with neighboring amino acids are highlighted that are the result of the variant. These models 
can be viewed directly from the Validator website or can be downloaded, visualized and 
analyzed in the state of the art protein visualization tool YASARA. The newly developed 
Validator, the FMDB and the 3DM structure-based super-family alignment are freely 
available at http://3DMCSIS.systemsbiology.nl/FMDB/. The source codes of Validator and 
Mutator are currently an integral part of the 3DM commercial software suite. For other 
protein families commercial licenses can be obtained. 
Materials & Methods
3DM Structure-based Super-Family Alignment Generation
The structure-based super-family alignment of the alpha-amylase protein super-family was 
generated as outlined by Folkertsma et. al. [13] and Joosten et. al. [9]. This method was 
automated in the 3DM suite, extensively reviewed by Kuipers et. al. [14] and is only briefly 
described here: All structure files from the SCOP [15] alpha-amylase family were extracted 
from the SCOP database to obtain a list of protein structure files with the alpha-amylase 
fold. The protein sequence of each distinct structure on this list was used as query to BLAST 
[16] against the PDB database [17] with a cut-off e-value of 0.005 to obtain a complete list 
of available structure files. For multi-domain proteins, only the alpha-amylase domain of the 
sequence was used as blast query to prevent inclusion of proteins that only contain a domain 
not related to the alpha-amylase super-family. Identical BLAST search settings were used for 
searches performed against the Swiss-Prot and TrEMBL [18] databases to collect sequences 
for which no structure is available. 3DM was used to generate a structure-based super-family 
alignment from these sequences and structures in three steps:
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1. The structure files were superimposed on the structure of the human GLA (pdb code 1R47 
[19]). From the resulting superpositioning, a structure-based multiple sequence alignment 
was extracted composed of structurally equivalent residues (core). Structural equivalence is 
defined as three or more consecutive residues that have their C-alphas within a 2.5Å sphere 
from the equivalent GLA residues. 
2. The sequences of the resulting core alignment were divided into subgroups so that the 
sequences of each subgroup are no more than 80% identical to the next subgroup. For 
each subgroup a representative template structure is selected based on criteria such as the 
quality of the structure, the number of residues for which 3D coordinates are available in the 
structure, and the number of residues in the core as determined in step 1.
3. An iterative profile based alignment procedure [20] (automated in 3DM) was used to 
separately generate subfamily alignments by aligning each super-family sequence to the most 
similar template structure. These separate subfamily alignments were combined to generate 
the ultimate super-family alignment using the core alignment from step 2 as a guide.
Mutator
An overview of the workflow of Mutator is given in figure 1. To collect a large set of articles 
that potentially contain mutational information on GLA (or proteins homologues to GLA), 
a keyword list was created. This list is used by Mutator to query the PubMed database to 
obtain a list of full text articles. Mutator collects mutations in four steps: 
A) Retrieval of keyword selected (full text) publications; B) screening of the individual (full 
text) publications for mutational data using regular expressions; C) selection of sequences 
Figure 1. Schematic flowchart of 
Mutator program. See supplementary 
workflow S1 for the algorithm of 
Mutator and supplementary figure S2 
for a more detailed flowchart of the 
algorithm. 
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matching the wildtype subject protein sequence: D) overall scoring of combined feature 
of individual (full text) publications. For scoring of the mutations a Sequence Score 
(SQ-score) was used. Mutations extracted from publications that scored above the 
experimentally derived threshold levels were stored in a database. Details of the Mutator 
workflow (fig. 1) are presented in supplementary figure S2 and supplementary workflow S1. 
Mutator was specifically designed to collect mutational information reported in proteins (or 
genes) related to certain diseases in patients. Therefore, in addition to the MuteXt method a 
module was added to Mutator that can detect mutations reported in DNA sequences. 
Validator
Validator is a graphical user interface, specifically designed for DNA-diagnostic purposes. 
It can be used for variant analysis and retrieval of literature derived mutation data for a 
specific sequence of the 3DM database. After providing a mutation to the tool it returns 
the by Mutator extracted associated literature and a structural protein model visualizing the 
mutation including potential bumps with surrounding amino acids (fig. 3 & 6). In addition 
it predicts the likelihood that the mutation is pathogenic based on super-family alignment 
statistics such as (structural) conservation, amino acid distributions per alignment position 
(detailed in the results section). For a given mutation Validator also presents the Grantham 
distance [21], the Blosum62 substitution score [22], the solvent accessibility, and provides 
links to PolyPhen prediction tool [23] and  the SIFT classification [24].
Results & Discussion
Mutator applied to Fabry disease: generation of the FMDB
This work presents a collection of GLA mutations retrieved from literature last accessed 
on 29 April 2009. It should be mentioned that the fully automated nature of Mutator 
enables continuous scanning of the literature and that the dataset presented here will 
soon be outdated. Yip et al. [7] recently described a method to retrieve single amino acid 
polymorphism data from the Swiss-Prot database. Specifically for GLA this dataset contains 
137 mutations that cover 101 residues of the GLA sequence. The human gene mutation 
database (HGMD) contains mutations that are both automatically and manually collected. 
Excluding splice-site mutations, insertions, deletions, stop codons and frame shifts the free 
section of the 2009 version of the HGMD database contains 256 unique point mutations that 
cover 166 residue positions of the GLA sequence. The restricted HGMD contains 301 unique 
GLA point mutations in total. HGMD describes a mutation only once. Mutator, however, 
stores references to all literature available of each specific mutation providing access to disease 
related metadata such as literature sources that contain variant phenotypic expression data in 
different patients. An overview of mutations available in the FMDB, HGMD and UniProt 
is available in supp. table S1.
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Mutator uses a four step procedure to extract mutations from the literature; i) retrieval of 
keyword selected publications ii) screening of the individual publications for mutational data 
using regular expressions iii) evaluation of mutational data with respect to the corresponding 
subject sequence (here GLA) and iv) scoring of combined features above a set threshold. 
Supplementary table S2 shows the keyword list used by Mutator to query the PubMed 
database for Fabry disease related publications. This Fabry list resulted in the retrieval of 
12,847 full text publications. From this set Mutator extracted and stored in the FMDB 
1,781 mutations (371 unique mutations). All articles that Mutator selected for the first 100 
GLA residues were manually examined for the presence of Fabry related mutational data. 
For these first 100 residues, Mutator collected 338 mutations from exactly 100 articles. Of 
these 100 articles, only six could be considered as false positives, since these six described 
mutations not related to Fabry. Three of these six articles described mutations in a human 
protein (human coagulation factor X) that contains a domain which is abbreviated with 
GLA. The other three articles described the human matrix GLA protein. To cope with 
this type of inconsistencies due to ambiguous keywords, extracted mutational data should 
also match the corresponding subject sequence. For example when Mutator extracts the 
mutation G11V from a keyword selected text file, the program verifies that residue number 
11 of the GLA subject protein sequence is indeed a glycine. In theory this step should reduce 
the false positive discovery rate for single extracted mutations to 5%. Besides having the 
right keywords all six articles contain mutational information at positions for which the 
GLA sequence has the same residue type such as the single G11V mutation described for 
the Gla domain of human coagulation factor X [25]. Therefore, an option was added that 
enables the user to provide a black list of keywords. Rerunning Mutator using “matrix gla 
protein”, “human factor” and “coagulation factor” as black list keywords removed these six 
false positive articles from the final set. Excluding splice-site mutations, insertions, deletions, 
stop codons and frame shifts, this set contains 1512 unique mutations and is highly (if not 
exclusively) populated with fabry related mutations. Comparison of this set of mutations 
with mutations stored in the HGMD and Swiss-Prot mutational databases showed that 
Mutator had collected 70 additional unique mutations. Six mutations were missed by 
Mutator because they were published in journals to which no subscription was available. 
This large set of fabry mutations enabled us to find correlations between pathogenicity of 
mutations in GLA and other data types that are stored in a 3DM database. Although here 
we have focused on GLA, it must be noted that the alpha-amylase super-family (see below) 
also includes human alpha-N-acetylgalactosaminidase (alpha-NAGA; alpha galactosidase 
B; MIM# 611458). Substitutions in alpha-NAGA can cause Schindlers disease. Upon 
switching from GLA to alpha-NAGA (Swiss-Prot: P17050) Mutator extracted from the 
literature all alpha-NAGA mutations that are reported in the OMIM database. 
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Alpha-amylase super-family alignment
The GLA gene is a member of the alpha-amylase protein super-family and protein super-
family derived data can be used to describe individual functions of residues in proteins 
[13, 14]. The structures available of the alpha-amylase super-family can be divided into 
41 sequentially distinct groups. The following structure files from the PDB database 
were chosen as representative structures to generate the super-family alignment: 1A47A, 
1AMYA, 1AQHA, 1B2YA, 1BAGA, 1BF2A, 1BLIA, 1BVZA, 1EA9C, 1EH9A, 1G5AA, 
1GCYA, 1GJUA, 1GVIA, 1H3GA, 1HVXA, 1IZJA, 1LWJA, 1M53A, 1M7XA, 1MXGA, 
1QHOA, 1R47B, 1UD2A, 1UOKA, 1W9XA, 1WZAA, 2AAAA, 2BHUA, 2DH3A, 
2E8YA, 2FH8A, 2GUYA, 2VUYA, 2Z1KA, 2ZE0A, 2ZICA, 3BC9A, 3CC1A, 3CZGA, 
and 3DHUA. The resulting super-family alignment contains 4,986 unique sequences and 
217 structurally conserved positions (the core).
 Figure 2 shows that 80% of the reported mutations are at structurally conserved 
positions (core). Two regions outside the core are highly populated with Fabry related 
Figure 2. Number of independently reported Fabry disease related mutations per GLA residue position. 
Independently reported mutations detected at structural conserved positions (core) are in light grey. Structural 
non-conserved positions are in dark grey. More then 40 independently reported mutations were extracted for 
3D-positions 47, 124, and 172 corresponding with R112, N215, and R301, respectively of the GLA amino 
acid sequence. Note that, although only 50% of the GLA residues are core positions, the large majority of the 
mutations (1117 out of a total of 1512) are observed at those positions.
Figure 3. YASARA ball and stick backbone representation of seven superimposed protein structures of 
different sub-families of the alpha-amylase super-family. 3A: In red equivalent helices from the seven proteins. 
This helix is present in almost all super-family members, but could not be included in the core due to variable 
positioning within the crystal structures. 3B: The yellow and red colored residues are part of a structural highly 
conserved loop at 3D positions 47 and 48, respectively. 3D-postion 47 is a highly conserved glycine. 3D-postion 
48 is in GLA a phenylalanine and the most reported mutated residue.
A B
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mutational data. These two regions are a helix in the middle of the GLA sequence and a 
beta-sheet at the C-terminal end of the protein (fig. 2) and contain 77 and 72 mutations, 
respectively. These two regions are present in most alpha-amylase structures. However, due 
to positional variability within the super-family structures the superposing of these regions 
was ambiguous (fig. 3a). These two regions were therefore not included in the core. A more 
straightforward approach to determine structural important positions would be to assign 
structural importance only to residues of secondary structural elements (e.g. helices and 
beta-sheets). The advantage of such a method is that only the structure of the target protein 
(here GLA) is needed. However, it should be noted that, even though the core mostly consists 
of secondary structural elements, using only secondary structural elements as a delimiter is 
no solution. For instance, the residue position with the highest number of extracted Fabry 
related mutations (3D-number 47; fig 2) is not part of any secondary structural element, 
but is positioned in a structural highly-conserved loop (fig. 3b) located at the outside of 
the protein. Additionally, alignment position 48 which is also part of this loop is a highly 
conserved glycine residue, which demonstrates that important residues are not exclusively 
located in secondary structural elements. If both core and secondary structural elements 
are considered to be structural important positions, 84% of all Fabry related mutations are 
linked to this group. This result suggests that it is 5 times more likely that a random mutation 
will result in manifestation of Fabry disease  if this mutation involves a structural important 
position. The Validator tool (see below) therefore defines both core and secondary structural 
elements as structural important positions.
Figure 4. Correlation between the relative amino acid conservation (x-axis) and frequency of reported Fabry 
related mutations (y-axis). The x-axis represents the percentage of sequences that contains the mutated residue. 
The y-axis represents the percentage of the total number of fabry related mutation collected by Mutator. This 
plot shows that Fabry disease is most often the result of a mutation in GLA that resulted in a residue that is not 
commonly observed at the corresponding alignment position. Obviously there is a clear relation between the 
frequency of reported Fabry related mutations and the occurrence of amino acids at alignment positions.
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Mutation analysis  
1 Fabry disease-causing mutations and amino acid occurrences.
Super-family alignments can be considered as inventories of nature’s successful mutagenesis 
experiments conducted during millions of years of evolution. In theory, the spectrum of 
residues present at a specific alignment position could be considered as allowed substitutions. 
Statistical analysis of super-family alignments can therefore potentially be used to predict 
the pathogenicity of specific mutations. This idea was tested using the set of Fabry related 
mutations collected in the FMDB. Figure 4 shows the relationship between the relative 
occurrence of amino acids at core positions and reported corresponding GLA mutations. 
For example, only 4% of the 1,117 reported GLA mutations in the core are mutations to 
an amino acid residue that is present at the corresponding alignment position in more than 
26% of the aligned alpha-amylase sequences. Conversely, only 17% of mutations reported 
in structural conserved residues are mutated into an amino acid present at the corresponding 
alignment position in more than 7% of the aligned alpha-amylase sequences. Thus, the 
introduction of a new residue type that is infrequently observed in the complete alignment of 
the super-family at the particular alignment position has a high probability to be pathogenic 
implicating that this correlation can in principle be used to predict the pathogenicity of an 
unclassified variant (UV) in GLA. For example, if a particular UV is a mutation to an amino 
acid that is present in more than 25% of the alpha-amylase sequences at the corresponding 
alignment position, then the analysis suggest a small probability for pathogenicity for this 
particular UV. On the other hand, when the particular UV is present in less than 5% of the 
alpha-amylase sequences at the corresponding alignment position, then the analysis suggests 
a high probability for pathogenicity for the particular UV. 
 This correlation is not valid for non-core positions. For these positions only the 
amino acid occurrences of the 77 sequentially related sequences of the of GLA subfamily 
can be used. However, even within this small set, mutations at highly conserved positions 
are more likely to be pathogenic (see examples below). 
2 Fabry disease-causing mutations and solvent accessibility
Solvent accessibility is the degree to which a residue in a structure is solvent exposed 
(e.g. more at the surface of the structure). Using a limited dataset of 278 missense mutations 
Garman [26] has shown that there is a strong correlation between solvent accessibility 
of residues and observed Fabry disease-causing mutations. The substantially increased 
mutational data collected in this study and the availability of the structural alignment makes 
it possible to study the predictability of solvent accessibility both at structurally conserved 
and non-conserved positions (Fig 5). Two correlations are plotted: 1) The correlation 
between Fabry disease-causing mutations at structurally conserved core positions and 
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their solvent accessibility and 2) correlation between Fabry disease-causing mutations at 
structurally non-conserved positions and their solvent accessibility. The plot clearly shows 
that this strong correlation exists specifically, almost exclusively, for core positions. This 
surprising observation is very important because it suggests that solvent accessibility should 
be used as indicator for pathogenicity only at core positions.
3 Structural analysis of a specific amino acid change.  
Validator performs a conformational analysis based on an estimation of the steric hindrance 
between the mutated residue and neighbouring residues in the 3D-structure. For that it 
generates an in silico model of the protein highlighting the substituted position including its 
van der Waals surface.
 These types of analysis are done by Validator for each mutation uploaded to the 
FMDB website. The outcomes of other in DNA diagnostics commonly used classifiers 
(e.g. Grantham scores, BLOSUM62 scores) are also reported. Furthermore, amino acid 
specific information is provided, such as domain interface residue, active site residue and 
substrate contact information. Combining these predictions can lead to a better prediction.
Figure 5. The correlation between Fabry disease-causing mutations at structurally conserved and 
non-conserved core positions and their solvent accessibility. X-axis: Percentage of accessible side chain surface 
area for each residue in the human GLA protein. Y-axis: Percentage of the total set of Fabry disease-causing 
mutations. Two plots are drawn. 1) The correlation between Fabry disease-causing mutations at structurally 
conserved core positions and their solvent accessibility (light grey line) and 2) correlation between Fabry disease-
causing mutations at structurally non-conserved positions and their solvent accessibility (dark grey line). The 
vertical black line indicates that only 7% of the 1,117 Fabry mutations located in the core are at positions of which 
the solvent accessibility > 33%. In contrast, almost half (44%) of the Fabry mutations located outside the core are 
at positions of which the residue has a solvent accessibility of > 33%.
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For example, Fabry disease associated publications often report for 3D core position 76 
(Ala143 in the GLA primary sequence) p.A143P. This mutation predisposes to a classical 
phenotype in males [27]. A statistical analysis of the complete super-family alignment 
indicates that at this position proline is the most abundant amino acid residue being present 
in 43% of the alpha-amylase sequences. The relative high solvent accessibility of Ala143 in 
GLA also suggests a low probability for pathogenicity at this site. Despite the above, the in 
silico model structure however, clearly indicates that specifically in GLA a proline at this 
position clashes with the neighboring aspartic acid with 3D-number 32 (Asp93 in GLA) 
(Fig. 6). Therefore, it is more likely that the p.A143P substitution is not allowed in the 
GLA protein and therefore can be considered as probably pathogenic. In contrast, Validator 
suggests that p.A143T would structurally be less damaging and has been reported to lead 
to a much milder variant of Fabry disease [27]. In this case the statistical analysis of the 
structural super-family alignment suggests pathogenicity since a threonine is seldom present 
(0.8%) in other alpha-amylase protein super-family members. The fact that p.A143T would 
structurally be less damaging fits well with a milder phenotype. 
4. Performance of Validator tool on classical Fabry mutations.
To test the performance of Validator predictions, mutations known to result in the classical 
form of Fabry were selected being mutations, p.M42V, p.H46Y, p.D92Y, p.R112C, 
p.C142R, p.W226R, p.N320Y at core positions and p.P40S p.R100T at non-core positions. 
In addition the special case p.D313Y is discussed.
 For p.H46Y, Validator predicts a high probability for pathogenicity. In the super-
family alignment the occurrence of Y is only 4.1% and Figure 5 shows that more than 
75% of the recorded Fabry mutations are the result of such a substitution. Also the solvent 
accessibility is 1.5% indicating that the H46 is buried inside the protein. Furthermore, 
the in silico model suggests that p.H46Y causes bumps with surrounding amino acids. 
Since histidine residues are hydrophilic, a buried histidine almost always has an important 
function. Although currently no weight is given to the various indicators for this buried 
histidine solvent accessibility is probably the most important indicator.
Figure 6. YASARA ball and stick 
backbone visualization of mutation 
p.A143P in GLA. The alanine to 
proline substitution at 3D-position 
76 is depicted in red and surrounded 
by its Van der Waals surface. Clearly 
steric hindrance is observed with the 
side-chain of aspartate 93.
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Arguments listed above for p.H46Y are also true for p.D92Y. The fact that both position 
H46 and  D92 are reported in more than 10 independent Fabry disease associated 
publications reporting substitutions to a number of different amino acids clearly match 
Validator predictions.
 R112 is an almost completely buried hydrophilic residue. Almost all other sequences 
of the super-family have hydrophobic residues at this position instead. This indicates that 
R112 has an important function which is specific for GLA, which suggests that p.R112C 
will most probably be pathogenic. Furthermore, a cysteine is not a common residue at 
position 112 (0.1%) and the high number of publications (81) that report this position in 
relation to Fabry’s disease again indicate a very high probability for pathogenicity. 
 The Validator tool indicates that C142 forms a cysteine bridge. The p.C142R 
mutation therefore disrupts the formation of this cysteine bridge. This type of information 
will overrule all others, since disrupting a cysteine bridge will most probably always be 
pathogenic independent of solvent accessibility, amino acid occurrences or other factors. 
Finally, almost all information that the Validator tool returns for mutations p.W226R 
and p.N320Y indicate a very high probability for pathogenicity again supported by a high 
number of publication reporting mutations to various amino acid types. 
 Mutations p.P40S and p.R100T are not included in the core, so only the 77 
sequences of the GLA sub-family alignment can be used for statistics. In the sub-family both 
P40 and R100 are 100% conserved which suggests a high probability for pathogenicity for 
both. 
 The only mutation that is predicted not to be pathogenic is p.M42V. Even after 
meticulous manual inspection of the protein model of p.M42V, no reasonable explanation 
can be given for the pathogenicity of this mutation. The only indication that this is a true 
pathogenic mutation is the high number of literature references that report mutations to 
different amino acids at this position.
 In the literature mutation p.D313Y is ambiguously linked with Fabry disease and 
the prediction from the 3DM data is contradicting. Although tyrosine is not a common 
residue at this position (suggesting a high chance for pathogenicity) solvent accessibility 
indicates that the residue is located on the outside of the protein and introducing a tyrosine 
residue does not cause any bumps with surrounding amino acids (suggesting low probability 
for pathogenicity). The p.D313Y mutation has been tested for activity in vitro. Transient 
expression of the p.D313Y construct in COS-7 cells resulted in an active enzyme with >67% 
of the expressed wild type activity [28]. Mutator extracted 17 different publications from 
the literature all describing the single p.D313Y mutation but remarkably so far no other 
substitutions have been detected. Could this then be a naturally occurring variant? There 
are 46 other residues in the GLA protein sequence for which more than 10 independent 
Fabry disease related literature references are available. These are for residues 34, 40, 42, 
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46, 49, 22, 65, 66, 89, 92, 93, 97, 100, 112, 113, 138, 142, 143, 148, 156, 162, 172, 
183, 205, 215, 220, 223, 226, 227, 236, 259, 266, 272, 279, 287, 296, 298, 301, 317, 
320, 328, 342, 356, 357, 358, and 409. In contrast with reports for position D313 for all 
these positions, except for R220, a range of amino acid changes are reported. For R220 
all 21 available independent publications report a stopcodon at position 220 (p.R220X). 
The fact that at these 46 positions different amino acid substitutions have been reported to 
result in Fabry disease significantly increases the chance that mutations at these positions 
are pathogenic. Furthermore, this result also indicates that p.D313Y is probably a naturally 
occurring variant, since it is unlikely that only the introduction of a tyrosine results in 
Fabry disease. The results for the A143T and D313Y mutations fit whit what is clinically 
observed. Authors who report D313Y should comment that it is unlikely (but possible) to 
be pathogenic. 
 In this paper it is shown that a collection of super-family data can be used to predict 
effects of mutations. It must be noted, however, that predicting the pathogenicity of specific 
mutations is still difficult and statistical analysis of large 3DM alignments should only be 
used as guidance. For example, if we take the seven core positions that are conserved in 
more than 95% of the aligned sequences (3d-numbers 39, 73, 100, 102, 123, 145, 146) 
we see that for two of these positions (73, 123) Mutator has not been able to extract from 
the literature any mutations causing Fabry disease. Is this unexpected result caused by a still 
limited set of mutations or do mutations at these positions not lead to Fabry disease? 
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Introduction
The α/β-hydrolase fold enzyme superfamily is one of the largest groups of structurally 
related enzymes [1]. Applications of the members of this versatile enzyme family range 
from the kinetic resolution of precursors of pharmaceutical compounds [2], degradation 
of pollutants[3], and bulk applications such as lipid modification [4] and laundry 
detergents[2a]. The family is characterized by the α/β-hydrolase fold, consisting of a central 
β-sheet surrounded by several a-helices [5] and by a common catalytic triad formed of 
a catalytic nucleophile, a histidine and an acidic residue. The superfamily covers a large 
diversity of catalytic activities like the hydrolysis of carboxylic acid esters, carboxylic 
acid amides, thioesters and epoxides, C-C bond-formation by hydroxynitrile lyases and 
the dehalogenation and haloperoxidation of organic compounds.[6] In addition, many 
α/β-hydrolase fold enzymes show ‘catalytic promiscuity’, e.g. they are able to catalyze more 
than one type of chemical transformation.[7] 
 Protein engineering proved to be an efficient method to tailor α/β-hydrolase fold 
enzymes towards a desired property, for instance with a drastically improved thermostability 
[8] and with completely inverted enantiopreference [9]. Moreover, enzymes with completely 
new catalytic activities have been generated. Impressive examples are the conversion of an 
esterase from Pseudomonas fluorescens into an epoxide hydrolase [10] a perhydrolase [11] 
and of an esterase [12] or a heme-free bromoperoxidase [13] into enzymes with lipase-like 
properties. Lipases can be engineered by implementing major structural modifications such 
as the exchange of secondary structure elements in lid swapping [14] or even major structural 
modifications such as circular permutation [15]. Nevertheless, despite an impressive progress 
over the last years [16], protein design has not been established as a routine procedure so 
far. One of the major bottlenecks lies in the insufficient knowledge about structure-function 
relationships and the unsatisfactory reliability of in silico predictions. For α/β-hydrolase 
fold enzymes, two major strategies have been used to overcome this limitation: Molecular 
modeling of the enzymatic mechanisms [3, 9d] or an analysis of structural relationships 
between different enzymes.[17] The ultimate objective of a computational tool for protein 
engineering applications would be to make reliable predictions on the outcome of amino 
acid exchanges on the properties and performance of a given enzyme.
 Due to the limitations in predictibility, random approaches, often referred to as 
directed evolution [16, 18] are still the method of choice. The major advantage of directed 
evolution compared to all other approaches is its relative independence from information 
input. In principle, the gene encoding the targeted protein is sufficient to perform the 
experiment with a reasonable chance to find improved variants, but only if fast and reliable 
screening or selection systems are available.
 Powered by rapidly increasing availability of information about proteins such as 
structures, sequences and biochemical data, and the ongoing progress in computational 
technologies directed evolution experiments are more and more moving towards 
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combination with rational concepts. The computational part of those experiments is thereby 
often limited to the prediction of amino acid positions that are likely to influence a desired 
enzyme property without suggesting specific amino exchanges. Reetz et al. proposed creating 
the diversity only in those parts of the enzyme that are believed to have an influence on 
the targeted enzyme function [19]. Thus, by subsequently randomizing active site residues 
(CASTing) in the epoxide hydrolase of Aspergillus niger the enantioselectivity of this enzyme 
could be evolved from E = 4.6 to 115 [18d]. This example illustrates that directed evolution 
is not anymore the naïve introduction of mutations followed by screening or selection, but 
has developed to a more focused diversification that concentrates on certain protein regions 
to create superior protein libraries. A recent study on the focused directed evolution of a 
Baeyer-Villiger monooxygenase demonstrated that high quality alignments are of particular 
value for the identification of potential randomization sites, especially in cases where a highly 
dynamic molecular mechanism makes predictions of the result of amino exchanges difficult 
[20].
 Classical molecular modeling of α/β-hydrolase fold enzymes has mainly focused 
on the tetrahedral intermediate, which is assumed to resemble the rate limiting step [21]. 
Recently, other steps than the tetrahedral intermediate came into the focus. For instance, the 
accessibility of the active site to the substrate [10, 22] or water access tunnels [3, 23] can also 
be crucial for the selectivity of an enzyme. Hult and co-workers pointed out the importance 
of entropy in the hydrolysis of chiral alcohols [9d, 24]. Although molecular modeling of 
the catalytic mechanism of hydrolases has led to multiple successful predictions, no general 
applicable method has been developed yet. This can in part be attributed to the limited 
information value of the available structural data. Most crystal structures of α/β-hydrolase 
fold enzymes represent empty enzymes or have an inhibitor in the active site, whereas 
structures with the substrate of interest are the exception. Moreover, catalytic properties, 
such as the enantioselectivity, are often governed by very subtle effects in the catalytic site 
and are difficult to predict. Furthermore, recent studies suggest that an enzyme can undergo 
several sub-states during catalysis, which are difficult to determine by X-ray crystallography 
[25]. Nevertheless, due to ongoing developments in X-ray crystallography and NMR 
spectroscopy it can be expected that the quality of future structural data may increase. In 
addition, progress in the generation of smart tools for computational biochemistry raises 
access to a better understanding of molecular catalysis in enzymes [26]. 
 A stringent classification of the α/β-hydrolase fold super-family according to 
function, amino acid sequence and three-dimensional structure would provide the basis for 
a deeper analysis of structure-function relationships and would facilitate the identification of 
target amino acids for directed evolution. However, the classification of the vast and growing 
amount of sequential and structural data on α/β-hydrolase fold enzymes has been hampered 
by the high degree of diversity within the superfamily. Analog functional properties of its 
members do often not correlate with similarity of the three-dimensional structure or the 
amino acid sequence. For instance, lipases share common features such as activity towards 
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long-chain fatty acids and interfacial activation but are enzymes with a high structural and 
sequential diversity [17a]. Arpigny and Jaeger [17a] proposed a classification of bacterial 
lipases into eight classes based on their amino acid sequences and functional properties. 
Several databases for specific groups of α/β-hydrolase fold enzymes such as carboxylesterases 
[27-29], lipases [30], and epoxide hydrolases [31] have been established and reveal structural 
consensus motifs, which resulted in valuable insights into structure-function relationships. 
Fischer and Pleiss [30] suggested that most lipases and esterases can be classified according to 
the composition of their oxyanion hole into GX- and GGG(A)X-hydrolases. Interestingly, 
functional properties such as the activity of esterases toward tertiary alcohols could be later 
derived from this classification [17b]. In contrast to the diversity found in lipases, hydroxy 
nitrile lyases, epoxide hydrolases and haloalkane dehalogenases have a very high structural 
similarity to GX-carboxyl ester hydrolases. Nevertheless, the transformation of an esterase to 
an epoxide hydrolase by means of directed evolution proved to be very difficult and was only 
achieved by the generation of a chimeric hybrid enzyme [10]. These examples underline the 
challenges for a proper classification of the α/β-hydrolase fold enzyme super family. 
 The α/β-Hydrolase Fold Enzyme Family 3DM Database (ABHDB) is a high 
quality structure based multiple sequence alignment that is based on almost all available 
α/β-hydrolase fold enzymes and is composed of separate subfamily sequence alignments 
of subfamilies where a structure is available [32]. 3DM is a tool that can automatically 
generate super-family databases and has been applied to different protein superfamilies 
such as receptors, antibodies, and several enzyme protein families. These databases are 
used in the early stages of drug design [32, 33] for validation of undetermined variants in 
DNA diagnostics [34], and as guidance in enzyme engineering projects targeting different 
enzyme features. For instance, 3DM enabled prediction of mutations that changed enzyme 
specificity of an oxaloacetate hydrolase (OAH) [37], and it was used to selectively remove 
OAH activity from the petal death protein [35]. 3DM was also applied for the suggestion of 
specific mutations that increase enzyme activity of phosphoglucose isomerase [36] and the 
oxidation rate of a FAD-binding oxidase [37]. The automated structure of 3DM allows for 
easy updating of the database. This is vital in order to keep pace with the fast growing amount 
of data. 3DM tools, such as Comulator[36],  Mutator [34], a sophisticated filter management 
system and a systematic numbering scheme facilitate the analysis of correlations between 
amino acids and the fast tracking of literature on mutagenesis data of specific positions in an 
α/β-hydrolase fold enzyme. 
Figure 1 (page 179). Conserved regions in different groups of the 3DM-based α/β-hydrolase fold enzyme 
database. The colouring of the phylogenetic tree corresponds to the colours of the schematic representations of 
the α/β-hydrolase folds of the different families. Parts shown in grey are variable regions of the example protein, 
the coloured parts represent the conserved core region of the corresponding family. The following proteins were 
used as representative examples: 1VA4: Pseudomonas fluorescens aryl esterase (PFEI); 1QE3: Bacillus subtilis 
p-nitrobenzyl esterase (pNBE); 1JJI: Archaegobus fulgidus carboxylesterase (AFEST); 5YAS: Hevea brasiliensis 
hydroxynitrile lyase (HB-HNL); 1CPY: Saccharomyces cerevisiae carboxypeptidase Y (CPD-Y).
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Thus, ABHDB provides protein engineers with a practical tool for the identification of 
target amino acid residues in members of the α/β-hydrolase fold enzyme superfamily and 
allows a facilitated analysis of the results. This article intends to provide an overview on the 
scope of the α/β-hydrolase fold enzyme superfamily and the corresponding 3DM database 
and gives some recent examples for its application in protein engineering.
Aligning the haystack: Generation of a database containing most 
enzymes of the superfamily
The standard 3DM method with default settings [32] was used to generate the α/β-hydrolase 
fold enzyme superfamily database (http://fungen.wur.nl/ABHDB). However, due to the size 
and complexity of this super-family, 3DM needed adjustments and several extensions were 
generated. The first step in the generation of a 3DM database is the collection of sequences 
and structures. 3DM collected 668 pdb structure files which contain 1,172 separate chains 
that have the characteristic α/β-hydrolase fold. In the second step these 1,172 chains were 
superimposed and a common core of structural conserved positions was determined. The 
second step is the determination of the structurally conserved core of the superfamily. Using 
default cut-off values, 3DM detected a common core of 88 structurally conserved residue 
positions. In 92 of the 1,172 available structures, 3DM was not able to automatically 
detect the required number of core residues (default 3DM cut-off: >90%). These structures 
were excluded from the initial set. The third step is the determination of representative 
structures that will be the basis for the generation of distinct subfamilies. Normally this 
step is performed manually, but the size of this family requested for automation. A script 
was developed that chooses the representative structures automatically. To find these, 3DM 
uses the structural core alignment to generate a phylogenetic tree (figure 1) thereby forming 
groups of the sequences. Each group contains sequences that are at least 80% identical at 
the core positions. To perform this step 3DM uses the Levenstein algorithm [38]. After 
grouping all sequences, the best representative was chosen using the following criteria: (1) 
The number of core residues that could be detected by 3DM for a specific sequence (each 
sequence can maximally miss eight residues, since the cut-off for inclusion is 90% of all 
core residues). Obviously, sequences for which the core was completely detected are the best 
candidates to serve as sub-family templates; (2) The number of sequentially missing core 
residues: sequences for which 3DM could not detect the core for two or more neighboring 
residues are not taken as template; (3) The reason for missing core residues: sometimes pdb 
files have gaps in the structures because these parts of the structure could not be solved 
by X-ray analysis. In these cases 3DM excludes the files from the list of possible template 
structures. If a structure has a single gap in a core and the corresponding sequence of the 
structure contains exactly one residue at this gap position (only outside the cut-off of 2.5 
Å), 3DM will simply add this residue to the core. 3DM will then select the structure for 
which this residue has the smallest error with respect to phy-psi angles. (4) The quality of 
the structure: If criteria (1) to (3) do not lead to one template candidate for a subfamily, 
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3DM chooses the best candidate using structure quality (e.g the resolution or RSMD 
[root-mean-square deviation] value) as delimiters. This procedure resulted in a core alignment 
that contains 99 distinct subfamily templates. In the fifth step of the database generation, 
superfamily sequences for which no structure is available, are collected by BLAST [39] 
searches using the template sequences as queries. To cope with the size of this superfamily 
an automated iterative BLASTing method was designed that was used to iteratively blast 
the sequences of these 99 templates against the Swiss-Prot and TrEMBL databases (cut-off 
E-value 1e-5) resulting in a set of 14,998 sequences. In the last step, 3DM aligns all resulting 
superfamily sequences to all templates using a four-step iterative profile based alignment 
procedure [40]. It then generates separate subfamilies by assigning each sequence to the 
nearest template using the similarities that were generated during the alignment procedure. 
Due to the size of the α/β-hydrolase fold enzyme superfamily iteratively aligning all 14,998 
sequences to all 99 template structures would require too much CPU time and would result 
in large amounts of useless alignment data. Therefore, a new 3DM extension was developed 
that uses the BLAST results to preselect sequences that are related to starting template 
sequences. Manual inspection showed that BLAST cut-offs of 1e-90, 1e-70, 1e-30, and 1e-5 
result in sets of sequences that can reliably be aligned in the four consecutive steps of the 
3DM alignment procedure. This procedure led to the generation of 99 separate subfamily 
alignments. These separate subfamily alignments were combined using the core alignment 
of step (3) as guidance, which resulted in a superfamily alignment that contains a total of 
12,431 sequences.
Structure of the α/β-hydrolase fold superfamily database
A consequence of the high diversity is that only 88 amino acids are sufficiently conserved 
throughout the superfamily I to form a consensus core. For most applications it would 
not be necessary to include all available structures into an alignment. The most related 
might be sufficient and even allow a more detailed analysis. Therefore, five subsets (II-VI) 
of evolutionary more closely related members were generated (figure 1, table 1). Since these 
members share a higher similarity, the consensus folds of these subsets contain a high number 
of structurally conserved residues. The phylogenetic analysis shows that these five subsets 
cover most of the superfamily structures. The attempt to generate a lipase-specific subset 
failed due to the high structural diversity of these enzymes. Figure 1 gives an overview of the 
numbers of subfamilies, consensus fold residues and details about the catalytic triad. 3DM 
designs a general numbering scheme (3D-numbers) for structural equivalent positions. This 
numbering scheme is applied to all data, such as sequences, structures, mutational data, 
co-evolution data, conservation data, amino acid contact data, etc. The systematic numbering 
connects all the different data types to each other which in turn enables detection of hidden 
correlations between different data types. Conserved residues are given with the Roman 
numeral of the family and the Arabic number of the residue in the consensus fold, e.g. I_1 
stands for the first residue of the superfamily I. The systematic 3DM numbering can be 
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used for all enzymes of the five groups of α/β-hydrolase fold enzymes. Hence, its systematic 
use would greatly facilitate the tracking of mutagenesis data on these enzymes by keyword 
searches in databases.
Group Sub-
families
Seqs. CS.a Var.b Catalytic triadc
Nucleophile Acidic 
residue
His
I Superfamily 99 12,430 88 1,468 32 
87% S
8% D
64 
74% D
19% E
87 
99% H
II GHSXGG 22 2,811 194 694 83 
63% S
35% D
156 
84% D
8% G
179 
99% H
III GESAGA 13 1,350 325 1,243 156 
92% S
6% G
233 
91% E
7% D
273 
97% H
IV GDSAGG 7 1,939 217 405 96 
96% S 
174 
84% D
14% E
204 
86 % H, 
4% E
V GNSMGG 7 344 180 96 67 
96% S
132 
97% D
160 
98% H
VI GESYAG 3 575 324 253 122  
99% S
261 
98% D
310 
98% H
Overview of the α/β-hydrolase fold superfamily 
Family I covers most of the known α/β-hydrolase fold enzymes. The high diversity of these 
enzymes limits the size of the conserved section to 88 amino acids. The highest degree of 
conservation is mostly found in defined secondary structures in the inner core of the enzyme, 
mainly in the central β-sheet. The peripheral regions, and, interestingly, the substrate binding 
sites are much less conserved. The consensus section includes β-strands 1-7 of the central 
β-sheet and α-helices C and E (Figure 1) of the α/β-hydrolase fold proposed by Ollis et al. 
in 1992 [1].
	 β-strand 5 and α-helix C, the so-called catalytic elbow [1], the residues of the 
catalytic triad with the acidic residue I_64 and the catalytic nucleophile I_32 are part of 
the consensus section. The highly conserved catalytic histidine I_87 is present in a loop 
of four amino acids (I_84-88). The residues of the GXSXG consensus motif are highly 
conserved throughout the whole superfamily: Gly I_30 94%, Ser I_32 63%, Gly I_34 
Table 1. Structure of ABHDB. a) Core size. The consensus core contains the structurally most conserved amino 
acids of a group of enzyme structures; b) Variability. Number of mutations within the conserved amino acids; c) 
The residues according to the 3DM numbering are given in bold numbers; % of the amino acid in the active site.
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70%. Residues at positions X were assumed to be variable. For true lipases, a more specified 
consensus pattern [LIV]-X-[LIVFY]-[LIVMST]-G-[HYWV]-S-X-G-[GSTAC] (PROSITE 
pattern PS00120: LIPASE_SER) could be assigned. It should be kept in mind however, 
that the term true lipase refers to a class of functional similar enzymes that have very diverse 
structures. An analysis using 3DM shows that the variable residues X are indeed highly 
conserved in the individual enzyme families of the superfamily (Figure 1), which allows 
a division of the α/β-hydrolase fold enzyme superfamily according to the composition 
of the catalytic elbow into five families: II. GHSXGG, III. GESAGA, IV. GDSAGG, V. 
GNSMGG and VI. GESYAG (Table 2). These findings clearly suggest that these positions 
are involved in determining the specificity of the different hydrolases.
Group GXSXG-lipase consensus motif
G Xa Sb X G G
I Superfamily 30
94% G
31
25%H 
16%E 
12%D
32
87% S
8% D
33
93%G
34
70% G
II GHSXGG 81
83% G
82
54% H
83
63% S 
35% D
84
>90% M or 
hydrophobic residue
85
97% G
86
66% G
22% A
III GESAGA 154
99% G
155
64% E
156 
92% S
6% G
157c
90% A
158
100% G
159
46% A
40% G
IV GDSAGG 94
100% G
95
66% D 
10% E
96
96% S
97c
81% A
98
100% G
99
80% G
20% A
V GNSMGG 65
94% G
66
64% N
22% H
67
96% S
68
>90% M or 
hydrophobic residuec
69
97% G
70
98% G
VI GESYAG 120
95% G
121
90% D
7% E
122 
99% S
123
96% Y
124
77% A
16% G
125
99% G
 
Table 2. The GXSXG-lipase pattern is highly conserved in the individual enzyme families. a) assumed to 
be variable in lipases; b) catalytic nucleophile; c) involved in the stabilization of the oxyanion in the catalytic 
mechanism; The residues according to the 3DM numbering are given in bold numbers.% of the amino acid in 
the active site. sidues according to the 3DM numbering are given in bold numbers; % of the amino acid in the 
active site.
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The composition of the oxyanion hole differs between the enzyme families. It is consequently 
not part of the 88 amino acid core. In many cases it is preceded by the conserved histidine 
I_16. In the oxyanion hole, the consensus motifs II. HGX, III./IV. HGGG(A)X, V. HSG 
and VI. NGGP can be found (table 3). The structure of the oxyanion hole has been associated 
with the rare ability of some esterases and lipases to convert tertiary alcohols [17b], which 
has facilitated the isolation of highly enantioselective enzymes for the synthesis of these 
difficult substrates [41]. The knowledge about conserved structure-function relationships 
can thus be used to guide the search or novel enzymes. 
GHSXGG: Epoxide hydrolases, dehalogenases, perhydrolases and 
GX-esterases
Family II contains 2,811 members of highly diverse functionalities including epoxide hydro-
lases, haloalkane dehalogenases, haloacid dehalogenases, haloperoxidases and GX-esterases. 
The 194 amino acids of the conserved core include the main α/β-hydrolase fold except the 
αD-helix of the main domain and three out of four helices that form the double V-shaped 
cap domain.
  As expected, either a serine or an aspartate is situated on the nucleophile position 
II-83 since the serine reflects esterases and haloperoxidases while the aspartate could be 
found mainly in haloalkane dehalogenases, haloacid dehalogenases and epoxide hydrolases 
(table 2). The catalytic nucleophile is most often flanked with a GHNu–XG-motif. Nu– rep-
resents the nucleophile and in most cases X stands for methionine (25%) or a hydrophobic 
residue. The oxyanion hole of class II enzymes is composed of an HGX-motif. Thereby the 
nature of X is relatively diverse, but most often a voluminous residue such as Phe (31%) or 
Trp (20%) is present at this position.
 Despite the high similarity between the esterases, epoxide hydrolases and 
dehalogenases, conserved key residues determining the chemoselectivity of the enzymes were 
found: C-terminal to the oxyanion hole (pos. II_26) Pro or Gly are highly accumulated 
in the alignment. Interestingly, this proline correlates to almost 100% with aspartate as 
catalytic nucleophile while the position is less conserved when the nucleophile is a serine. It 
can be assumed that this proline has a high importance for specificity of epoxide hydrolases 
and dehalogenases. Furthermore, there is a high correlation between the catalytic aspartate 
and the position II_84. A conserved tryptophane in this position next to the catalytic 
nucleophile is known to be important for the stabilization of the halide in haloalkane 
dehalogenases. A similar observation could be made for epoxide hydrolases: Amino acids on 
position II_128 are predominantly tyrosines if the nucleophile is an aspartate and thus are 
believed to represent the residue involved in the protonation of the epoxide.
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Group H/N G G G(A)/P F/W/Y/L
I Superfamily 16  
65% Hc
13% Y
n.i.a n.i.a n.i.a n.i.a
II GHSXGG 23
94%H
24
95% G
25
31% F
20% W
- 25
31% F
20% T
III GESAGA 81
56% H
30% Y
8% F
82
95% G
83
98% G
84
64% G
21% A
10% S
85
64% F
18% Y
12% L
3% W
IV GDSAGG 31
98% H
32
97% G
33
97% G
34
82% G
10% A
4% S
3% C
35
55% F
23% W
14% Y
V GNSMGG 7
98% H
8
94% G
4.4% T 
(HNLs)b
9
41% S
27% G
13% A
10
71% G
19% C
VI GESYAG 32 65%N 33 99% G 34 99% G 35 97% P 36 96%G
GESAGA-family: Acetylcholine esterases, liver esterases, fungal lipases 
and related enzymes
The 1,350 members of this enzyme family are mostly lipases and esterases from gram 
positive bacteria, fungi and animals, such as acetylcholine esterase or esterases from pig 
liver, from Bacillus subtilis and Candida rugosa lipase. The large consensus core of 325 amino 
acids spans the greatest part of the central β-sheet, the surrounding α-helices, two α-helices 
of the cap region, the catalytic triad and the GGG(A)X motif within the oxyanion hole 
(figure 1) [30]. The core is longer than that of the closely related family IV and contains two 
additional strands at the C-terminus. The active site of family III is rather exposed to the 
solvent. The catalytic elbow bears a highly conserved GESAGA motif (table 2). Family III is 
the only one where the acidic residue of the catalytic triad is glutamate instead of aspartate. 
The C-terminal neighbor of the catalytic III_156 serine is mostly alanine III_157. This 
residue is often involved together with residues from the GGG(A)X-motif in the formation 
of the oxyanion hole [30]. The N-terminal neighbor of the catalytic nucleophile is a highly 
Table 3. The composition of the oxyanion hole in different enzyme families. a) n.i.: not included in the 
consensus fold; b) hydroxynitrile lyases have a highly conserved threonine in this position; c) the residues 
according to the 3DM numbering are given in bold numbers. % of the amino acid in the active site.
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conserved (65%) glutamate III_155. This residue has been discussed in the context of the 
ability of the promiscuitiv activity of some esterases of family III towards carboxylic acid 
amides [42] and forms a highly conserved triangle of 5-7 Å with the catalytic glutamate 
III_233 and the acidic residue III_276 (63% E, 34% D). Interestingly, the three charged 
residues are positioned in proximity of the catalytic machinery. They are connected by 
hydrogen bridges via water molecules. The high degree of conservation of this structural 
motif suggests an important function in catalysis. 
GDSAGG: Hormone-sensitive lipase-like
The 1,950 sequences of IV include animal lipases such as the hormone-sensitive lipase, 
enzymes from bacteria and from archea and a high number of enzymes from the metagenome. 
Several proteins without enzymatic activity such as a putative gibberellin receptor GID1L1 
from Arabidopsis thaliana [43] are also included. Interestingly, group IV contains several 
thermophilic esterases.
 The central β-sheet with the surrounding α-helices is represented in the consensus 
fold of 217 amino acids. Family IV shares with family III the GGG(A)X-motif in the 
oxyanion hole (figure 1). Several structural features distinguish both enzyme families: The 
acidic residue IV_174 of the catalytic triad of family IV is mostly aspartate, not glutamate as 
in III. Also the N-terminal neighbor of the catalytic serine is an aspartate, and the Glu-Glu-
Glu triangle of family III has no equivalent in IV. Interestingly, the N-terminus of family 
IV is part of the cap-region and shields the active site (figure 1).
GNSMGG: Hydroxynitrile lyases and related enzymes
Enzymes present in this family are mainly hydroxynitrile lyases (HNLs), esterases (salicylic 
acid-binding proteins) and C-C bond hydrolases, while the first two are plant enzymes; 
the latter are from bacterial sources. The catalytic triad is highly conserved in this family V 
(Table 1). The HNLs use two additional amino acids Thr V_8 and Lys V_161 for catalysis, 
which are conserved among only the HNL subfamily, Thr V_8 (100%) and Lys V_161 
(92%). Their consensus is, however, low in the GNXMG-family (only 4.4% and 3.5% 
respectively), which clearly differentiates the diverse function of HNLs in the family. Five 
of seven subfamilies of the GNSMGG-family are C-C bond hydrolases, belonging to the 
group of hydrolases of meta-fission products (MFP) also referred to as meta-cleavage product 
hydrolases. These enzymes share the ability to hydrolyse products of the degradation of 
aromatic compounds such as catechols [6,44].  Interestingly, most of the sequences of MFP 
hydrolases appear in family V and II, which is also demonstrated in figure 1. The catalytic 
motif GXSXG, in C-C bond hydrolases is GNSM(F)GG where the methionine stabilizes 
the oxyanion substrate in the catalytic site. Interestingly, the motif in the esterase- (II) and 
HNL- (IV) subfamilies is GHSLGG and GESCG(A)G, respectively, which proves that 
a difference in structure/sequence relates to the function of the enzyme. Another highly 
conserved motif V_7-10 (Table 2) important for catalysis despite of the dissimilar functions 
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of the family is observed throughout the family. It constitutes (a) a part of the oxyanion 
hole in case of SABP2 esterase (main chain of Ala, V_9) and in case of C-C bond hydrolysis 
reaction catalyzed by BphD [45], (b) a main catalytic residue for HNL activity, V_8 (Thr) 
which stabilizes the hydroxy group of cyanohydrins by H-bonding. Like the role of the 
catalytic motif in other enzymes, Glu V_66 and Cys V_68, the adjacent residues of catalytic 
nucleophile Ser V_67 are important for HNL activity as their replacement with A drastically 
reduced the HNL activity mainly in Hevea brasiliensis HNL [46]. The cap domain of HNLs 
consists of three α-helices and two β-sheets. Like most other α/β-hydrolase fold enzymes the 
cap domain of HNLs lies in-between the nucleophile Ser and the acid Asp, but the β-sheets 
are not common in the superfamily.
GESYAG: Carboxypeptidases and related enzymes
Family VI contains carboxypeptidases and a high number of uncharacterized proteins, mainly 
from yeast, but also from animals and plants. Family III with 325 amino acids and VI with 
324 are by far the largest ones of the α/β-hydrolase fold enzyme superfamily. The consensus 
core with nine α-helices and 12 β-strands is well conserved. The carboxypeptidases have an 
insertion of two conserved β-strands between α-helix A and β-strand 4. Interestingly, the 
connections of the conserved C-terminal α-helices and 12 β-strands differ from all other 
enzyme families. Family VI shows some similarity to families III and IV. In the oxyanion 
hole a conserved GGP-motif with some similarity to the GGG(A)X-motif can be found. The 
different structure of the C-terminus of family VI distinguishes it from the other families 
within the α/β-hydrolase fold superfamily.
Enzymes not covered by the classification
Several sequences and structures could not be classified into any of the homogenous enzyme 
families II-VI. A prominent member of these enzymes is lipase A from Candida antarctica 
[47]. This lipase is distinguished by several unique catalytic properties such as the ability 
to convert tertiary alcohols and a preference towards the trans-isomers of unsaturated fatty 
acids [48]. Its recently resolved structure cannot be grouped into the GX- or the GGG(A)
X-classes [47]. This presumably also holds true for related lipases from Ustilago maydis [49] 
and Kurtzmanomyces sp. I-11 [50]. Several other bacterial and fungal lipases differ to a high 
degree from the other known α/β-hydrolase fold enzymes and cannot yet be classified by the 
structural alignment using 3DM.
ABHDB as a tool for protein engineering
The classification of esterases and lipases according to the composition of their oxyanion hole 
distinguishes enzymes bearing one glycine (GX) followed by a voluminous amino acid (X) 
from enzymes bearing three glycines or two glycines followed by an alanine (GGG(A)X, table 
2) [30]. These enzymes can be found in families III and IV of the ABHDB. The consensus 
pattern has been related to the activity of α/β-hydrolase fold enzymes towards tertiary 
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alcohols [17b]. Recently, it was found that esterase EstA from Paenibacillus barcinonensis has 
a very low activity towards tertiary alcohols. It belongs to class III and has a serine III_84 
in the third position of the consensus motif. Serine in this position has an abundance of 
only 10% according to 3DM. A back mutation to the highly conserved glycine yielded an 
enzyme variant with strongly increased activity towards tertiary alcohols [51]. Furthermore, 
the position III_82 had been shown previously to be a determinant of the enantioselectivity 
as a sixfold increased enantioselectivity was observed when the mutation Gly III_82 to Ala 
was introduced into esterase BS2 from B. subtilis [41a]. Interestingly, the analog mutant 
III_82A of EstA also had a strongly increased enantioselectivity in the kinetic resolution of 
tertiary alcohols. This example underlines the value of homology-based analyses of structure-
function relationships for the engineering of catalytic properties of enzymes.
 The vast protein data set that is ordered and stored by 3DM is of high value for 
the guidance of directed evolution experiments. Due to the procedure of 3DM to create 
structure-based multiple sequence alignments, all amino acids in a given sequence within 
the 3DM core can be assumed to be on the same structural position in every enzyme that 
is included in the alignment. Thus, the program allows the determination of the amino 
acid distributions at these positions. Those distributions can be effectively used to generate 
‘smart’ mutant libraries for a saturation mutagenesis. We have already successfully applied 
this approach to improve the enantioselectivity of an esterase from Pseudomonas fluorescens 
by variation of four residues in the acyl-binding pocket [52], resulting in the identification 
of variants with substantially increased enantioselectivity [53] within a set of only 500 
variants screened. This success was attributed to the high quality of the libraries designed 
using ABHDB analysis reducing the theoretical screening effort from 3 million [54] to just 
10,000 clones to cover 95% of all possible combinations. In a similar approach three surface 
residues of the same enzyme were targeted to increase the thermostability (unpublished). 
Outlook
The vast amount of sequential and structural data on α/β-hydrolase fold enzymes is difficult 
to assess by standard bioinformatic methods and databases. To our knowledge, ABHDB is 
the first structural alignment of all known enzymes of this superfamily, which is a key feature 
distinguishing it from sequence-based approaches [27-30]. It represents a very helpful tool 
for the analysis of structure-function relationships and the mechanistic determinants of 
substrate specificity, even if not all known sequences could be incorporated. Despite the 
diverse nature of α/β-hydrolase fold enzymes it is striking that the central core of the fold 
and the catalytic triad is well-conserved throughout the 12,431 sequences of the database. 
The residues contributing to the stabilization of the oxyanion, however, differ considerably, 
but are itself highly conserved in different subgroups. They can be related to the functionality 
of the enzyme, making them useful fingerprint motifs for the classification and discovery of 
novel biocatalysts.
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Literature search in organic chemistry is considerably easier than in protein engineering. It 
is very easy to confirm the state of the art on a given organic compound. A simple search 
for structure, sum formula or systematic name in databases like CrossFire Beilstein gives 
comprehensive information on synthesis, structural data and applications. This is vital to 
confirm the novelty of results. In contrast, there is no such a tool for mutagenesis and the 
scientist has to rely on his or her literature knowledge. Also a systematic nomenclature of 
amino acid residues in consensus scaffolds is missing. Besides qualitative designations such 
as ‘catalytic nucleophile’ or ‘histidine of the catalytic triad’ keyword searches in databases 
will not reveal specific amino acid exchanges in analog positions of different enzymes. This 
may lead to cases were a given amino acid exchange in an enzyme scaffold may have been 
investigated independently in different laboratories several times. The scientists would 
perhaps not be aware of each other’s work due to the use of different key words or because 
the exchange was performed in analogue enzymes such as, for instance, a GX-esterase and 
a haloalkane dehalogenase. Herein we present with the 3DM numbering a systematic 
nomenclature for the five enzyme groups of the α/β-hydrolase fold enzymes. Usage of this 
system may facilitate the future tracking of mutations in these enzymes. In addition, the tool 
mutator of ABHDB connects amino acids of α/β-hydrolase fold enzymes to literature data 
on their mutagenesis. Despite the limitations – only conserved amino acids are analyzed and 
the search is confined to scientific publications but not patents – this tool would offer the 
technology for the future systematic assessment of mutagenesis. Such a tool would enable 
access to all mutagenesis done to a certain position in a scaffold. It might attain a similar 
significance as Scifinder and Pubmed [55] already have in the every-day life of scientists in 
life sciences and biotechnology.
 Directed evolution has been described as finding the needle in the haystack. We 
believe that the ABHDB contributes considerably to ordering the vast and complex data 
of the α/β-hydrolase fold enzyme superfamily. This is particularly important in view of 
the future incorporation of vast numbers of sequences and structures from genomic and 
metagenomic sources that can be expected from the recent progress in sequencing techniques. 
The possibility of an automatic update perhaps is not the last useful tool of 3DM, as it allows 
keeping pace with the progress. ABHDB can be used together with molecular modelling 
and other computational tools to guide rational protein design. A particular interesting 
application of ABHDB is the generation of smart libraries of small size for directed evolution 
experiments – the haystack can easily be aligned before the needle gets explored.
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Abstract
Sucrose phosphorylase is a promising biocatalyst for the glycosylation of a wide variety 
of acceptor molecules, but its low thermostability is a serious drawback for industrial 
applications. In this work, the stability of the enzyme from Bifidobacterium adolescentis 
has been significantly improved by a combination of smart and rational mutagenesis. The 
former consists of substituting the most flexible residues with amino acids that occur more 
frequently at the corresponding positions in related sequences, while the latter is based on a 
careful inspection of the enzyme’s crystal structure to promote electrostatic interactions. In 
that way, a variant enzyme could be created that contains 6 mutations and whose half-life 
at the industrially relevant temperature of 60 °C has more than doubled compared to the 
wild-type enzyme. An increased stability in the presence of organic co-solvents could also be 
observed, although these effects were most noticeable at low temperatures. 
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Introduction
Sucrose phosphorylase (SP) catalyzes the reversible phosphorolysis of sucrose into 
α-D-glucose-1-phosphate and fructose. Although it is formally classified as a glycosyl 
transferase (EC 2.4.1.7), the enzyme belongs to glycoside hydrolase family 13 and follows 
the typical double displacement mechanism of retaining glycosidases [1]. Thanks to its 
broad acceptor specificity, SP can be employed for the transfer of glucose to a wide variety 
of carbohydrates as well as non-carbohydrate molecules [2]. For example, an exceptionally 
efficient process for the regioselective glucosylation of glycerol has recently been developed 
[3]. The product is a moisturizing agent for cosmetics and is commercially available under 
the tradename Glycoin.
 For industrial application, carbohydrate conversions are preferably performed 
at 60 °C or higher, mainly to avoid microbial contamination [4]. Unfortunately, SP 
has so far been identified only in a relatively small number of micro-organisms, none of 
which are thermophilic [2]. The low thermostability of available SP enzymes thus forms 
a serious limitation for their commercial exploitation. We have recently shown that the 
thermostability of the SP from Bifidobacterium adolescentis can be dramatically improved by 
immobilization, either by covalent coupling to a Sepabeads enzyme carrier or in the form 
of a cross-linked enzyme aggregate [5,6]. Although immobilization is often employed in 
industrial processes to enable recovery of enzymes, the procedure can be time-consuming 
and expensive, especially when carriers are involved. The creation of stable enzyme variants 
thus still is an attractive alternative. Furthermore, the resulting proteins could serve as robust 
templates for the engineering of the specificity of SP, as stable enzymes have been shown to 
be more tolerant towards the introduction of amino acid substitutions [7,8]. 
 The thermostability of a protein can be increased by either random or site-specific 
mutagenesis [9]. The SP from Streptococcus mutans, for example, has been stabilized by the 
introduction of 8 random mutations, identified through error-prone PCR [10]. However, 
the resulting enzyme variant retains only 60% of its activity after 20 minutes incubation 
at 60 °C, which is not enough for industrial applications. The crystal structure of the SP 
from B. adolescentis has been determined [11] and can be used to select specific sites for 
mutagenesis in this particular enzyme. Although no general rules for the rational engineering 
of thermostability have yet been formulated, some trends have emerged [12]. These include 
introducing Pro residues [13], removing Gly, Asn and Gln residues [14], extending the 
electrostatic interactions at the protein surface [15], and stabilizing the dipole moment of 
α-helices [16].
 Semi-rational approaches to the engineering of thermostability have also been 
developed. For example, in the so-called B-Factor Iterative Test (B-FIT) positions that 
display the highest flexibility (highest B-factor) in an enzyme’s crystal structure are submitted 
to site-saturation mutagenesis [17]. The best hit obtained at one site is subsequently used 
as a template for randomization at another site and the process is repeated iteratively until 
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the desired improvement is achieved. In this way, the T50 of the lipase from Bacillus subtilis 
could be increased from 48 °C to 93 °C by the substitution of only 7 amino acid residues 
[17]. To reduce the size of the libraries and thus the screening effort, an extension of the 
B-FIT procedure has recently been proposed, in which the randomization at each site is 
limited to amino acids that are frequently present in an alignment of related sequences [18]. 
These residues are assumed to be more favorable for the enzyme’s stability and/or activity, as 
they have been propagated through natural selection. This ‘smart library’ approach has been 
successfully applied to the engineering of the esterase from Pseudomonas fluorescens, in which 
the number of colonies that needed to be screened could be reduced with a factor 300 [18].
 Limiting the number of variants is especially convenient for SP, because the 
thermostability of this enzyme depends strongly on the protein concentration [6]. The 
high-throughput screening of mutant libraries is, therefore, not an attractive option, 
as this would be complicated by the detection of false positives whose thermostability 
is overestimated due to their low concentration. Indeed, variant enzymes are frequently 
expressed at a lower level than the wild-type enzyme, even when just a single amino acid 
has been mutated [19]. This problem can be circumvented by creating a small number 
of site-directed variants that can be processed manually to eliminate the effect of protein 
concentration. In that respect, the proposed strategy somewhat resembles the consensus 
approach [20], although more than one amino acid can still be introduced at any given 
position. 
 Here, we present the engineering of the SP from B. adolescentis by a combination of 
smart and purely rational mutagenesis for increased thermostability. In addition, the solvent 
stability of the enzyme variants has also been determined, as this feature is often correlated 
with thermal stability [21,22]. From a practical perspective, the addition of organic 
co-solvents to the reaction mixture should enable the use of hydrophobic molecules as 
acceptors in the glycosylation reaction catalyzed by SP.
Materials and Methods
Design and analysis of mutations
The B-factors of all the amino acids in the crystal structure of the SP from B. adolescentis 
were extracted from PDB-file 1r7a [11] with the computer program B-FITTER (Reetz et 
al., 2006). The effect of introduced mutations was simulated by generating a homology 
model of each variant with the program YASARA [23], using AMBER03 as force field for 
energy minimizations [24].
Site-directed mutagenesis
The gene coding for the SP from B. adolescentis was cloned into the constitutive expression 
vector pCXP14h as described previously [25]. Site-directed mutations were then introduced 
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with a two-step PCR protocol, using the mutagenic primers listed in the supplementary 
data (Table S1). PCR cycling conditions were as follows: 95 °C (3 min); 30 cycles of 95 
°C (1 min), 55 °C (1 min) and 65 °C (9 min). Each reaction contained 75 ng of plasmid 
DNA, 2.5 U PfuUltra DNA polymerase (Stratagene), 10x PfuUltra HF AD buffer, 0.2 mM 
of dNTP mix (Westburg) and 0.4 µM of mutagenic primer (Sigma) in a total volume of 
25 µl. After the reaction, template DNA was digested with 10 U of DpnI (New England 
Biolabs) at 37 °C for 6 h. The PCR mixture was transformed into electrocompetent E. coli 
BL21(DE3) cells (Novagen) and the transformation mixture was plated on LB medium 
supplemented with ampicillin. The presence of mutations was confirmed by sequencing 
(LGC Genomics) of plasmids isolated with a Miniprep Spin kit (Qiagen). 
Enzyme production and purification
All enzymes were produced in 1l shake flasks containing 200 mL LB medium supplemented 
with 0.1 g/l ampicillin. Cultures were grown at 37 °C and 200 rpm for 8 hours, after 
which the cells were harvested by centrifugation (6,000 rcf, 4 °C, 20 min). The obtained 
pellets were frozen at -20 °C until further use. The recombinant enzyme was extracted 
by suspending the pellet in lysis solution (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, 1 mg/ml lysozyme and 0.1 mM PMSF, pH 8) at 4 °C for 30 min, followed by 
sonication for 2 x 2 min (Branson 250 Sonifier, level 3, 50 % duty cycle). Cell debris was 
removed by centrifugation (18,000 rcf, 4 °C, 30 min). The His6-tagged protein was purified 
by Ni-NTA chromatography as described by the supplier (Qiagen), after which the buffer 
was exchanged to 100 mM phosphate pH 7 in a Centricon YM-30 (Millipore). Protein 
concentrations were measured according to the Lowry method [26] using BSA as standard. 
Activity assays
The phosphorolysis of sucrose was measured continuously with an enzymatic assay, in 
which the production of α-D-glucose-1-phosphate is coupled to the reduction of NAD+ 
in the presence of phosphoglucomutase (PGM) and glucose-6-phosphate dehydrogenase 
(G6P-DH) [27,28]. The assay solution consisted of 2 mM EDTA, 10 mM MgSO4, 2 mM 
β-NAD, 10 µM glucose-1,6-diphosphate, 1.2 U PGM, 1.2 U G6P-DH and 100 mM 
sucrose in 100 mM phosphate buffer at pH 7 and 37 °C. The absorbance was measured at 
340 nm in a microplate reader 680XR (Bio-Rad). One unit (U) of SP activity corresponds to 
the release of 1 µmole product per minute under these conditions. All assays were performed 
in triplicate and had a CV of less than 10 %. The kinetic parameters were determined at pH 
7 and 60 °C by measuring the initial rate of fructose release with the BCA assay [6], and 
were calculated by non-linear regression of the Michaelis-Menten curve with the program 
SigmaPlot.
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Stability assays
The thermostability of the variants containing a single mutation was evaluated by incubating 
eppendorfs containing 100 µl of purified enzyme (diluted to 8.5 µg/ml in 100 mM 
phosphate buffer pH 7) for 24 hours in a water bath at 60 °C. Their residual activity was 
then measured and compared to the activity of the untreated enzymes. Subsequently, the 
beneficial mutations were combined and the resulting enzyme variants examined in more 
detail. Their half-life at 60 °C was determined by sampling at regular intervals until the 
residual activity had dropped to 50 %. The corresponding t50-values were calculated from a 
first-order fit of the stability curves. In addition, the thermodynamic stability of the variants 
was determined by incubating PCR tubes containing 100 µl of purified enzyme (diluted 
to 5 µg/ml in 100 mM phosphate buffer pH 7) for one hour in a Gradient Thermocycler 
(Biometra) at 58-70 °C. Their residual activity was then measured and compared to the 
activity of the untreated enzymes. The T50-values were calculated by fitting of the linear part 
of the stability curves.
 The solvent stability of the enzymes was determined by measuring their activity in 
0-55 % (v/v) dimethylsulfoxide (DMSO). Enzyme reactions were performed at 37, 60 and 
65 °C in eppendorfs containing 200 µl of purified enzyme (diluted to 0.5 µg/ml in 150 mM 
phosphate buffer pH 7) and 400 µl of a water/DMSO mixture containing 75 mM sucrose. 
The SP activity was determined with the BCA assay and the C50-values were calculated by 
fitting of the linear part of the stability curves. 
 The difference in residual activity between the wild-type enzyme and the final 
variant at the t50, T50 and C50 values were shown to be significant by means of an unpaired, 
two-sided t-test (p < 0.01).
Results and Discussion
Increasing the thermostability by ‘smart’ mutations
The residues with the highest flexibility in the SP from B. adolescentis have been identified 
based on their B-factor in the enzyme’s crystal structure [11]. Since SP forms a homodimer, 
the average B-factor of both chains was used as parameter to select the target residues 
(Supplementary data, Table S2). Although some variation in B-factors could be observed 
between the monomers, the top 6 positions consistently ranked among the most flexible 
residues. Interestingly, the bias towards arginine and lysine residues reported in previous 
studies [18,29] was hardly observed in our case, and a cluster of three aspartate residues at 
positions 445-447 was found to be the most flexible region. This cluster is located in a loop 
segment of the C-terminal domain, far away from both the active site and dimer interface.
 The top 10 positions were then examined in the 3DM-database [30], which contains 
a structure-based alignment of all sequences (~ 5,092) in glycosidase family 13, also known as 
the α-amylase family. Only 2 of the target positions turned out to be structurally conserved 
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and thus to be represented in the alignment, i.e. D445 and D446. At those 2 positions, 
the amino acid distribution was determined within the group of SP enzymes (subfamily 
GH13_18), which comprises 149 sequences with an identity of at least 30 % [31]. At the 
former position, Pro (22.8 %) occurs more frequently than Asp (20.8 %), while both Gly 
(23.5 %) and Thr (17.4 %) are more abundant than Asp (16.8 %) at the latter. Pro also 
occurs at the latter position (4.7 %) and has been included in our library because this amino 
acid is known to be important for protein stability. Combinations of all the corresponding 
substitutions were introduced in the SP from B. adolescentis by site-directed mutagenesis 
(Table 1). The resulting enzyme variants were purified by His-tag chromatography and 
diluted to the same protein concentration to determine their thermostability. 
Enzyme Mutations Specific Activity Residual Activity Thermostability
(U/mg)a (%)b (%)c
wild-type - 213.0 ± 1.9 30.0 ± 1.7 100
Variant A D445P 204.3 ± 2.1 31.5 ± 1.2 105
Variant B D446G 214.9 ± 3.6 29.4 ± 1.6 98
Variant C D446T 174.0 ± 4.5 29.1 ± 1.1 97
Variant D D446P 218.4 ± 1.4 30.0 ± 1.2 100
Variant E D445P/D446G 202.8 ± 1.9 41.1 ± 2.0 137
Variant F D445P/D446T 197.1 ± 4.6 41.7 ± 1.8 139
Variant G D445P/D446P 202.5 ± 2.7 30.0 ± 1.7 100
Variant H L306H 215.6 ± 3.1 30.3 ± 1.4 101
Variant I Q331E 208.7 ± 4.6 42.9 ± 2.5 143
Variant J N414D 198.6 ± 2.8 15.3 ± 1.5 51
Variant K A498H 188.6 ± 5.2 26.7 ± 1.3 89
Variant L Q460E/E485H 192.7 ± 3.4 42.3 ± 1.9 141
Variant M N325D/V473H 189.2 ± 2.2 24.3 ± 1.3 81
Variant N R393N 207.8 ± 2.7 40.8 ± 2.1 136
Two SP variants showed a significantly increased activity after one day incubation at 60 
°C. Indeed, the substitution of the DD-motif with either PT or PG resulted in a relative 
thermostability of 137 % and 139 %, respectively, compared to the wild-type enzyme 
(Table 1). A proline at position 445 thus seems to be crucial for thermostability, at least in 
combination with a threonine or glycine at position 446. In accordance with its lower amino 
acid occurrence, a proline at position 446 does not have a significant effect on stability. In 
Table 1: Thermostability of the variants create by (semi-)rational design. a) At pH 7 and 37°C. b) After 24h 
incubation at 60°C. c) Relative to the wild-type.
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fact, the stabilized variants contain the most frequent residues at both positions, exactly as 
would be predicted by the consensus concept [20]. None of the individual substitutions are 
able to increase the stability of SP when the neighbouring residue is not mutated, which 
points towards a synergistic effect between positions 445 and 446. 
Increasing the thermostability by rational design
In parallel with the ‘smart’ mutagenesis, additional targets for mutagenesis have been selected 
on a purely rational basis. To that end, the enzyme’s crystal structure has been carefully 
inspected for amino acid substitutions that could extend the network of electrostatic 
interactions on its surface (variants H-M, Table 1). In addition, one mutation (variant N) 
has been included that could possibly increase the interaction between the enzyme’s subunits. 
The corresponding variants were then created by site-directed mutagenesis, purified by 
His-tag chromatography and diluted to the same protein concentration to determine their 
thermostability.
  Three out of the seven variants showed a significantly increased residual activity 
after one day incubation at 60 °C (Table 1). Two of these were designed to introduce 
additional salt bridges, i.e. Q331E and Q460E/E485H. The substitution of Q331 by a 
glutamate was envisaged to promote an interaction with 
H323, which indeed seems very plausible based on the 
modelled structure of the resulting enzyme variant (Figure 
1A). In contrast, variant L was constructed to influence 
more than one interaction. Residue Q460 is located close 
to R455, with which a negatively charged residue should 
be able to interact more favourably (Figure 1B). However, 
the glutamate at position 485 could then perhaps cause 
electrostatic repulsion of E460 as well as of D490. It has, 
therefore, been substituted by a histidine to create a network 
of ion pairs. Finally, variant N was created to promote the 
interaction between the enzyme’s subunits. Indeed, residue 
R393 is located at the enzyme’s dimer interface and was 
believed to induce electrostatic repulsion by interacting 
with the same residue from the other monomer (Figure 1C). 
Replacing it with an asparagine seems to have alleviated this 
problem.
 
Figure 1. The rational mutations that increase the stability of SP. (A) 
variant I, (B) variant L, and (C) variant N. The mutations (in yellow) 
have been simulated in a homology model, which was superposed on the 
wild-type structure (in grey).
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In contrast, the other four variants created by rational design did not display an increased 
thermostability (Table 1). These negative results are difficult to interpret, although some 
suggestions can be formulated based on an investigation of the variants’ structural models 
(supplementary data, Figure S1). In variant H, for example, the substitution of L306 by 
a histidine was expected to introduce a salt bridge with D303. The latter might, however, 
already be involved in a hydrogen bond with S305 and thus not carry the required charge. 
In turn, the asparagine at position 414 might be crucial for the stability of SP because of 
its interaction with a backbone carbonyl group. This could explain why its substitution by 
Asp lowers the stability of variant J, although a salt bridge with R417 should have been 
created. Finally, the histidine residue introduced at position 498 and 473 of variant K and 
M, respectively, does not seem to adopt the required orientation to form a salt bridge with 
the neighbouring carboxylic group (D495 and D325, respectively).  
Enzyme t 50 (h)
a T50 (°C)
b C50 (%)
c KM (mM)
d kcat (s
-1)d
wild-type 24 64 34 6.5 201
variant LNFI 62 67 41 6.7 204
Combining the beneficial mutations
In a next step, the different mutations were combined to examine whether they have an 
additive effect on thermostability. To that end, the half-life (t50) of the combined variants 
was determined at the industrially relevant temperature of 60 °C (Figure 2). A stepwise 
increase in stability could be observed, resulting in a final variant (LNFI) with a half-life 
that has more than doubled compared to the wild-type enzyme (Table 2). Furthermore, it 
was found that the increased stability does not come at the expense of activity, since the kcat 
Figure 2. The kinetic stability of the 
improved SP variants. The enzymes 
were incubated at 60 °C for various 
times, after which their residual activity 
was compared with that of the untreated 
enzymes. All assays were performed in 
triplicate and had a CV of less than 10 
%.
Table 2. Stability and activity of the optimized SP variant. a) At 60°C. b) After 1h incubation. c) Of DMSO 
at 37°C. d) At 60°C and pH 7.
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has remained constant at a value of about 200 s-1 (Table 2). In fact, none of the introduced 
mutations have a dramatic impact on the enzyme’s activity, probably because the selected 
positions are located far away from the active site (Table 1). These results demonstrate the 
practical usefulness of our engineering efforts, which should stimulate the development of 
the various glycosylation reactions catalyzed by SP into commercial processes.
 Further proof of the increased thermostability of the SP variants was obtained by 
determining their T50-value, which is the temperature required to reduce the initial activity 
by 50 % after one hour incubation. This parameter reflects an enzyme’s thermodynamic 
stability, as opposed to the kinetic stability described by its half-life [17]. The introduction 
of each additional mutation increased the T50 with nearly 1 °C (Figure 3), and the variant 
that contains all of the beneficial mutations displayed a T50 that is 3 °C higher than that of 
the wild-type enzyme (Table 2). This feature would probably allow the use of the SP variant 
Figure 3. The thermodynamic 
stability of the improved SP 
variants. The enzymes were 
incubated for one hour at 
various temperatures, after 
which their residual activity 
was compared with that of the 
untreated enzymes. All assays 
were performed in triplicate 
and had a CV of less than 10 
%.
Figure 4. The solvent 
stability of the improved SP 
variants.  Relative activities at 
37 °C were determined in the 
presence of various amounts 
of DMSO as co-solvent. All 
assays were performed in 
triplicate and had a CV of less 
than 10 %.
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at temperatures higher than 60 °C, although that was not the goal of the current research 
project. 
Stability against the presence of organic co-solvents
When SP is to be applied for the glycosylation of hydrophobic molecules, organic co-
solvents will need to be added to the reaction medium to increase the solubility of the 
acceptors. As thermostable enzymes often display a high tolerance towards other denaturing 
factors [21,22], the stability of the variant enzymes against the presence of DMSO as organic 
co-solvent has also been examined. For practical reasons, the tests were first performed at 
37 °C. At that temperature, a significant improvement in solvent stability could be observed 
(Figure 4). Indeed, the C50-value, which is the solvent concentration at which the enzyme 
retains half of its initial activity, has shifted from 34 % for the wild-type enzyme to 41 % 
for variant LNFI (Table 2). 
 Remarkably, an increased SP activity was observed at a DMSO concentration of 
about 20 %, which became even more pronounced in the stabilized variants (Figure 4). The 
assay temperature of 37 °C is, however, far below the optimum of 58 °C for the wild-type 
SP [6]. This could mean that the enzymes are too rigid for optimal functioning, a problem 
that might be compensated for by the addition of a low concentration of solvent. To test 
this hypothesis, the experiments have been repeated at higher temperatures. The ‘bump’ in 
activity was found to slowly disappear in function of temperature, being all but gone at 65 °C 
(Figure 5). Unfortunately, the difference in stability between the variant and wild-type SP is 
no longer apparent in that case, as the C50-value has dropped to about 23 % for all enzymes 
(not shown). The thermodynamic stability of SP can thus be evidenced either by increasing 
the temperature or by the addition of co-solvents, but not by a combination of both.
Figure 5. The influence of 
temperature on the solvent 
stability of variant LNFI. 
The activity of the enzyme 
was determined at various 
temperatures in the presence 
of various amounts of DMSO 
as co-solvent. All assays were 
performed in triplicate and had 
a CV of less than 10 %.
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Conclusions
Sucrose phosphorylase is a promising biocatalyst for the glycosylation of a wide variety 
of acceptor molecules, but its use in industrial processes has been hampered by the low 
thermostability of the available enzymes. We have shown here that the stability of the SP 
from B. adolescentis at the process temperature of 60 °C can be efficiently improved by 
a combination of smart (sequence-based) and rational (structure-based) mutagenesis. In 
total, fourteen enzyme variants have been created, of which five displayed a considerable 
increase in thermostability. As expected, the introduction of consensus residues at the most 
flexible positions (445-446) had a positive effect on stability, although a pairwise mutation 
was required to achieve a synergistic effect. The rational design of thermostable variants, 
in contrast, proved to be a more challenging task, mainly because the interactions of the 
introduced amino acids with their neighbouring residues are difficult to predict. Nevertheless, 
creating additional salt bridges at the protein surface was found to be a successful strategy in 
about half of the cases.
 Combining all of the beneficial mutations in a single sequence generated a 
biocatalyst with a half-life at 60 °C of 62 h, which is more than twice as long as the wild-
type enzyme. Furthermore, the thermodynamic stability of the improved variant was also 
markedly enhanced, as illustrated by an increase in T50 from 64 to 67 °C. The addition 
of low concentrations (~20 %) of organic co-solvent was found to mimic the increased 
temperature optimum of the enzymes, but an improved solvent stability could only be 
observed at low temperatures. Overall, these new properties can be expected to stimulate the 
industrial exploitation of the various glycosylation reactions catalyzed by SP. 
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Background
Detailed knowledge of all aspects of protein structure, function, and dynamics are important 
for many, often commercially interesting, research areas in the life sciences. In protein 
engineering this knowledge is applied in, for example, food and feed optimization [1], 
improvements of laundry detergents [2], and antibody humanization [3]. DNA diagnostics 
projects focus on using mutations in proteins to diagnose patients, and drug design projects 
study the mechanisms of proteins to create new drugs. Traditionally, these projects focused 
on the role of one component in one system eg. the characterization of one protein in one 
organism. In many such projects however, the focus is shifting to a more holistic approach 
by studying many proteins with similar functionality in many systems. Such systems 
biology like projects are however hardly possible without high-quality data sets and the 
proper bioinformatics tools to handle these data sets. With the ongoing advancement of 
high throughput acquisition technologies more and more of these data sets are becoming 
freely available online as producing these sets becomes both cheaper and easier. These data 
sets are produced using different equipment, standards, and methodologies and published 
using different methods and data formats. Obtaining and integrating the data required to 
study complex system in the life-sciences thus remains a challenge. The 3DM platform was 
specifically designed to retrieve and interlink available data sets in various formats for a 
protein superfamily and to make these data sets easily accessible for the user.
Extracting data from literature
One of the main focal points of this thesis is the application of 3DM systems in the fields of 
DNA diagnostics and protein engineering. In these fields a large amount of published data 
is available because no matter how niche the topic may be, chances are that more articles 
have been published about it than can be read in a lifetime. In some fields even the number 
of reviews is too large to keep up with. Additionally, the holistic protein superfamily based 
approach used by 3DM means that data obtained for related proteins are just as valuable 
as data obtained for the protein of interest itself. Lots of articles might therefore contain 
data relevant for a given study. Text mining [6] is the obvious solution to find these relevant 
articles and extract data from them. Many text-mining tools are available for one or more 
parts of the retrieval process. Projects like Open PHACTS [7] aims to use these tools to for 
a specific field automatically extract knowledge from the literature. 
 Extracting knowledge from articles is however still hampered by many challenges. 
The main problem is the widely varying and sometimes obfuscated language used to describe 
concepts and results. For Mutator, the 3DM mutation extraction tool described in chapter 
5, we have therefore initially focused on retrieving only mutations from articles. There are 
two main reasons for selecting mutations as target. Firstly, mutations are often written 
relatively concise. The most common format is <wildtype><position><mutant> eg. A23W. 
Small variations in the way an amino acid is described and whether spaces, dashes, or other 
213
General Discussion
characters are used to separate the amino acids from the position can be relatively easily 
included in the parser. Secondly, mutations specifically described in the text are mentioned 
for a reason and as such are an important source of information that can be directly used for 
various analyses. For example, if a mutation is retrieved from literature that has a detrimental 
effect on the structure or function of a non-human protein the same mutation for the human 
variant can most likely be classified as pathogenic.
 Even such a simple format as a mutation presents various problems when extracting 
data from the literature. Instead of the short form a longer form may be used such as ‘the 
alanine on position 23 was mutated to a cysteine’. Variation in such sentences is much more 
diverse and much harder to capture using bioinformatics tools. Another problem results 
from ambiguous strings such as molecular formula, gene abbreviations, or even bookmarks 
that might match the mutation format. This inability to reliably extract knowledge stored 
in articles means that much data, once published, is essentially lost. Finding all articles 
containing relevant data for a topic is a nontrivial task, retrieving these articles and extracting 
knowledge from them is even harder. Much effort is therefore duplicated and money is 
wasted simply because the article containing data of interest was not found or the specific 
data could not be automatically extracted from it. In the future we however want to expand 
the range of data extracted from articles beyond mutations. Due to the enormous diversity 
in language and writing styles found in articles it is however extremely difficult to extract 
specific data using software tools. There are two possible solutions for this problem. On the 
one hand we can continue to attempt to create more advanced and more robust text-mining 
tools that are capable of retrieving ever more complicated data and knowledge from articles. 
The alternative approach is to change the publication process itself. Guidelines already 
exist for sequences and structures in publications. These data types are required to have 
been deposited in a public database in a specific format before the publication is accepted. 
Articles describing structures or sequences without a PDB identifier or UniProt/GenBank 
accession code will simply be rejected. If similar guidelines are adopted for mutations, an 
extremely valuable data set will become available. Concepts like RDF triplets [8] and nano-
publications [9] are currently popular candidates for an ontology based publication method. 
Eventually, these guidelines will have to be extended to the publication of more complex 
data such as km and kcat values for reactions, protein-protein interactions, etc. Systems like 
3DM offer a glimpse of how much more efficient and productive the life sciences could 
become when data is generated, stored, and published using rigid standards. Future systems 
biology tools will benefit enormously from these structured knowledge bases, as much more 
data will be directly available instead of hidden away in articles.
Synthesis of Biochemicals
One of the main branches of protein engineering is the production of chemicals through 
the modification of existing enzymes. This is especially interesting for end products that are 
difficult, expensive or environment unfriendly to produce using non-biological processes.
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The result of billions of years of evolution is a large number of proteins with a wide diversity 
in function. The ideal enzyme to produce a given chemical in an industrial setting is however 
seldom found. Even if such an enzyme is available other factors might prevent successful 
commercial application such as slow reaction speed, low affinity for the substrate, or host 
requirements unsuitable for large scale application. 3DM systems focus on the study of 
a super-family containing many related proteins with similar functionalities. Super-
family data can be used by 3DM to quickly pinpoint functionally important amino acid 
positions for properties of interest. 3DM systems are therefore currently most productively 
used in protein engineering studies to improve the industrial usability of proteins. It is 
rewarding from a scientific point of view that 3DM systems have been shown to be capable 
of predicting amino acids positions that when mutated increase activity (chapter 3, [11]), 
tune substrate specificity (chapter 3, [12]), increase thermostability (chapter 7), and change 
enantio specificity (chapter 8, [13]). 
DNA Diagnostics
In DNA diagnostics one tries to find the causal link between gene(s) and disorder. For 
monogenetic disorders this relationship can relatively easily be established using, for 
example, genome wide association studies. In a sense, the chance that a given mutation is 
causal for a genetic disorder is proportional to the product of three terms: the role of the 
residue in the protein, the role of the protein in the affected pathway, and the role of the 
pathway in the genetic disorder. In this thesis the focus has been mainly on the functional 
role of the amino acid position for the structure and for the function of the protein, and to 
a smaller extent on the role of the protein in its pathway. A non-synonymous ‘mutation’ in 
a disorder related gene is however not sufficient evidence to diagnose a patient for having 
the disorder. Differences between a sequenced gene from a patient and the ‘reference’ gene 
might simply be due to natural variation rather than a pathogenic mutation. Additionally, 
the phenotypes of many diseases overlap making it difficult to sort the ‘pathogenic’ from the 
‘benign’ mutations. In chapters 4 and 6 for monogenetic disorders different methods are 
shown to distinguish natural variants from pathogenic mutations using the available data. 
 Many diseases however, are not directly related to a single gene but result from 
interactions between numerous proteins and metabolites in a complex system that operates 
on the same task or are part of the same pathway [14]. For polygenetic disorders, therefore, 
a systems biology approach is important to understand the biology of all aspects of the 
system, rather than the effects of mutations in the individual proteins. A full systems biology 
approach to study polygenetic diseases is not yet possible with current 3DM technology but 
combining 3DM systems for interacting proteins obviously would be the next logical step. A 
start to a more holistic approach has already been made. 3DM for example now can visualize 
data on external contacts such as protein-DNA or protein-ion contacts (chapter 2.3.11). 
In addition to these contacts, analysis of a mutation using HOPE (chapter 4) can detect 
whether a mutation might affect the regulatory domains of a protein. These heuristics are the 
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starting point for a systems biology approach to study polygenetic diseases on a higher level. 
Given enough time, we hope to be able to support such studies with 3DM like systems.
Drug Design
The third main field of interest for 3DM like systems is drug design. Drug design combines 
everything known about molecules to study and improve drugs but the process still relies 
very much on trial and error [4]. Several 3DM systems were made in collaboration with 
a pharmaceutical company (Organon now MSD) to study protein families of interest to 
pharma such as the Nuclear Receptor family. Unfortunately, research in pharma is seldom 
published, nevertheless the automatic data collection and integration in 3DM systems were 
able to significantly reduce the time required for certain projects [15].
Correlated Mutation Analyses
Generally literature provides only little information for a specific residue. In such cases one 
can check if any facts from literature are known about ‘correlating’ residues. Correlated 
residue positions co-evolve during evolution, that is when they mutate, they mutate together. 
In such cases one can assume that the residues are functionally linked and knowledge 
about the one residue can normally be directly transferred to the other residue. Trivially, if 
mutation of an arginine in a salt bridge causes a certain phenotypic effect, then the same 
effect will be expected on mutations of its partner. This is one of the reasons why Comulator 
(chapter 5) was developed. Examples of the usage of the Comulator tool are shown in 
chapters 3, 5, 7 and 8 where we show, for example, the use of correlated mutation analyses 
to improve substrate specificity and/or enzyme activity. 
Outlook
One of the major tasks in the near future is to overcome some of the most important 
limitations we run into in both DNA diagnostics and protein engineering: the study of 
protein complexes. While working on the determination of the mode of interaction of Class 
B GPCRs with their endogenous ligands Florence Horn [16] showed the importance of 
synchronizing two MCSIS systems. The goal is thus to create 3DM systems for the individual 
parts of a pathway or protein factory, and organize the data in these 3DM systems so flexibly 
that we can interlink these systems and thereby facilitate studies such as the Class B GPCR 
ligand study. A chain of 3DM systems for proteins that are part of a pathway for example, 
might be used to determine if consecutively functioning enzymes need to physically interact 
or that each enzyme can just take the product of the previous step as its substrate. Inter-
protein correlated mutation analyses could for example be used to highlight binding or 
protein interaction sites. In DNA diagnostics, such systems might be used for the study 
of polygenetic diseases to link multi-factorial causes to certain phenotypes. Eventually, we 
might even provide powerful inference engines for systems biology.
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 3DM was designed and built on the experiences gathered over many years in 
developing and using various MCSIS systems. Several publications have shown successful 
applications of 3DM systems in various enzyme engineering and DNA diagnostics projects. 
It is hoped that in the future 3DM systems can be used to easily and automatically extract, 
store and combine data and knowledge for complex pathways. With such powerful systems 
ever more complicated research projects can be facilitated.
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Summary
As the active component of many biological systems, proteins are of great interest to life 
scientists. Proteins are used in a large number of different applications such as the production 
of precursors and compounds, for bioremediation, as drug targets, to diagnose patients 
suffering from genetic disorders, etc. Many research  projects have therefore focussed on 
the characterization  of proteins and on improving the understanding of the functional and 
mechanistic properties of proteins. Studies have examined folding mechanisms, reaction 
mechanisms, stability under stress, effects of mutations, etc. All these research projects have 
resulted in an enormous amount of available data in lots of different formats that are difficult 
to retrieve, combine, and use efficiently.
 The main topic of this thesis is the 3DM platform that was developed to generate 
Molecular Class Specific Information Systems (3DM systems) for protein superfamilies. 
These superfamily systems can be used to collect and interlink heterogeneous data sets based 
on structure based multiple sequence alignments. 3DM systems can be used to integrate 
protein, structure, mutation, reaction, conservation, correlation, contact, and many other 
types of data. Data is visualized using websites, directly in protein structures using YASARA, 
and in literature using Utopia Documents. 3DM systems contain a number of modules 
that can be used to analyze superfamily characteristics namely Comulator for correlated 
mutation analyses, Mutator for mutation retrieval, and Validator for mutant pathogenicity 
prediction. To be able to determine the characteristics of subsets of proteins and to be able to 
compare the characteristics of different subsets a powerful filtering mechanism is available. 
3DM systems can be used as a central knowledge base for projects in protein engineering, 
DNA diagnostics, and drug design.
 The scientific and technical background of the 3DM platform is described in the 
first two chapters. Chapter 1 describes the scientific background, starting with an overview 
of the foundations of the 3DM platform. Alignment methods and tools for both structure 
and sequence alignments, and the techniques used in the 3DM modules are described in 
detail.  Alternative methods are also described with the advantages and disadvantages of the 
various strategies. Chapter 2 contains a technical description of the implementation of the 
3DM platform and the 3DM modules. A schematic overview of the database used to store 
the data is provided together with a description of the various tables and the steps required 
to create new 3DM systems. The techniques used in the Comulator, Mutator and Validator 
modules of the 3DM platforms are discussed in more detail. 
 Chapter 3 contains a concise overview of the 3DM platform, its capabilities, and 
the results of protein engineering projects using 3DM systems. Thirteen 3DM systems were 
generated for superfamilies such as the PEPM/ICL and Nuclear Receptors. These systems 
are available online for further examination. Protein engineering studies aimed at optimizing 
substrate specificity, enzyme activity, or thermostability were designed targeting proteins 
from these superfamilies. Preliminary results of drug design and DNA diagnostics projects 
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are also included to highlight the diversity of projects 3DM systems can be applied to. 
 Project HOPE: a biomedical tool to predict the effect of a mutation on the 
structure of a protein is described in chapter 4. Project HOPE is developed at the Radboud 
University Nijmegen Medical Center under supervision of H. Venselaar. Project HOPE 
employs webservices to optimally reuse existing databases and computing facilities. After 
selection of a mutant in a protein, data is collected from various sources such as UniProt and 
PISA. A homology model is created to determine features such as contacts and side-chain 
accessibility directly in the structure. Using a decision tree, the available data is evaluated to 
predict the effects of the mutation on the protein. 
 Chapter 5 describes Comulator: the 3DM module for correlated mutation 
analyses. Two positions in an alignment correlate when they co-evolve, that is they mutate 
simultaneously or not at all. Comulator uses a statistical coupling algorithm to calculate 
correlated mutation analyses. Correlated mutations are visualized using heatmaps, or 
directly in protein structures using YASARA. Analyses of correlated mutations in various 
superfamilies showed that positions that correlate are often found in networks and that the 
positions in these networks often share a common function. Using these networks, mutants 
were predicted to increase  the specificity or activity of proteins. Mutational studies confirmed 
that correlated mutation analyses are a valuable tool for rational design of proteins. 
 Mutator, the text mining tool used to incorporate mutations into 3DM systems 
is described in chapter 6. Mutator was designed to automatically retrieve mutations from 
literature and store these mutations in a 3DM system. A PubMed search using keywords 
from the 3DM system is used to preselect articles of interest. These articles are retrieved 
from the internet, converted to text, and parsed for mutations. Mutations are then grounded 
to proteins and stored in a 3DM database. Mutation retrieval was tested on the alpha-
amylase superfamily as this superfamily contains the enzyme involved in Fabry’s disease: 
an x linked lysosomal storage disease. Compared to existing mutant databases, such as the 
HGMD and SwissProt, Mutator retrieved 30% more mutations from literature. A major 
problem in  DNA diagnostics is the differentiation between natural variants and pathogenic 
mutations.To distinguish between pathogenic mutations and natural variation in proteins 
the Validator modules was added to 3DM. Validator uses the data available in a 3DM 
system to predict the pathogenicity of a mutant using, for example, the residue conservation 
of the mutants alignment position, side-chain accessibility of the mutant in the structure, 
and the number of mutations found in literature for the alignment position. Mutator and 
Validator can be used to study mutants found in disorder related genes. Although these tools 
are not the definitive solution for DNA diagnostics they can hopefully be used to increase 
our understanding of the molecular basis of disorders.
 Chapter 7 and 8 describe applied research projects using 3DM systems containg 
proteins of potential commercial interest. A 3DM system for the α/β-beta hydrolases 
superfamily is described in chapter 7. This superfamily consists of almost 20,000 proteins 
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with a diverse range of functions. Superfamily alignments were generated for the common 
beta-barrel fold shared by all superfamily members, and for five distinct subtypes within 
the superfamily. Due to the size and functional diversity of the superfamily, there is a lot 
of potential for industrial application of superfamily members. Chapter 8 describes a study 
focussing on a sucrose phosphorylase enzyme from the α-amylase superfamily. This enzyme 
can be potentially used in an industrial setting for the transfer of glucose to a wide variety 
of molecules. The aim of the study was to increase the stability of the protein at higher 
temperatures. A combination of rational design using a 3DM system, and in-depth study 
of the protein structure, led to a series of mutations that resulted in more then doubling the 
half-life of the protein at 60°C.
 3DM systems have been successfully applied in a wide range of protein engineering 
and DNA diagnostics studies. Currently, 3DM systems are applied most successfully in 
project studying a single protein family or monogenetic disorder. In the future, we hope to 
be able to apply 3DM to more complex scenarios such as enzyme factories and polygenetic 
disorders by combining multiple 3DM systems for interacting proteins.
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Samenvatting
De centrale plaats die eiwitten in veel biologische systemen innemen maakt hen van groot 
belang voor de levenswetenschappen. Eiwitten worden gebruikt in een groot aantal zeer 
diverse toepassingen zoals waterstof productie, opschonen van vervuilde grond, als medicijn, 
voor het diagnosticeren van patiënten, etc. Er is daarom veel onderzoek gedaan om eiwitten 
te karakteriseren en om de functionele en mechanistische eigenschappen beter te kunnen 
begrijpen. Onderzoekers hebben zich onder andere gericht op de opvouwing van eiwitten, 
reactie mechanismen, stress tolerantie, het effect van mutaties, etc. Al dit onderzoek heeft 
geresulteerd in een enorme hoeveelheid beschikbare data die aangeboden wordt door veel 
verschillende partijen en in veel verschillende formaten. Door deze enorme diversiteit is 
het lastig om de data automatisch te verzamelen, te combineren en te gebruiken in nieuwe 
projecten.
 Hoofdonderwerp van dit proefschrift is het 3DM platform dat is ontwikkeld om 
automatisch databases voor eiwit families (Molecular Class Specific Information Systems, 
MCSIS/3DM systems) te kunnen genereren. Deze superfamilie systemen kunnen gebruikt 
worden om data te verzamelen en aan elkaar te koppelen middels op eiwit structuren 
gebaseerde sequentie-alignments. 3DM systemen bevatten onder andere eiwit, structuur, 
mutatie, reactie, conservering, correlatie, contact en vele andere soorten data. Al deze data 
wordt automatisch opgehaald, geconverteerd, aan elkaar gelinked en in een 3DM database 
opgeslagen. De data in een 3DM system wordt gevisualiseerd middels webpagina’s, maar kan 
ook direct in eiwit structuren of artikelen getoond worden middels plugins voor YASARA 
en Utopia Documents. 3DM systemen bevatten een aantal tools zoals gecorreleerde mutatie 
analyses die gebruikt kunnen worden om de eigenschappen van de gehele familie of 
individuele positites en residuen te bestuderen. Om de eigenschappen van groepen eiwitten 
binnen de families te kunnen bestuderen en om groepen eiwitten met elkaar te kunnen 
vergelijken beschikt 3DM over de mogelijkheid om dynamische subsets aan te maken. 
Deze subsets bestaan uit een deel van de eiwitten in het systeem en kunnen op een aantal 
verschillende manieren gedefinieerd worden zoals op basis van de aanwezigheid van residuen 
op bepaalde posities, soort organisme, annotatie in structuur files, etc. 3DM systemen 
zijn daarom uitstekend geschikt om gebruikt te worden als centrale database voor protein 
engineering, DNA diagnostiek en drug design projecten.
 De wetenschappelijke en technische achtergrond van het 3DM platform wordt 
beschreven in de eerste twee hoofdstukken. Hoofdstuk 1 beschrijft de wetenschappelijke 
achtergrond, beginnend met een overzicht van de basis principes van 3DM en daarna  volgen 
beschrijvingen van hoofdmodules van het 3DM platform. De basis van elk 3DM systeem 
zijn de op structuren gebaseerde sequentie-alignments. Verschillende alignment methodes 
voor zowel structuur- als sequentie-alignments worden beschreven in combinatie met hun 
toepassingen en voor- en nadelen. Het 3DM platform bevat modules voor gecorreleerde 
mutatie analyses, mutatie extractie uit de wetenschappelijke literatuur en een pathogeniciteits 
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voorspeller voor onbekende varianten in genen die aan menselijke ziektes gekoppeld zijn. 
De achtergrond van gecorreleerde mutaties wordt behandeld aan de hand van verschillende 
implementaties. Problemen bij het automatisch verzamelen en opslaan van mutaties uit de 
literatuur worden behandeld. Hoofdstuk 2 beschrijft de architectuur van het 3DM platform 
vanuit een technisch perspectief. De 3DM database wordt beschreven aan de hand van een 
schematisch overzicht en een beschrijving van de inhoud van de belangrijkste tabellen. De 
benodigde stappen om een 3DM systeem op te zetten voor een superfamilie worden een voor 
een beschreven. 3DM modules voor gecorreleerde mutatie analyses (Comulator), mutatie 
extractie uit wetenschappelijke literatuur (Mutator) en het bepalen van de pathogeniciteit 
van mutanten (Validator) worden uitgebreid beschreven.
 Hoofdstuk 3 bevat een beknopt overzicht van het 3DM platform, de verschillende 
modules binnen het platform en de resultaten van projecten gericht op het verbeteren van 
eiwitten. Dertien 3DM systemen zijn gegenereerd waaronder de PEPM/ICL en Nuclear 
Receptor superfamilies. Deze systemen zijn online beschikbaar en publiek toegankelijk voor 
vervolgonderzoek. Verschillende protein engineering studies zijn ondernomen aan de hand 
van deze 3DM systemen en zijn gericht op de optimalisatie van substraat specificiteit, het 
verhogen van enzym activiteit en het verbeteren van de stabiliteit bij hogere temperaturen.
 Project HOPE, een tool voor het voorspellen van de effecten van een mutatie 
in een menselijk gen op de 3D structuur van het eiwit, wordt beschreven in hoofdstuk 
4. Project HOPE wordt ontwikkeld aan de Radboud Universteit Nijmegen, Medical 
Center, onder supervisie van H. Venselaar. Een van de hoofddoelen van Project HOPE 
was het zoveel mogelijk hergebruiken van bestaande faciliteiten en databases middels het 
gebruik van webservices. Webservices maken het onder andere mogelijk om middels een 
gestandaardiseerde methode data op te halen en analyses elders uit te laten voeren. Dit 
vermindert de noodzaak voor krachtige lokale machines en databases. Na selectie van een 
mutant wordt data uit een aantal bronnen zoals UniProt en PISA verzameld. Een homology 
model wordt gegenereerd om de eigenschappen van residuen in de structuur te kunnen 
beoordelen. Effecten van de mutant op de structuur en op de functie van het eiwit worden 
beoordeeld met behulp van een beslissingsboom. Het resultaat is een overzichtelijk rapport 
waarin de effecten van de mutant worden beschreven. 
  Hoofdstuk 5 beschrijft Comulator: de 3DM module voor gecorreleerde mutatie 
analyse. Twee posities in een alignment correleren als deze ofwel allebei veranderen, oftewel 
geen van beide. Comulator berekent de correlatie tussen alignment posities binnen 3DM 
aan de hand van een statistical coupling algoritme. Statistical coupling is een techniek die 
frequentie van amino zuren op alignment posities analyseert en met elkaar vergelijkt om een 
gecorreleerde mutatie analyses score (CMA score) te berekenen. Correlaties worden in 3DM 
gevisualiseerd door middel van heatmaps en grafieken en kunnen in een eiwitstructuur 
getoond worden middels een plugin voor YASARA. Analyse van gecorreleerde mutaties 
in verschillende superfamilies toont aan dat sterk correlerende posities vaak in netwerken 
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voorkomen en dat de posities binnen deze netwerken vaak een gezamenlijke functie of 
eigenschap verzorgen. Aan de hand van deze karakteristieken zijn verschillende mutanten 
voorspeld om de specificiteit en activiteit van eiwitten te veranderen. Deze mutatiestudies 
bevestigen de voorspelde functies van de posities en tonen het nut van gecorreleerde mutaties 
aan voor rationeel eiwit design.
  Mutator, de 3DM module voor text mining die gebruikt wordt om mutaties uit de 
wetenschappelijke literatuur te extraheren en in 3DM systemen op te slaan wordt besproken 
in hoofdstuk 6. Potentieel interessante artikelen worden geselecteerd via zoekqueries in 
PubMed. Deze artikelen worden gedownload, omgezet naar platte tekst en doorzocht op 
mutaties. De mutaties worden vervolgens gelinked aan eiwitten in een proces dat grounding 
wordt genoemd en opgeslagen in een 3DM database. Mutator is getest middels een 3DM 
systeem voor de alpha-amylase familie. Deze familie bevat het GLA eiwit waarvan bekend is 
dat mutaties leiden tot de ziekte van Fabry. In vergelijking met bestaande mutant databases 
zoals de HGMD en Swiss-Prot, bleek Mutator in staat om 30% meer mutaties uit de 
literatuur te verzamelen. Een veelvoorkomend probleem bij het voorspellen van de effecten 
van mutaties zijn de vele natuurlijke varianten die in een gen kunnen optreden zonder 
groot effect op de functie van het eiwit. Om pathogene mutanten van natuurlijke variatie 
te kunnen onderscheiden is daarom de Validator module aan 3DM toegevoegd. Validator 
gebruikt superfamilie data uit 3DM systemen om de pathogeniciteit van onbekende 
varianten te voorspellen. Onder andere conserveringsdata, toegankelijkheid van de zijketen 
in de structuur en het aantal mutanten dat voor een positie uit de literatuur is gehaald, 
kunnen gebruikt worden voor pathogeniciteits voorspellingen. Mutator en Validator bieden 
niet de definitieve oplossing voor het karakteriseren van onbekende varianten, maar zij 
kunnen hopelijk gebruikt worden om de moleculaire oorzaak van ziekte in beeld te brengen 
en de kennis over pathogene mutanten te vergroten.
 De hoofdstukken 7 en 8 beschrijven 3DM systemen voor eiwitten met mogelijke 
commerciële en industriële toepassingen. Hoofdstuk 7 beschrijft het alpha-beta hydrolases 
3DM systeem dat bestaat uit ruim 20.000 eiwitten met een grote diversiteit aan functies. Naast 
de structuur alignment voor de beta-barrel die alle eiwitten gemeenschappelijk hebben zijn er 
ook structuur alignments gemaakt voor 4 andere subtypes binnen de hydrolase familie. Elk 
van deze subgroepen heeft een unieke eigen conformatie naast de gezamenlijke beta-barrel. 
Het aantal eiwitten binnen deze superfamilie en de diversiteit aan functies van deze eiwitten 
resulteert in een groot aantal potentiële targets voor eiwit engineering projecten. Verschillende 
vervolgstudies die gebruik hebben gemaakt van het 3DM systeem hebben dit ook aangetoond. 
Tot slot beschrijft hoofdstuk 8 een project gericht op sucrose phosphorylase uit de alpha-
amylase superfamilie. Dit eiwit kan potentieel op industriële schaal gebruikt worden om 
glucose moleculen te koppelen aan diverse andere moleculen. Doel van het onderzoek was 
het verbeteren van de stabiliteit van het eiwit bij temperaturen zoals deze vaak in industriele 
processen gebruikt worden. Middels een combinatie van rationeel eiwit design en structuur 
studies bleek het mogelijk om de halveringstijd van het eiwit op 60°C meer dan te verdubbelen.
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3DM systemen zijn succesvol toegepast in een groot aantal verschillende protein engineering 
en DNA diagnostiek projecten. 3DM systemen zijn uitstekend geschikt gebleken voor 
gebruik in karakterisering en optimalisatie studies voor eiwit families en monogenetische 
ziektes. In de toekomst hopen we 3DM uit te breiden, zodat ook complexere systemen zoals 
enzyme factories en polygenetische ziektes middels geschakelde 3DM systemen onderzocht 
kunnen worden.
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